KR20010014410A - 3-(Substituted phenyl)-4-halopyridazine derivatives, pesticides containing the same as the active ingredient, and intermediates thereof - Google Patents

3-(Substituted phenyl)-4-halopyridazine derivatives, pesticides containing the same as the active ingredient, and intermediates thereof Download PDF

Info

Publication number
KR20010014410A
KR20010014410A KR1019997012591A KR19997012591A KR20010014410A KR 20010014410 A KR20010014410 A KR 20010014410A KR 1019997012591 A KR1019997012591 A KR 1019997012591A KR 19997012591 A KR19997012591 A KR 19997012591A KR 20010014410 A KR20010014410 A KR 20010014410A
Authority
KR
South Korea
Prior art keywords
group
atom
substituted
alkyl
hydrogen atom
Prior art date
Application number
KR1019997012591A
Other languages
Korean (ko)
Inventor
기시다마사시
나쓰메분지
도미다마사유키
이케다오사무
Original Assignee
미우라 아끼라
미쓰비시 가가꾸 가부시키가이샤
치사카 히데오
자이단호진 닛폰쇼쿠부츠쵸세츠자이겐큐쿄카이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 미우라 아끼라, 미쓰비시 가가꾸 가부시키가이샤, 치사카 히데오, 자이단호진 닛폰쇼쿠부츠쵸세츠자이겐큐쿄카이 filed Critical 미우라 아끼라
Publication of KR20010014410A publication Critical patent/KR20010014410A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/581,2-Diazines; Hydrogenated 1,2-diazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/08Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

본 발명은 농약, 특히 제초제로서 유용한 신규한 3-치환된 페닐-4-할로피리다진 유도체를 제공한다.The present invention provides novel 3-substituted phenyl-4-halopyridazine derivatives useful as pesticides, in particular herbicides.

Description

3-치환된 페닐-4-할로피리다진 유도체, 이를 유효 성분으로 하는 농약 및 이의 중간체{3-(Substituted phenyl)-4-halopyridazine derivatives, pesticides containing the same as the active ingredient, and intermediates thereof}3-substituted phenyl-4-halopyridazine derivatives, pesticides containing the same as the active ingredient, and intermediates according to the present invention.

종래부터 중요한 작물, 예를 들면, 보리, 옥수수, 콩, 벼 등의 재배에 있어서 많은 제초제가 사용되고 있다. 요망되는 제초제의 조건으로서는 적은 사용량으로 제초 효과가 높고, 살초(殺草) 스펙트럼이 넓으며, 적절한 잔효성을 가지며, 작물에 대하여 안전성이 충분한 것 등을 들 수 있지만, 기존 제초제의 다수는 이들 조건을 충분히 만족하고 있다고는 말할 수 없는 것이 현재의 상황이다.Conventionally, many herbicides have been used in the cultivation of important crops such as barley, corn, soybeans, and rice. Desired herbicide conditions include high herbicidal effect, low herbicidal spectrum, adequate reactivity, and sufficient safety for crops. It is the present situation that we cannot say that we are satisfied enough.

한편, 3-치환된 페닐-4-할로피리다진류인 4-클로로-3-페닐-6,7-디하이드로-5H-사이클로펜타[c]피리다진이나 4-클로로-3-페닐-5,6,7,8-테트라하이드로신놀린의 합성법에 관해서는 문헌[참고: Tetrahedron Letters, 37, 1351(1996)]에 기재되어 있지만, 당해 문헌에는 4-클로로-3-페닐-6,7-디하이드로-5H-사이클로펜타[c]피리다진이나 4-클로로-3-페닐-5,6,7,8-테트라하이드로신놀린이 제초 활성을 갖는 것에 관해서는 조금도 기재되어 있지 않다. 또한, 피리다진 환이나 신놀린 환의 3위치의 페닐기에 치환기를 갖는 화합물에 관해서도 조금도 기재되어 있지 않다.On the other hand, 4-chloro-3-phenyl-6,7-dihydro-5H-cyclopenta [c] pyridazine or 4-chloro-3-phenyl-5,6 which is 3-substituted phenyl-4-halopyridazines A method for synthesizing, 7,8-tetrahydrocinnoline is described in Tetrahedron Letters, 37, 1351 (1996), but this document describes 4-chloro-3-phenyl-6,7-dihydro. No mention is made of the fact that -5H-cyclopenta [c] pyridazine or 4-chloro-3-phenyl-5,6,7,8-tetrahydrocinnoline has herbicidal activity. In addition, the compound which has a substituent in the phenyl group of the 3-position of a pyridazine ring and a cinnoline ring is not described at all.

또한, 3-치환된 페닐피리다진류의 합성법 및 제초 활성에 관해서는 미국 특허 제5,623,072호 및 제5,616,789호에 기재되어 있다. 그러나, 당해 문헌에서 피리다진 환의 3위치의 페닐기의 치환기는 2위치에 수소원자, 3위치에 할로알킬 등, 4위치에 수소원자, 니트로기 또는 아미노기를 갖는 것을 특징으로 하고 있으며, 피리다진 환의 3위치의 페닐기가 4위치에 할로겐 또는 시아노기를 갖는 화합물의 제초 활성에 관해서는 조금도 기재되어 있지 않다.Synthesis and herbicidal activity of 3-substituted phenylpyridazines are also described in US Pat. Nos. 5,623,072 and 5,616,789. However, in this document, the substituent of the phenyl group at the 3-position of the pyridazine ring is characterized by having a hydrogen atom, a nitro group or an amino group at the 4-position, such as a hydrogen atom at the 2-position, a haloalkyl at the 3-position, and the 3 of the pyridazine ring. The herbicidal activity of the compound having a halogen or cyano group at the 4 position in the phenyl group at the position is not described at all.

본 발명은 신규의 3-치환된 페닐-4-할로피리다진 유도체 및 이를 유효 성분으로 하는 농약, 특히 제초제로서 효과적인 농약을 제공하는 것이다.The present invention provides novel 3-substituted phenyl-4-halopyridazine derivatives and pesticides having the same as active ingredients, particularly pesticides effective as herbicides.

본 발명자 등은 상술한 바와 같은 제초제에 대한 과제를 해결하기 위하여 3-치환된 페닐-4-할로피리다진 유도체의 합성과 이의 제초 활성에 관해서 예의 검토를 거듭한 결과, 피리다진 환의 3위치의 페닐기의 4위치에 할로겐 또는 시아노기를 갖는 3-치환된 페닐-4-할로피리다진 유도체가 높은 제초 효과를 갖을 뿐만 아니라, 몇가지 중요한 작물에 대하여 충분한 안전성을 나타내는 것을 발견하여 본 발명을 완성시키기에 이르렀다.MEANS TO SOLVE THE PROBLEM The present inventors earnestly examined the synthesis | combination of the 3-substituted phenyl-4-halopyridazine derivatives, and its herbicidal activity in order to solve the problem with the herbicide mentioned above, The phenyl group of the 3-position of a pyridazine ring The 3-substituted phenyl-4-halopyridazine derivative having a halogen or cyano group at position 4 of the present invention not only has high herbicidal effect but also shows sufficient safety against several important crops, thus completing the present invention. .

즉, 본 발명의 요지는 화학식 I의 3-치환된 페닐-4-할로피리다진 유도체 및 이를 유효 성분으로 하는 농약, 특히 제초제에 있다.That is, the gist of the present invention lies in the 3-substituted phenyl-4-halopyridazine derivatives of the formula (I) and pesticides, in particular herbicides, comprising the active ingredient thereof.

위의 화학식 I에서,In Formula I above,

X는 할로겐 원자이고,X is a halogen atom,

Y는 수소원자 또는 할로겐 원자이고,Y is a hydrogen atom or a halogen atom,

Z는 할로겐 원자 또는 시아노기이고,Z is a halogen atom or a cyano group,

n 및 m은 각각 독립적으로 0 또는 1이고,n and m are each independently 0 or 1,

R1은 수소원자, 할로겐 원자, C1-C6의 알킬기 또는 C1-C6의 할로알킬기이고,R 1 is an alkyl group or a haloalkyl group of C 1 -C 6 a hydrogen atom, a halogen atom, a C 1 -C 6,

R2는 수소원자 또는 C1-C6의 알킬기이거나, R1과 함께 -K-L-M-의 환[여기서, K는 CR4R5, CR4R5CR6R7, 산소원자, 황원자 또는 C1-C6의 알킬기로 치환된 질소원자이고, L은 CR8R9, 산소원자, 황원자 또는 C1-C6의 알킬기로 치환된 질소원자이고, M은 CR10R11, 산소원자, 황원자 또는 C1-C6의 알킬기로 치환된 질소원자이고(여기서, 치환기 R4내지 R11은 각각 독립적으로 수소원자 또는 C1-C6의 알킬기이다), 단 K, L 및 M이 동시에 산소원자, 황원자 또는 C1-C6의 알킬기로 치환된 질소원자인 것은 아니다]을 형성하고,R 2 is a hydrogen atom or an alkyl group of C 1 -C 6 , or a ring of -KLM- with R 1 , wherein K is CR 4 R 5 , CR 4 R 5 CR 6 R 7 , oxygen atom, sulfur atom or C 1 A nitrogen atom substituted with an alkyl group of -C 6 , L is CR 8 R 9 , an oxygen atom, a sulfur atom or a nitrogen atom substituted with an alkyl group of C 1 -C 6 , and M is a CR 10 R 11 , an oxygen atom, a sulfur atom or A nitrogen atom substituted with a C 1 -C 6 alkyl group (wherein the substituents R 4 to R 11 are each independently a hydrogen atom or a C 1 -C 6 alkyl group) provided that K, L and M are oxygen atoms at the same time, Not a sulfur atom or a nitrogen atom substituted with a C 1 -C 6 alkyl group;

R3은 수소원자, 니트로기 또는 -QR12{여기서, Q는 산소원자, 황원자, 설피닐기, 설포닐기 또는 -NR13-(여기서, R13은 수소원자, C1-C6의 알킬기, C2-C6의 알케닐기, C2-C6의 알키닐기, C1-C6의 할로알킬기, C2-C6의 할로알케닐기, C2-C6의 알콕시알킬기, C2-C6의 아실기, C1-C6의 알킬설포닐기, C1-C6의 할로알킬설포닐기, C2-C6의 알케닐설포닐기, C2-C6의 알콕시카보닐기, 페닐기 또는 페닐기로 치환된 C1-C3의 알킬기이다)이고, R12는 수소원자, C1-C10의 알킬기, C2-C10의 알케닐기, C2-C10의 알키닐기, C3-C8의 사이클로알킬기, C4-C10의 알킬기로 치환된 사이클로알킬기, C4-C10의 (사이클로알킬)알킬기, C3-C8의 사이클로알케닐기, C1-C10의 할로알킬기, C2-C10의 할로알케닐기, C3-C8의 할로사이클로알킬기, C2-C7의 시아노알킬기, C2-C10의 알콕시알킬기, C2-C10의 알킬티오알킬기, C2-C10의 알킬설포닐알킬기, C2-C6의 아실기, C3-C6의 옥소알킬기, C1-C6의 알킬설포닐기, C1-C6의 할로알킬설포닐기, C2-C6의 알케닐설포닐기, 페닐기, 페닐기로 치환된 C1-C3의 알킬기, 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자, 황원자 및/또는 질소원자를 함유한다), 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자, 황원자 및/또는 질소원자를 함유한다)로 치환된 C1-C3의 알킬기, 화학식(II)의 기 또는 화학식(III)의 기[여기서, R14는 수소원자 또는 C1-C4의 알킬기이고, W는 산소원자, 황원자 또는 -NR16-(여기서, R16은 수소원자 또는 C1-C4의 알킬기이다)이고, R15는 수소원자, C1-C6의 알킬기, C2-C6의 알케닐기, C2-C6의 알키닐기, C3-C6의 사이클로알킬기, C4-C10의 알킬기로 치환된 사이클로알킬기, C3-C6의 사이클로알케닐기, C1-C6의 할로알킬기, C2-C6의 할로알케닐기, C3-C6의 할로사이클로알킬기, C2-C5의 시아노알킬기, C2-C6의 알콕시알킬기, C2-C6의 알킬티오알킬기, C2-C6의 알킬설포닐알킬기, C3-C6의 옥소알킬기, C3-C7의 아실옥시알킬기, C3-C7의 알콕시카보닐알킬기, 페닐기, 페닐기로 치환된 C1-C3의 알킬기, 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자, 황원자 및/또는 질소원자를 함유한다) 또는 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자, 황원자 및/또는 질소원자를 함유한다)로 치환된 C1-C3의 알킬기이고, 또한 R15는, W가 -NR16-을 나타내는 경우, W와 함께 1 또는 2개의 질소원자 및/또는 0 또는 1개의 산소원자를 함유하는 5원 또는 6원의 복소환기를 형성할 수 있다]이고, R12, R13또는 R15가 페닐기, 페닐기로 치환된 C1-C3의 알킬기, 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자, 황원자 및/또는 질소원자를 함유한다) 또는 3원 내지 6원 환의 복소환기(당해 환은 1 또는 2개의 산소원자, 황원자 및/또는 질소원자를 함유한다)로 치환된 C1-C3의 알킬기인 경우, 당해 페닐기 및 복소환기는 1 내지 3개의 동일하거나 상이한 할로겐 원자, C1-C4의 알킬기, 트리플루오로메틸기, C1-C4의 알콕시기, C2-C5의 아실옥시기, C1-C4의 알킬티오기, C1-C4의 알킬설포닐기, 니트로기, 시아노기 또는 C2-C5의 알콕시카보닐기로 치환될 수 있다}이다.R 3 is a hydrogen atom, a nitro group or -QR 12 {where Q is an oxygen atom, a sulfur atom, a sulfinyl group, a sulfonyl group or -NR 13- (wherein R 13 is a hydrogen atom, an alkyl group of C 1 -C 6 , C 2 -C 6 alkenyl group, a halo-alkenyl group, an alkoxyalkyl group of C 2 -C 6 C 2 -C 6 alkynyl group, C 1 -C 6 haloalkyl group, C 2 -C 6 of, C 2 -C 6 of an acyl group, a alkoxycarbonyl group, phenyl group or phenyl C 1 -C 6 alkylsulfonyl group, a halo-C 1 -C 6 alkylsulfonyl group, C 2 -C 6 alkenyl sulfonyl group, C 2 -C 6 of the alkyl group substituted by a C 1 -C 3), and, R 12 is an alkynyl group of a hydrogen atom, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 of, C 3 -C 8 a cycloalkyl group, a cycloalkyl group of C 4, C 4 -C 10 a (cycloalkyl) alkyl group, a cyclo alkenyl group of C 3 -C 8, C 1 -C 10 alkyl group substituted with -C 10 haloalkyl group, C 2 -C 10 haloalkenyl group, C 3 -C 8 halocycloalkyl group, C 2 -C 7 cyano Alkyl group, C 2 -C 10 alkoxyalkyl group, C 2 -C 10 alkylthioalkyl group, C 2 -C 10 alkylsulfonylalkyl group, C 2 -C 6 acyl group, C 3 -C 6 oxoalkyl group, C 1 -C 6 alkylsulfonyl group, C 1 -C 6 haloalkylsulfonyl group, C 2 -C 6 alkenylsulfonyl group, phenyl group, C 1 -C 3 alkyl group substituted with phenyl group, 3- to 6 Heterocyclic groups of a member (wherein the ring contains one or two oxygen atoms, sulfur atoms and / or nitrogen atoms), three to six membered heterocyclic groups (wherein the rings contain one or two oxygen atoms, sulfur atoms and / or nitrogen atoms) C 1 -C 3 alkyl group substituted with Group or formula of (II) Group of (III), wherein R 14 is a hydrogen atom or an alkyl group of C 1 -C 4 , W is an oxygen atom, a sulfur atom or -NR 16- , wherein R 16 is a hydrogen atom or an alkyl group of C 1 -C 4 a), and, R 15 is a hydrogen atom, an alkynyl group, a cycloalkyl group of C 3 -C 6 of the C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 of, C 4 -C 10 A cycloalkyl group substituted with an alkyl group of C, a cycloalkenyl group of C 3 -C 6 , a haloalkyl group of C 1 -C 6 , a haloalkenyl group of C 2 -C 6 , a halocycloalkyl group of C 3 -C 6 , C 2- C 5 cyanoalkyl group, C 2 -C 6 alkoxyalkyl group, C 2 -C 6 alkylthioalkyl group, C 2 -C 6 alkylsulfonylalkyl group, C 3 -C 6 oxoalkyl group, C 3 -C 7 acyloxyalkyl group, C 3 -C 7 alkoxycarbonylalkyl group, phenyl group, C 1 -C 3 alkyl group substituted with phenyl group, 3- to 6-membered heterocyclic group (the ring is 1 or 2 oxygen atoms, sulfur atom And / or contains nitrogen atoms) or from 3 to An alkyl group of C 1 -C 3 substituted with a six-membered heterocyclic group (wherein the ring contains one or two oxygen atoms, sulfur atoms and / or nitrogen atoms), and R 15 represents that W represents -NR 16- Can form a 5 or 6 membered heterocyclic group containing 1 or 2 nitrogen atoms and / or 0 or 1 oxygen atom together with W], and R 12 , R 13 or R 15 is a phenyl group, A C 1 -C 3 alkyl group substituted with a phenyl group, a 3- to 6-membered heterocyclic group (the ring contains one or two oxygen atoms, sulfur and / or nitrogen atoms) or a 3- to 6-membered heterocyclic group ( When the ring is a C 1 -C 3 alkyl group substituted with 1 or 2 oxygen atoms, sulfur atoms and / or nitrogen atoms), the phenyl group and heterocyclic group are 1 to 3 identical or different halogen atoms, C 1 -C group with an alkyl group, a trifluoromethyl 4, an alkoxy group, an acyloxy group of C 2 -C 5 in the C 1 -C 4, C 1 -C 4 Alkylthio group, the alkoxycarbonyl may be substituted}, of C 1 -C 4 alkylsulfonyl group, a nitro group, a cyano group or a C 2 -C 5.

하기에 본 발명을 더욱 상세히 설명한다.The present invention is explained in more detail below.

본 발명에 있어서 제초제로서 사용되는 3-치환된 페닐-4-할로피리다진 유도체는 상기 화학식 I의 화합물이다.The 3-substituted phenyl-4-halopyridazine derivatives used as herbicides in the present invention are compounds of formula (I) above.

상기 화학식 I에 있어서,In Chemical Formula I,

X로서는 불소원자, 염소원자, 브롬원자 또는 요오드 원자 등의 할로겐 원자를 들 수 있으며, 이 중에서 염소원자가 바람직하다.As X, halogen atoms, such as a fluorine atom, a chlorine atom, a bromine atom, or an iodine atom, are mentioned, Among these, a chlorine atom is preferable.

Y로서는 수소원자; 불소원자, 염소원자, 브롬원자 또는 요오드 원자 등의 할로겐 원자를 들 수 있으며, 이 중에서 염소원자 또는 불소원자가 바람직하며, 특히 불소원자가 바람직하다.Y is a hydrogen atom; Halogen atoms, such as a fluorine atom, a chlorine atom, a bromine atom, or an iodine atom, are mentioned, Among these, a chlorine atom or a fluorine atom is preferable, and a fluorine atom is especially preferable.

Z로서는 불소원자, 염소원자, 브롬원자 또는 요오드 원자 등의 할로겐 원자; 또는 시아노기를 들 수 있으며, 이 중에서 염소원자가 바람직하다.As Z, halogen atoms, such as a fluorine atom, a chlorine atom, a bromine atom, or an iodine atom; Or cyano groups, of which chlorine atoms are preferred.

n 및 m은 각각 독립적으로 0 또는 1이고, 바람직하게는 m=0이고, 특히 바람직하게는 n=0인 동시에 m=0이다.n and m are each independently 0 or 1, preferably m = 0, particularly preferably n = 0 and m = 0.

R1으로서는 수소원자; 불소원자, 염소원자, 브롬원자, 또는 요오드 원자 등의 할로겐 원자; 메틸기, 에틸기, 프로필기, 이소프로필기, 부틸기, 이소부틸기, 2급-부틸기, 3급-부틸기, 펜틸기, 이소펜틸기, 네오펜틸기, 3급-펜틸기, 1-메틸부틸기, 2-메틸부틸기, 1-에틸프로필기, 1,2-디메틸프로필기, 1,3-디메틸프로필기, 헥실기, 이소헥실기, 1-메틸펜틸기, 2-메틸펜틸기, 3-메틸펜틸기, 1,1-디메틸부틸기, 1,2-디메틸부틸기, 1,3-디메틸부틸기, 3,3-디메틸부틸기, 1-에틸부틸기, 2-에틸부틸기, 1,1,2-트리메틸프로필기, 1-에틸-1-메틸프로필기, 1-에틸-2-메틸프로필기 등의 C1-C6의 알킬기;As R 1 , a hydrogen atom; Halogen atoms such as fluorine atom, chlorine atom, bromine atom or iodine atom; Methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, secondary-butyl group, tert-butyl group, pentyl group, isopentyl group, neopentyl group, tert-pentyl group, 1-methyl Butyl group, 2-methylbutyl group, 1-ethylpropyl group, 1,2-dimethylpropyl group, 1,3-dimethylpropyl group, hexyl group, isohexyl group, 1-methylpentyl group, 2-methylpentyl group, 3-methylpentyl group, 1,1-dimethylbutyl group, 1,2-dimethylbutyl group, 1,3-dimethylbutyl group, 3,3-dimethylbutyl group, 1-ethylbutyl group, 2-ethylbutyl group, Alkyl groups of C 1 -C 6 such as 1,1,2-trimethylpropyl group, 1-ethyl-1-methylpropyl group and 1-ethyl-2-methylpropyl group;

플루오로메틸기, 클로로메틸기, 브로모메틸기, 디플루오로메틸기, 트리플루오로메틸기, 2-플루오로에틸기, 2-클로로에틸기, 2-브로모에틸기, 2,2,2-트리플루오로에틸기, 1,1,2,2,2-펜타플루오로에틸기, 2-플루오로프로필기, 2-클로로프로필기, 2-브로모프로필기, 3-플루오로프로필기, 3-클로로프로필기, 3-브로모프로필기, 2,2,3,3,3-펜타플루오로프로필기, 1,1,2,2,3,3,3-헵타플루오로프로필기, 2,2,2-트리플루오로-1-메틸에틸기, 4-플루오로부틸기, 4-클로로부틸기, 4-브로모부틸기, 2,2,3,3,4,4,4-헵타플루오로부틸기 등의 C1-C6의 할로알킬기를 들 수 있으며, 이 중에서 바람직하게는 수소원자, 알킬기 또는 할로알킬기이다.Fluoromethyl group, chloromethyl group, bromomethyl group, difluoromethyl group, trifluoromethyl group, 2-fluoroethyl group, 2-chloroethyl group, 2-bromoethyl group, 2,2,2-trifluoroethyl group, 1 , 1,2,2,2-pentafluoroethyl group, 2-fluoropropyl group, 2-chloropropyl group, 2-bromopropyl group, 3-fluoropropyl group, 3-chloropropyl group, 3-bro Mother profile, 2,2,3,3,3-pentafluoropropyl group, 1,1,2,2,3,3,3-heptafluoropropyl group, 2,2,2-trifluoro- C 1 -C such as 1-methylethyl group, 4-fluorobutyl group, 4-chlorobutyl group, 4-bromobutyl group, 2,2,3,3,4,4,4-heptafluorobutyl group The haloalkyl group of 6 is mentioned, Among these, Preferably, they are a hydrogen atom, an alkyl group, or a haloalkyl group.

R2로서는 수소원자; 메틸기, 에틸기, 프로필기, 이소프로필기, 부틸기, 이소부틸기, 2급-부틸기, 3급-부틸기, 펜틸기, 이소펜틸기, 네오펜틸기, 3급-펜틸기, 1-메틸부틸기, 2-메틸부틸기, 1-에틸프로필기, 1,2-디메틸프로필기, 1,3-디메틸프로필기, 헥실기, 이소헥실기, 1-메틸펜틸기, 2-메틸펜틸기, 3-메틸펜틸기, 1,1-디메틸부틸기, 1,2-디메틸부틸기, 1,3-디메틸부틸기, 3,3-디메틸부틸기, 1-에틸부틸기, 2-에틸부틸기, 1,1,2-트리메틸프로필기, 1-에틸-1-메틸프로필기, 1-에틸-2-메틸프로필기 등의 C1-C6의 알킬기를 들 수 있다.As R 2, a hydrogen atom; Methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, secondary-butyl group, tert-butyl group, pentyl group, isopentyl group, neopentyl group, tert-pentyl group, 1-methyl Butyl group, 2-methylbutyl group, 1-ethylpropyl group, 1,2-dimethylpropyl group, 1,3-dimethylpropyl group, hexyl group, isohexyl group, 1-methylpentyl group, 2-methylpentyl group, 3-methylpentyl group, 1,1-dimethylbutyl group, 1,2-dimethylbutyl group, 1,3-dimethylbutyl group, 3,3-dimethylbutyl group, 1-ethylbutyl group, 2-ethylbutyl group, 1,1,2-trimethyl propyl group, there may be mentioned an alkyl group of C 1 -C 6, such as 1-ethyl-1-methylpropyl group, 1-ethyl-2-methylpropyl group.

또한, R1과 R2가 결합하여 -K-L-M-의 환을 형성할 수 있다. 여기서, K는 CR4R5또는 CR4R5CR6R7의 기; 산소원자; 황원자; 또는 메틸기, 에틸기, 프로필기, 이소프로필기 등의 C1-C6의 알킬기로 치환된 질소원자이고, L은 CR8R9의 기; 산소원자; 황원자; 또는 메틸기, 에틸기, 프로필기, 이소프로필기 등의 C1-C6의 알킬기로 치환된 질소원자이고, M은 CR10R11의 기; 산소원자; 황원자; 또는 메틸기, 에틸기, 프로필기, 이소프로필기 등의 C1-C6의 알킬기로 치환된 질소원자이다.In addition, R 1 and R 2 may be bonded to each other to form a ring of -KLM-. Wherein K is a group of CR 4 R 5 or CR 4 R 5 CR 6 R 7 ; Oxygen atom; Sulfur atom; Or a nitrogen atom substituted with a C 1 -C 6 alkyl group such as a methyl group, an ethyl group, a propyl group, or an isopropyl group, and L is a group of CR 8 R 9 ; Oxygen atom; Sulfur atom; Or a nitrogen atom substituted with a C 1 -C 6 alkyl group such as a methyl group, an ethyl group, a propyl group, or an isopropyl group, and M is a group of CR 10 R 11 ; Oxygen atom; Sulfur atom; Or a nitrogen atom substituted with a C 1 -C 6 alkyl group such as methyl group, ethyl group, propyl group, and isopropyl group.

상기 치환기 R4내지 R11로서는 각각 독립적으로 수소원자; 메틸기, 에틸기, 프로필기, 이소프로필기, 부틸기, 이소부틸기, 2급-부틸기, 3급-부틸기, 펜틸기, 이소펜틸기, 네오펜틸기, 3급-펜틸기, 1-메틸부틸기, 2-메틸부틸기, 1-에틸프로필기, 1,2-디메틸프로필기, 1,3-디메틸프로필기, 헥실기, 이소헥실기, 1-메틸펜틸기, 2-메틸펜틸기, 3-메틸펜틸기, 1,1-디메틸부틸기, 1,2-디메틸부틸기, 1,3-디메틸부틸기, 3,3-디메틸부틸기, 1-에틸부틸기, 2-에틸부틸기, 1,1,2-트리메틸프로필기, 1-에틸-1-메틸프로필기, 1-에틸-2-메틸프로필기 등의 C1-C6의 알킬기 등을 들 수 있다.The substituents R 4 to R 11 are each independently a hydrogen atom; Methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, secondary-butyl group, tert-butyl group, pentyl group, isopentyl group, neopentyl group, tert-pentyl group, 1-methyl Butyl group, 2-methylbutyl group, 1-ethylpropyl group, 1,2-dimethylpropyl group, 1,3-dimethylpropyl group, hexyl group, isohexyl group, 1-methylpentyl group, 2-methylpentyl group, 3-methylpentyl group, 1,1-dimethylbutyl group, 1,2-dimethylbutyl group, 1,3-dimethylbutyl group, 3,3-dimethylbutyl group, 1-ethylbutyl group, 2-ethylbutyl group, 1,1,2-trimethyl-propyl, and 1-ethyl-1-methylpropyl group, 1-ethyl-2-methylpropyl group alkyl of C 1 -C 6, such as.

R1과 R2가 결합하여 -K-L-M-의 환을 형성하는 경우, 바람직하게는 K가 CR4R5또는 CR4R5CR6R7의 기; 또는 산소원자이고, L이 CR8R9의 기 또는 산소원자이고, M이 CR10R11의 기 또는 산소원자인 경우이고, 특히 바람직하게는 K가 CR4R5또는 CR4R5CR6R7의 기이고, L이 CR8R9의 기이고, M이 CR10R11의 기인 환(環) 원수 5 또는 6의 탄화수소기를 형성하고 있는 경우이고, 더욱 바람직하게는 K, L 및 M이 각각 메틸렌기인 경우이다.When R 1 and R 2 combine to form a ring of -KLM-, K is preferably a group of CR 4 R 5 or CR 4 R 5 CR 6 R 7 ; Or an oxygen atom, L is a group of CR 8 R 9 or an oxygen atom, M is a group of CR 10 R 11 or an oxygen atom, particularly preferably K is CR 4 R 5 or CR 4 R 5 CR 6 It is a group of R <7> , L is group of CR <8> R <9> , M is the case of forming the hydrocarbon group of 5 or 6 ring members which is CR <10> R <11> , More preferably, it is K, L, and M Each of these is a methylene group.

R3는 수소원자, 니트로기 또는 -QR12의 기이다.R 3 is a hydrogen atom, a nitro group or a group of —QR 12 .

-QR12에서 Q는 산소원자, 황원자, 설피닐기, 설포닐기 또는 -NR13-의 기이고, 산소원자 또는 -NR13-의 기가 바람직하며, 특히 산소원자가 바람직하다.Q in -QR 12 is an oxygen atom, a sulfur atom, a sulfinyl group, a sulfonyl group or a group of -NR 13- , an oxygen atom or a group of -NR 13 -is preferable, and an oxygen atom is particularly preferable.

-NR13-에서 R13으로서는 수소원자; 메틸기, 에틸기, 프로필기, 이소프로필기, 부틸기, 이소부틸기, 2급-부틸기, 3급-부틸기, 펜틸기, 이소펜틸기, 네오펜틸기, 3급-펜틸기, 1-메틸부틸기, 2-메틸부틸기, 1-에틸프로필기, 1,2-디메틸프로필기, 1,3-디메틸프로필기, 헥실기, 이소헥실기, 1-메틸펜틸기, 2-메틸펜틸기, 3-메틸펜틸기, 1,1-디메틸부틸기, 1,2-디메틸부틸기, 1,3-디메틸부틸기, 3.8-디메틸부틸기, 1-에틸부틸기, 2-에틸부틸기, 1,1,2-트리메틸프로필기, 1-에틸-1-메틸프로필기, 1-에틸-2-메틸프로필기 등의 C1-C6의 알킬기;R 13 in —NR 13 — is a hydrogen atom; Methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, secondary-butyl group, tert-butyl group, pentyl group, isopentyl group, neopentyl group, tert-pentyl group, 1-methyl Butyl group, 2-methylbutyl group, 1-ethylpropyl group, 1,2-dimethylpropyl group, 1,3-dimethylpropyl group, hexyl group, isohexyl group, 1-methylpentyl group, 2-methylpentyl group, 3-methylpentyl group, 1,1-dimethylbutyl group, 1,2-dimethylbutyl group, 1,3-dimethylbutyl group, 3.8-dimethylbutyl group, 1-ethylbutyl group, 2-ethylbutyl group, 1, Alkyl groups of C 1 -C 6 such as 1,2-trimethylpropyl group, 1-ethyl-1-methylpropyl group, and 1-ethyl-2-methylpropyl group;

비닐기, 알릴기, 1-프로페닐기, 이소프로페닐기, 1-부테닐기, 2-부테닐기, 3-부테닐기, 1-메틸알릴기, 2-메틸알릴기, 1-펜테닐기, 2-펜테닐기, 3-펜테닐기, 4-펜테닐기, 1-메틸-2-부테닐기, 1-메틸-3-부테닐기, 2-메틸-3-부테닐기, 3-메틸-2-부테닐기, 3-메틸-3-부테닐기, 1,1-디메틸알릴기, 1-에틸알릴기, 1-헥세닐기, 2-헥세닐기, 3-헥세닐기, 4-헥세닐기, 5-헥세닐기, 4-메틸-3-펜테닐기, 1-프로필알릴기, 1-에틸-1-메틸알릴기 등의 C2-C6의 알케닐기;Vinyl, allyl, 1-propenyl, isopropenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methylallyl, 2-methylallyl, 1-pentenyl, 2-pente Neyl group, 3-pentenyl group, 4-pentenyl group, 1-methyl-2-butenyl group, 1-methyl-3-butenyl group, 2-methyl-3-butenyl group, 3-methyl-2-butenyl group, 3- Methyl-3-butenyl, 1,1-dimethylallyl, 1-ethylallyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl C 2 -C 6 alkenyl groups such as 4-methyl-3-pentenyl, 1-propylallyl, and 1-ethyl-1-methylallyl;

에티닐기, 1-프로피닐기, 2-프로피닐기, 1-부티닐기, 2-부티닐기, 3-부티닐기, 1-메틸-2-프로피닐기, 1-펜티닐기, 2-펜티닐기, 3-펜티닐기, 4-펜티닐기, 1-메틸-3-부티닐기, 1,1-디메틸-2-프로피닐기, 1-헥시닐기, 2-헥시닐기, 3-헥시닐기, 4-헥시닐기, 5-헥시닐기 등의 C2-C6의 알키닐기;Ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl, 3-pentyn Neyl group, 4-pentynyl group, 1-methyl-3-butynyl group, 1,1-dimethyl-2-propynyl group, 1-hexynyl group, 2-hexynyl group, 3-hexynyl group, 4-hexynyl group, 5-hexyl alkynyl of C 2 -C 6 such as a group;

플루오로메틸기, 클로로메틸기, 브로모메틸기, 디플루오로메틸기, 트리플루오로메틸기, 2-플루오로에틸기, 2-클로로에틸기, 2-브로모에틸기, 2,2,2-트리플루오로에틸기, 1,1,2,2,2-펜타플루오로에틸기, 2-플루오로프로필기, 2-클로로프로필기, 2-브로모프로필기, 3-플루오로프로필기, 3-클로로프로필기, 3-브로모프로필기, 2,2,3,3,8-펜타플루오로프로필기, 1,1,2,2,3,3,3-헵타플루오로프로필기, 2,2,2-트리플루오로-1-메틸에틸기, 4-플루오로부틸기, 4-클로로부틸기, 4-브로모부틸기, 2,2,3,3,4,4,4,-헵타플루오로부틸기 등의 C1-C6의 할로알킬기;Fluoromethyl group, chloromethyl group, bromomethyl group, difluoromethyl group, trifluoromethyl group, 2-fluoroethyl group, 2-chloroethyl group, 2-bromoethyl group, 2,2,2-trifluoroethyl group, 1 , 1,2,2,2-pentafluoroethyl group, 2-fluoropropyl group, 2-chloropropyl group, 2-bromopropyl group, 3-fluoropropyl group, 3-chloropropyl group, 3-bro Mother profile, 2,2,3,3,8-pentafluoropropyl group, 1,1,2,2,3,3,3-heptafluoropropyl group, 2,2,2-trifluoro- 1-methyl-ethyl group, a butyl group 4-fluoro, 4-chlorobutyl group, 4-bromo-butyl group, 2,2,3,3,4,4,4-heptafluoropropane, such as a butyl group C 1 - Haloalkyl group of C 6 ;

3,3-디클로로알릴기 등의 C2-C6의 할로알케닐기;Haloalkenyl groups such as C 2 -C 6 such as 3,3-dichloroallyl group;

메톡시메틸기, 에톡시메틸기, 프로폭시메틸기, 이소프로폭시메틸기, 부톡시메틸기, 2-메톡시에틸기, 2-에톡시에틸기, 2-프로폭시에틸기, 2-이소프로폭시에틸기, 2-부톡시에틸기, 3-메톡시프로필기, 4-메톡시부틸기, 5-메톡시펜틸기 등의 C2-C6의 알콕시알킬기;Methoxymethyl group, ethoxymethyl group, propoxymethyl group, isopropoxymethyl group, butoxymethyl group, 2-methoxyethyl group, 2-ethoxyethyl group, 2-propoxyethyl group, 2-isopropoxyethyl group, 2-butoxy C 2 -C 6 alkoxyalkyl groups such as ethyl group, 3-methoxypropyl group, 4-methoxybutyl group and 5-methoxypentyl group;

아세틸기, 프로피오닐기, 부티릴기, 이소부티릴기, 발레릴기, 이소발레릴기, 2-메틸부티릴기, 헥사노일기, 2,2-디메틸부티릴기, 2-에틸부티릴기, 2-메틸발레릴기, 3-메틸발레릴기, 4-메틸발레릴기 등의 C2-C6의 아실기;Acetyl, propionyl, butyryl, isobutyryl, valeryl, isovaleryl, 2-methylbutyryl, hexanoyl, 2,2-dimethylbutyryl, 2-ethylbutyryl, 2-methylvalrylyl, Acyl groups of C 2 -C 6 such as 3-methyl valeryl group and 4-methyl valeryl group;

메틸설포닐기, 에틸설포닐기, 프로필설포닐기, 이소프로필설포닐기, 부틸설포닐기, 펜틸설포닐기, 헥실설포닐기 등의 C1-C6의 알킬설포닐기;Methyl sulfonyl group, ethyl sulfonyl, propyl sulfonyl, isopropyl sulfonyl, butyl sulfonyl, pentyl sulfonyl, alkylsulfonyl of hexyl sulfonyl group such as a C 1 -C 6 group;

트리플루오로메틸설포닐기 등의 C1-C6의 할로알킬설포닐기;C 1 -C 6 haloalkylsulfonyl groups such as trifluoromethylsulfonyl group;

비닐설포닐기, 알릴설포닐기 등의 C2-C6의 알케닐설포닐기;Alkenyl sulfonyl group of the vinyl sulfonyl group, allyl sulfonyl group, such as C 2 -C 6;

메톡시카보닐기, 에톡시카보닐기, 프로필옥시카보닐기, 이소프로필카보닐기, 부톡시카보닐기, 펜틸옥시카보닐기 등의 C2-C6의 알콕시카보닐기;C 2 -C 6 alkoxycarbonyl groups such as methoxycarbonyl group, ethoxycarbonyl group, propyloxycarbonyl group, isopropylcarbonyl group, butoxycarbonyl group and pentyloxycarbonyl group;

페닐기, 4-클로로페닐기, 3-클로로페닐기, 2-클로로페닐기 등의 페닐기;Phenyl groups such as phenyl group, 4-chlorophenyl group, 3-chlorophenyl group and 2-chlorophenyl group;

또는 벤질기, 펜에틸기 등의 페닐기로 치환된 C1-C6의 알킬기를 들 수 있으며,Or a C 1 -C 6 alkyl group substituted with a phenyl group such as a benzyl group or a phenethyl group,

바람직하게는 수소원자, C2-C6의 아실기, C1-C6의 알킬설포닐기 또는 C2-C6의 알콕시카보닐기이고, 특히 바람직하게는 수소원자, C1-C6의 알킬설포닐기 또는 C2-C6의 알콕시카보닐기이다.Preferably a hydrogen atom, a C 2 -C 6 acyl group, an alkoxycarbonyl group of C 1 -C 6 alkylsulfonyl group or a C 2 -C 6, particularly preferably an alkyl hydrogen atom, C 1 -C 6 Sulfonyl group or C 2 -C 6 alkoxycarbonyl group.

-QR12에 있어서, R12로서는 수소원자; 메틸기, 에틸기, 프로필기, 이소프로필기, 부틸기, 이소부틸기, 2급-부틸기, 3급-부틸기, 펜틸기, 이소펜틸기, 네오펜틸기, 3급-펜틸기, 1-메틸부틸기, 2-메틸부틸기, 1-에틸프로필기, 1,2-디메틸프로필기, 1,3-디메틸프로필기, 헥실기, 이소헥실기, 1-메틸펜틸기, 2-메틸펜틸기, 3-메틸펜틸기, 1,1-디메틸부틸기, 1,2-디메틸부틸기, 1,3-디메틸부틸기, 3,3-디메틸부틸기, 1-에틸부틸기, 2-에틸부틸기, 1,1,2-트리메틸프로필기, 1-에틸-1-메틸프로필기, 1-에틸-2-메틸프로필기, 헵틸기, 옥틸기, 노닐기 등의 C1-C10의 알킬기;In QR 12 , R 12 is a hydrogen atom; Methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, secondary-butyl group, tert-butyl group, pentyl group, isopentyl group, neopentyl group, tert-pentyl group, 1-methyl Butyl group, 2-methylbutyl group, 1-ethylpropyl group, 1,2-dimethylpropyl group, 1,3-dimethylpropyl group, hexyl group, isohexyl group, 1-methylpentyl group, 2-methylpentyl group, 3-methylpentyl group, 1,1-dimethylbutyl group, 1,2-dimethylbutyl group, 1,3-dimethylbutyl group, 3,3-dimethylbutyl group, 1-ethylbutyl group, 2-ethylbutyl group, C 1 -C 10 alkyl groups such as 1,1,2-trimethylpropyl group, 1-ethyl-1-methylpropyl group, 1-ethyl-2-methylpropyl group, heptyl group, octyl group and nonyl group;

비닐기, 알릴기, 1-프로페닐기, 이소프로페닐기, 1-부테닐기, 2-부테닐기, 3-부테닐기, 1-메틸알릴기, 2-메틸알릴기, 1-펜테닐기, 2-펜테닐기, 3-펜테닐기, 4-펜테닐기, 1-메틸-2-부테닐기, 1-메틸-3-부테닐기, 2-메틸-3-부테닐기, 3-메틸-2-부테닐기, 3-메틸-3-부테닐기, 1,1-디메틸알릴기, 1-에틸알릴기, 1-헥세닐기, 2-헥세닐기, 3-헥세닐기, 4-헥세닐기, 5-헥세닐기, 4-메틸-3-펜테닐기, 1-프로필알릴기, 1-에틸-1-메틸알릴기, 게라닐기 등의 C2-C10의 알케닐기;Vinyl, allyl, 1-propenyl, isopropenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methylallyl, 2-methylallyl, 1-pentenyl, 2-pente Neyl group, 3-pentenyl group, 4-pentenyl group, 1-methyl-2-butenyl group, 1-methyl-3-butenyl group, 2-methyl-3-butenyl group, 3-methyl-2-butenyl group, 3- Methyl-3-butenyl, 1,1-dimethylallyl, 1-ethylallyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl C 2 -C 10 alkenyl groups such as 4-methyl-3-pentenyl, 1-propylallyl, 1-ethyl-1-methylallyl and geranyl;

에티닐기, 1-프로피닐기, 2-프로피닐기, 1-부티닐기, 2-부티닐기, 3-부티닐기, 1-메틸-2-프로피닐기, 1-펜티닐기, 2-펜티닐기, 3-펜티닐기, 4-펜티닐기, 1-메틸-3-부티닐기, 1,1-디메틸-2-프로피닐기, 1-헥시닐기, 2-헥시닐기, 3-헥시닐기, 4-헥시닐기, 5-헥시닐기 등의 C2-C10의 알키닐기;Ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl, 3-pentyn Neyl group, 4-pentynyl group, 1-methyl-3-butynyl group, 1,1-dimethyl-2-propynyl group, 1-hexynyl group, 2-hexynyl group, 3-hexynyl group, 4-hexynyl group, 5-hexyl alkynyl groups, such as C 2 -C 10 group;

사이클로프로필기, 사이클로부틸기, 사이클로펜틸기, 사이클로헥실기, 사이클로헵틸기, 사이클로옥틸기 등의 C3-C8의 사이클로알킬기;Cyclopropyl group, cyclobutyl group, cyclopentyl group, cyclohexyl group, cyclo heptyl, cyclooctane group and the like cycloalkyl group of C 3 -C 8;

1-메틸사이클로프로필기, 2-메틸사이클로프로필기, 1,2-디메틸사이클로프로필기, 2,2-디메틸사이클로프로필기, 2,3-디메틸사이클로프로필기, 1-에틸사이클로프로필기, 2-에틸사이클로프로필기, 1,2,3-트리메틸사이클로프로필기, 2,2,3-트리메틸사이클로프로필기, 1,2,2,3-테트라메틸사이클로프로필기, 1-메틸사이클로부틸기, 2-메틸사이클로부틸기, 3-메틸사이클로부틸기, 1,2-디메틸사이클로부틸기, 1,3-디메틸사이클로부틸기, 2,3-디메틸사이클로부틸기, 2,2-디메틸사이클로부틸기, 1-에틸사이클로부틸기, 2-에틸사이클로부틸기, 3-에틸사이클로부틸기, 1-메틸사이클로펜틸기, 2-메틸사이클로펜틸기, 3-메틸사이클로펜틸기, 1,2-디메틸사이클로펜틸기, 1,3-디메틸사이클로펜틸기, 2,2-디메틸사이클로펜틸기, 2,3-디메틸사이클로펜틸기, 3,3-디메틸사이클로펜틸기, 1-에틸사이클로펜틸기, 1-메틸사이클로헥실기, 2-메틸사이클로헥실기, 3-메틸사이클로헥실기, 4-메틸사이클로헥실기, 1,2-디메틸사이클로헥실기, 1,3-디메틸사이클로헥실기, 1,4-디메틸사이클로헥실기, 2,2-디메틸사이클로헥실기, 2,3-디메틸사이클로헥실기, 2,4-디메틸사이클로헥실기, 3,3-디메틸사이클로헥실기, 3,4-디메틸사이클로헥실기, 4,3-디메틸사이클로헥실기, 1-에틸사이클로헥실기 등의 C4-C10의 알킬기로 치환된 사이클로알킬기;1-methylcyclopropyl group, 2-methylcyclopropyl group, 1,2-dimethylcyclopropyl group, 2,2-dimethylcyclopropyl group, 2,3-dimethylcyclopropyl group, 1-ethylcyclopropyl group, 2- Ethylcyclopropyl group, 1,2,3-trimethylcyclopropyl group, 2,2,3-trimethylcyclopropyl group, 1,2,2,3-tetramethylcyclopropyl group, 1-methylcyclobutyl group, 2- Methylcyclobutyl group, 3-methylcyclobutyl group, 1,2-dimethylcyclobutyl group, 1,3-dimethylcyclobutyl group, 2,3-dimethylcyclobutyl group, 2,2-dimethylcyclobutyl group, 1- Ethylcyclobutyl group, 2-ethylcyclobutyl group, 3-ethylcyclobutyl group, 1-methylcyclopentyl group, 2-methylcyclopentyl group, 3-methylcyclopentyl group, 1,2-dimethylcyclopentyl group, 1 , 3-dimethylcyclopentyl group, 2,2-dimethylcyclopentyl group, 2,3-dimethylcyclopentyl group, 3,3-dimethylcyclopentyl group, 1- to Cyclopentyl group, 1-methylcyclohexyl group, 2-methylcyclohexyl group, 3-methylcyclohexyl group, 4-methylcyclohexyl group, 1,2-dimethylcyclohexyl group, 1,3-dimethylcyclohexyl group, 1,4-dimethylcyclohexyl group, 2,2-dimethylcyclohexyl group, 2,3-dimethylcyclohexyl group, 2,4-dimethylcyclohexyl group, 3,3-dimethylcyclohexyl group, 3,4-dimethyl Cycloalkyl groups substituted with C 4 -C 10 alkyl groups such as cyclohexyl, 4,3-dimethylcyclohexyl and 1-ethylcyclohexyl;

(사이클로프로필)메틸기, (사이클로부틸)메틸기, (사이클로펜틸)메틸기, (사이클로헥실)메틸기, (사이클로헵틸)메틸기, (사이클로옥틸)메틸기, (사이클로프로필)에틸기, (사이클로부틸)에틸기, (사이클로펜틸)에틸기, (사이클로헥실)에틸기, (사이클로헵틸)에틸기, (사이클로옥틸)에틸기, (사이클로프로필)프로틸기, (사이클로부틸)프로틸기, (사이클로펜틸)프로틸기, (사이클로헥실)프로틸기, (사이클로헵틸)푸롤기 등의 C4-C10의 (사이클로알킬)알킬기;(Cyclopropyl) methyl group, (cyclobutyl) methyl group, (cyclopentyl) methyl group, (cyclohexyl) methyl group, (cycloheptyl) methyl group, (cyclooctyl) methyl group, (cyclopropyl) ethyl group, (cyclobutyl) ethyl group, (cyclo Pentyl) ethyl group, (cyclohexyl) ethyl group, (cycloheptyl) ethyl group, (cyclooctyl) ethyl group, (cyclopropyl) propyl group, (cyclobutyl) propyl group, (cyclopentyl) propyl group, (cyclohexyl) propyl group, C 4 -C 10 (cycloalkyl) alkyl groups such as (cycloheptyl) furol group;

2-사이클로프로페닐기, 2-사이클로부테닐기, 2-사이클로펜테닐기, 3-사이클로펜테닐기, 2-사이클로헥세닐기, 3-사이클로헥세닐기 등의 C3-C8의 사이클로알케닐기;C 3 -C 8 cycloalkenyl groups such as 2-cyclopropenyl group, 2-cyclobutenyl group, 2-cyclopentenyl group, 3-cyclopentenyl group, 2-cyclohexenyl group, and 3-cyclohexenyl group;

플루오로메틸기, 클로로메틸기, 브로모메틸기, 디플루오로메틸기, 트리플루오로메틸기, 2-플루오로에틸기, 2-클로로에틸기, 2-브로모에틸기, 2,2,2-트리플루오로에틸기, 1,1,2,2,2-펜타플루오로에틸기, 2-플루오로프로필기, 2-클로로프로필기, 2-브로모프로필기, 3-플루오로프로필기, 3-클로로프로필기, 3-브로모프로필기, 2,2,3,3,3-펜타플루오로프로필기, 1,1,2,2,3,3,3-헵타플루오로프로필기, 2,2,2-트리플루오로-1-메틸에틸기, 4-플루오로부틸기, 4-클로로부틸기, 4-브로모부틸기, 2,2,3,3,4,4,4-헵타플루오로부틸기 등의 C1-C10의 할로알킬기;Fluoromethyl group, chloromethyl group, bromomethyl group, difluoromethyl group, trifluoromethyl group, 2-fluoroethyl group, 2-chloroethyl group, 2-bromoethyl group, 2,2,2-trifluoroethyl group, 1 , 1,2,2,2-pentafluoroethyl group, 2-fluoropropyl group, 2-chloropropyl group, 2-bromopropyl group, 3-fluoropropyl group, 3-chloropropyl group, 3-bro Mother profile, 2,2,3,3,3-pentafluoropropyl group, 1,1,2,2,3,3,3-heptafluoropropyl group, 2,2,2-trifluoro- C 1 -C such as 1-methylethyl group, 4-fluorobutyl group, 4-chlorobutyl group, 4-bromobutyl group, 2,2,3,3,4,4,4-heptafluorobutyl group 10 haloalkyl group;

3,3-디클로로알릴기 등의 C2-C10의 할로알케닐기;C 2 -C 10 haloalkenyl groups such as 3,3-dichloroallyl group;

2,2-디플루오로사이클로펜틸기 등의 C3-C8의 할로사이클로알킬기;Halocycloalkyl groups such as C 3 -C 8 , such as 2,2-difluorocyclopentyl group;

시아노메틸기, 1-시아노에틸기, 2-시아노에틸기, 1-시아노프로필기, 2-시아노프로필기, 3-시아노프로필기, 1-시아노부틸기, 2-시아노부틸기, 3-시아노부틸기, 4-시아노부틸기 등의 C2-C7의 시아노알킬기;Cyanomethyl group, 1-cyanoethyl group, 2-cyanoethyl group, 1-cyanopropyl group, 2-cyanopropyl group, 3-cyanopropyl group, 1-cyanobutyl group, 2-cyanobutyl group C 2 -C 7 cyanoalkyl groups such as 3-cyanobutyl group and 4-cyanobutyl group;

메톡시메틸기, 에톡시메틸기, 프로폭시메틸기, 이소프로폭시메틸기, 부톡시메틸기, 2-메톡시에틸기, 2-에톡시에틸기, 2-프로폭시에틸기, 2-이소프로폭시에틸기, 2-부톡시에틸기, 3-메톡시프로필기, 4-메톡시부틸기, 5-메톡시펜틸기 등의 C2-C10의 알콕시알킬기;Methoxymethyl group, ethoxymethyl group, propoxymethyl group, isopropoxymethyl group, butoxymethyl group, 2-methoxyethyl group, 2-ethoxyethyl group, 2-propoxyethyl group, 2-isopropoxyethyl group, 2-butoxy C 2 -C 10 alkoxyalkyl groups such as ethyl group, 3-methoxypropyl group, 4-methoxybutyl group and 5-methoxypentyl group;

메틸티오메틸기, 에틸티오메틸기, 프로필티오메틸기, 이소프로필티오메틸기, 부틸티오메틸기, 2-(메틸티오)에틸기, 2-(에틸티오)에틸기, 2-(프로필티오)에틸기, 2-(이소프로필티오)에틸기, 2-(부틸티오)에틸기, 3-(메틸티오)프로필기, 4-(메틸티오)부틸기, 5-(메틸티오)펜틸기 등의 C2-C10의 알킬티오알킬기;Methylthiomethyl group, ethylthiomethyl group, propylthiomethyl group, isopropylthiomethyl group, butylthiomethyl group, 2- (methylthio) ethyl group, 2- (ethylthio) ethyl group, 2- (propylthio) ethyl group, 2- (isopropyl thio) ethyl, 2- (butylthio) ethyl group, 3- (methylthio) propyl, 4- (methylthio) butyl group, 5- (methylthio) pentanoic alkylthio group of C 2 -C 10 group such as;

메틸설포닐메틸기, 에틸설포닐메틸기, 프로필설포닐메틸기, 이소프로필설포닐메틸기, 부틸설포닐메틸기, 2-(메틸설포닐)에틸기, 2-(에틸설포닐)에틸기, 2-(프로필설포닐)에틸기, 2-(이소프로필설포닐)에틸기, 2-(부틸설포닐)에틸기, 3-(메틸설포닐)프로필기, 4-(메틸설포닐)부틸기, 5-(메틸설포닐)펜틸기 등의 C2-C10의 알킬설포닐알킬기;Methylsulfonylmethyl group, ethylsulfonylmethyl group, propylsulfonylmethyl group, isopropylsulfonylmethyl group, butylsulfonylmethyl group, 2- (methylsulfonyl) ethyl group, 2- (ethylsulfonyl) ethyl group, 2- (propylsulfonyl ) Ethyl group, 2- (isopropylsulfonyl) ethyl group, 2- (butylsulfonyl) ethyl group, 3- (methylsulfonyl) propyl group, 4- (methylsulfonyl) butyl group, 5- (methylsulfonyl) phen alkyl sulfonic the C 2 -C 10 group such as a sulfonyl group;

아세틸기, 피로피오닐기, 부티릴기, 이소부티릴기, 발레릴기, 이소발레릴기, 2-메틸부티릴기, 헥사노일기, 2,2-디메틸부티릴기, 2-에틸부티릴기, 2-메틸발레릴기, 3-메틸발레릴기, 4-메틸발레릴기 등의 C2-C6의 아실기;Acetyl, pyridionyl, butyryl, isobutyryl, valeryl, isovaleryl, 2-methylbutyryl, hexanoyl, 2,2-dimethylbutyryl, 2-ethylbutyryl, 2-methylvalrylyl , 3-methyl-ballet group, an acyl group of C 2 -C 6, such as 4-methyl-ballet group;

2-옥소프로필기, 1-메틸-2-옥소프로필기, 1-메틸-2-옥소부틸기, 1-에틸-2-옥소부틸기, 1-프로필-2-옥소프로필기 등의 C3-C6의 옥소알킬기;C 3 -such as 2-oxopropyl group, 1-methyl-2-oxopropyl group, 1-methyl-2-oxobutyl group, 1-ethyl-2-oxobutyl group, 1-propyl-2-oxopropyl group, etc. An oxoalkyl group of C 6 ;

메틸설포닐기, 에틸설포닐기, 프로필설포닐기, 이소프로필설포닐기, 부틸설포닐기, 펜틸설포닐기, 헥실설포닐기 등의 C1-C6의 알킬설포닐기;Methyl sulfonyl group, ethyl sulfonyl, propyl sulfonyl, isopropyl sulfonyl, butyl sulfonyl, pentyl sulfonyl, alkylsulfonyl of hexyl sulfonyl group such as a C 1 -C 6 group;

트리플루오로메틸설포닐기 등의 C1-C6의 할로알킬설포닐기;C 1 -C 6 haloalkylsulfonyl groups such as trifluoromethylsulfonyl group;

비닐설포닐기, 알릴설포닐기 등의 C2-C6의 알케닐설포닐기;Alkenyl sulfonyl group of the vinyl sulfonyl group, allyl sulfonyl group, such as C 2 -C 6;

페닐기, 4-클로로페닐기, 3-클로로페닐기, 2-클로로페닐기 등의 페닐기;Phenyl groups such as phenyl group, 4-chlorophenyl group, 3-chlorophenyl group and 2-chlorophenyl group;

또는 벤질기, 펜에틸기 등의 페닐기로 치환된 C1-C3의 알킬기;Or a C 1 -C 3 alkyl group substituted with a phenyl group such as a benzyl group or a phenethyl group;

2-피리디닐기, 3-피리디닐기, 4-피리디닐기, 1-푸릴기, 2-푸릴기, 1-피라닐기, 2-피라닐기, 3-피라닐기, 1-디하이드로푸릴기, 2-디하이드로푸릴기, 1-디하이드로피라닐기, 2-디하이드로피라닐기, 3-디하이드로피라닐기, 1-테트라하이드로푸릴기, 2-테트라하이드로푸릴기, 1-테트라하이드로피라닐기, 2-테트라하이드로피라닐기, 3-테트라하이드로피라닐기 등의 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자, 황원자 및/또는 질소원자를 함유한다);2-pyridinyl group, 3-pyridinyl group, 4-pyridinyl group, 1-furyl group, 2-furyl group, 1-pyranyl group, 2-pyranyl group, 3-pyranyl group, 1-dihydrofuryl group, 2-dihydrofuryl group, 1-dihydropyranyl group, 2-dihydropyranyl group, 3-dihydropyranyl group, 1-tetrahydrofuryl group, 2-tetrahydrofuryl group, 1-tetrahydropyranyl group, 2 3- to 6-membered heterocyclic groups such as a tetrahydropyranyl group, 3-tetrahydropyranyl group, etc., wherein the ring contains one or two oxygen atoms, sulfur atoms and / or nitrogen atoms;

1-테트라하이드로메틸기, 2-테트라하이드로메틸기 등의 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자, 황원자 및/또는 질소원자를 함유한다)3- to 6-membered heterocyclic groups such as 1-tetrahydromethyl group and 2-tetrahydromethyl group (the rings contain 1 or 2 oxygen atoms, sulfur atoms and / or nitrogen atoms)

로 치환된 C1-C3의 알킬기;An alkyl group of C 1 -C 3 substituted with;

1-γ부티로락토닐기, 2-γ부티로락토닐 등의 화학식(II)의 기 또는 화학식(III)의 기;Chemical formula, such as 1- (gamma) butyrolactone group and 2- (gamma) butyrolactone group Group or formula of (II) Group of (III);

화학식 III에 있어서, R14로서는 수소원자; 또는 메틸기, 에틸기, 프로필기, 이소프로필기, 부틸기, 이소부틸기, 2급-부틸기, 3급-부틸기 등의 C1-C4의 알킬기를 들 수 있으며, W는 산소원자, 황원자 또는 -NR16-의 기이다.In formula (III), R 14 represents a hydrogen atom; Or a C 1 -C 4 alkyl group such as methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, secondary-butyl group, tert-butyl group, and W is an oxygen atom or a sulfur atom Or -NR 16- .

-NR16-의 R16으로서는 수소원자; 또는 메틸기, 에틸기, 프로필기, 이소프로필기, 부틸기, 이소부틸기, 2급-부틸기, 3급-부틸기 등의 C1-C4의 알킬기이다.R 16 of —NR 16 — is a hydrogen atom; Or a C 1 -C 4 alkyl group such as methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, secondary-butyl group or tert-butyl group.

R15로서는 수소원자; 메틸기, 에틸기, 프로필기, 이소프로필기, 부틸기, 이소부틸기, 2급-부틸기, 3급-부틸기, 펜틸기, 이소펜틸기, 네오펜틸기, 3급-펜틸기, 1-메틸부틸기, 2-메틸부틸기, 1-에틸프로필기, 1,2-디메틸프로필기, 1,3-디메틸프로필기, 헥실기, 이소헥실기, 1-메틸펜틸기, 2-메틸펜틸기, 3-메틸펜틸기, 1,1-디메틸부틸기, 1,2-디메틸부틸기, 1,3-디메틸부틸기, 3,3-디메틸부틸기, 1-에틸부틸기, 2-에틸부틸기, 1,1,2-트리메틸프로필기, 1-에틸-1-메틸프로필기, 1-에틸-2-메틸프로필기 등의 C1-C6의 알킬기;R 15 is selected from a hydrogen atom; Methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, secondary-butyl group, tert-butyl group, pentyl group, isopentyl group, neopentyl group, tert-pentyl group, 1-methyl Butyl group, 2-methylbutyl group, 1-ethylpropyl group, 1,2-dimethylpropyl group, 1,3-dimethylpropyl group, hexyl group, isohexyl group, 1-methylpentyl group, 2-methylpentyl group, 3-methylpentyl group, 1,1-dimethylbutyl group, 1,2-dimethylbutyl group, 1,3-dimethylbutyl group, 3,3-dimethylbutyl group, 1-ethylbutyl group, 2-ethylbutyl group, Alkyl groups of C 1 -C 6 such as 1,1,2-trimethylpropyl group, 1-ethyl-1-methylpropyl group and 1-ethyl-2-methylpropyl group;

비닐기, 알릴기, 1-프로페닐기, 이소프로페닐기, 1-부테닐기, 2-부테닐기, 3-부테닐기, 1-메틸알릴기, 2-메틸알릴기, 1-펜테닐기, 2-펜테닐기, 3-펜테닐기, 4-펜테닐기, 1-메틸-2-부테닐기, 1-메틸-3-부테닐기, 2-메틸-3-부테닐기, 3-메틸-2-부테닐기, 3-메틸-3-부테닐기, 1,1-디메틸알릴기, 1-에틸알릴기, 1-헥세닐기, 2-헥세닐기, 3-헥세닐기, 4-헥세닐기, 5-헥세닐기, 4-메틸-3-펜테닐기, 1-프로필알릴기, 1-에틸-1-메틸알릴기 등의 C2-C6의 알케닐기;Vinyl, allyl, 1-propenyl, isopropenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methylallyl, 2-methylallyl, 1-pentenyl, 2-pente Neyl group, 3-pentenyl group, 4-pentenyl group, 1-methyl-2-butenyl group, 1-methyl-3-butenyl group, 2-methyl-3-butenyl group, 3-methyl-2-butenyl group, 3- Methyl-3-butenyl, 1,1-dimethylallyl, 1-ethylallyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl C 2 -C 6 alkenyl groups such as 4-methyl-3-pentenyl, 1-propylallyl, and 1-ethyl-1-methylallyl;

에티닐기, 1-프로피닐기, 2-프로피닐기, 1-부티닐기, 2-부티닐기, 3-부티닐기, 1-메틸-2-프로피닐기, 1-펜티닐기, 2-펜티닐기, 3-펜티닐기, 4-펜티닐기, 1-메틸-3-부티닐기, 1,1-디메틸-2-프로피닐기, 1-헥시닐기, 2-헥시닐기, 3-헥시닐기, 4-헥시닐기, 5-헥시닐기 등의 C2-C6의 알키닐기;Ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl, 3-pentyn Neyl group, 4-pentynyl group, 1-methyl-3-butynyl group, 1,1-dimethyl-2-propynyl group, 1-hexynyl group, 2-hexynyl group, 3-hexynyl group, 4-hexynyl group, 5-hexyl alkynyl of C 2 -C 6 such as a group;

사이클로프로필기, 사이클로부틸기, 사이클로펜틸기, 사이클로헥실기 등의 C3-C6의 사이클로알킬기;Cyclopropyl group, a cyclobutyl group, a cyclopentyl group of the cycloalkyl groups, cyclohexyl groups, etc. of C 3 -C 6;

1-메틸사이클로프로필기, 2-메틸사이클로프로필기, 1,2-디메틸사이클로프로필기, 2,2-디메틸사이클로프로필기, 2,3-디메틸사이클로프로필기, 1-에틸사이클로프로필기, 2-에틸사이클로프로필기, 1,2,3-트리메틸사이클로프로필기, 2,2,3-트리메틸사이클로프로필기, 1,2,2,3-테트라메틸사이클로프로필기, 1-메틸사이클로부틸기, 2-메틸사이클로부틸기, 3-메틸사이클로부틸기, 1,2-디메틸사이클로부틸기, 1,3-디메틸사이클로부틸기, 2,3-디메틸사이클로부틸기, 2,2-디메틸사이클로부틸기, 1-에틸사이클로부틸기, 2-에틸사이클로부틸기, 3-에틸사이클로부틸기, 1-메틸사이클로펜틸기, 2-메틸사이클로펜틸기, 3-메틸사이클로펜틸기, 1, 2-디메틸사이클로펜틸기, 1,3-디메틸사이클로펜틸기, 2,2-디메틸사이클로펜틸기, 2,3-디메틸사이클로펜틸기, 3,3-디메틸클로펜틸기, 1-에틸사이클로펜틸기, 1-메틸사이클로헥실기, 2-메틸사이클로헥실기, 3-메틸사이클로헥실기, 4-메틸사이클로헥실기, 1,2-디메틸사이클로헥실기, 1,3-디메틸사이클로헥실기, 1,4-디메틸사이클로헥실기, 2,2-디메틸사이클로헥실기, 2,3-디메틸사이클로헥실기, 2,4-디메틸사이클로헥실기, 3,3-디메틸사이클로헥실기, 3,4-디메틸사이클로헥실기, 4,3-디메틸사이클로헥실기, 1-에틸사이클로헥실기 등의 C4-C10의 알킬기로 치환된 사이클로알킬기;1-methylcyclopropyl group, 2-methylcyclopropyl group, 1,2-dimethylcyclopropyl group, 2,2-dimethylcyclopropyl group, 2,3-dimethylcyclopropyl group, 1-ethylcyclopropyl group, 2- Ethylcyclopropyl group, 1,2,3-trimethylcyclopropyl group, 2,2,3-trimethylcyclopropyl group, 1,2,2,3-tetramethylcyclopropyl group, 1-methylcyclobutyl group, 2- Methylcyclobutyl group, 3-methylcyclobutyl group, 1,2-dimethylcyclobutyl group, 1,3-dimethylcyclobutyl group, 2,3-dimethylcyclobutyl group, 2,2-dimethylcyclobutyl group, 1- Ethylcyclobutyl group, 2-ethylcyclobutyl group, 3-ethylcyclobutyl group, 1-methylcyclopentyl group, 2-methylcyclopentyl group, 3-methylcyclopentyl group, 1, 2-dimethylcyclopentyl group, 1 , 3-dimethylcyclopentyl group, 2,2-dimethylcyclopentyl group, 2,3-dimethylcyclopentyl group, 3,3-dimethylclopentyl group, 1-ethyl yarn Clopentyl, 1-methylcyclohexyl, 2-methylcyclohexyl, 3-methylcyclohexyl, 4-methylcyclohexyl, 1,2-dimethylcyclohexyl, 1,3-dimethylcyclohexyl, 1,4-dimethylcyclohexyl group, 2,2-dimethylcyclohexyl group, 2,3-dimethylcyclohexyl group, 2,4-dimethylcyclohexyl group, 3,3-dimethylcyclohexyl group, 3,4-dimethyl Cycloalkyl groups substituted with C 4 -C 10 alkyl groups such as cyclohexyl, 4,3-dimethylcyclohexyl and 1-ethylcyclohexyl;

2-사이클로프로페닐기, 2-사이클로부테닐기, 2-사이클로펜테닐기, 3-사이클로펜테닐기, 2-사이클로헥세닐기, 3-사이클로헥세닐기 등의 C3-C6의 사이클로알케닐기;C 3 -C 6 cycloalkenyl groups such as 2-cyclopropenyl group, 2-cyclobutenyl group, 2-cyclopentenyl group, 3-cyclopentenyl group, 2-cyclohexenyl group, and 3-cyclohexenyl group;

플루오로메틸기, 클로로메틸기, 브로모메틸기, 디플루오로메틸기, 트리플루오로메틸기, 2-플루오로에틸기, 2-클로로에틸기, 2-브로모에틸기, 2,2,2-트리플루오로에틸기, 1,1,2,2,2-펜타플루오로에틸기, 2-플루오로프로필기, 2-클로로프로필기, 2-브로모프로필기, 3-플루오로프로필기, 3-클로로프로필기, 3-브로모프로필기, 2,2,3,3,3-펜타플루오로프로필기, 1,1,2,2,3,3,3-헵타플루오로프로필기, 2,2,2-트리플루오로-1-메틸에틸기, 4-플루오로부틸기, 4-클로로부틸기, 4-브로모부틸기, 2,2,3,3,4,4,4,-헵타플루오로부틸기 등의 C1-C6의 할로알킬기;Fluoromethyl group, chloromethyl group, bromomethyl group, difluoromethyl group, trifluoromethyl group, 2-fluoroethyl group, 2-chloroethyl group, 2-bromoethyl group, 2,2,2-trifluoroethyl group, 1 , 1,2,2,2-pentafluoroethyl group, 2-fluoropropyl group, 2-chloropropyl group, 2-bromopropyl group, 3-fluoropropyl group, 3-chloropropyl group, 3-bro Mother profile, 2,2,3,3,3-pentafluoropropyl group, 1,1,2,2,3,3,3-heptafluoropropyl group, 2,2,2-trifluoro- 1-methyl-ethyl group, a butyl group 4-fluoro, 4-chlorobutyl group, 4-bromo-butyl group, 2,2,3,3,4,4,4-heptafluoropropane, such as a butyl group C 1 - Haloalkyl group of C 6 ;

3,3-디클로로알릴기 등의 C2-C6의 할로알케닐기;Haloalkenyl groups such as C 2 -C 6 such as 3,3-dichloroallyl group;

2,2-디플루오로사이클로펜틸기 등의 C3-C6의 할로사이클로알킬기;Halocycloalkyl groups such as C 3 -C 6 such as 2,2-difluorocyclopentyl group;

시아노메틸기, 1-시아노에틸기, 2-시아노에틸기, 1-시아노프로필기, 2-시아노프로필기, 3-시아노프로필기, 1-시아노부틸기, 2-시아노부틸기, 3-시아노부틸기, 4-시아노부틸기 등의 C2-C5의 시아노알킬기;Cyanomethyl group, 1-cyanoethyl group, 2-cyanoethyl group, 1-cyanopropyl group, 2-cyanopropyl group, 3-cyanopropyl group, 1-cyanobutyl group, 2-cyanobutyl group C 2 -C 5 cyanoalkyl groups such as 3-cyanobutyl group and 4-cyanobutyl group;

메톡시메틸기, 에톡시메틸기, 프로폭시메틸기, 이소프로폭시메틸기, 부톡시메틸기, 2-메톡시에틸기, 2-에톡시에틸기, 2-프로폭시에틸기, 2-이소프로폭시에틸기, 2-부톡시에틸기, 3-메톡시프로필기, 4-메톡시부틸기, 5-메톡시펜틸기 등의 C2-C6의 알콕시알킬기;Methoxymethyl group, ethoxymethyl group, propoxymethyl group, isopropoxymethyl group, butoxymethyl group, 2-methoxyethyl group, 2-ethoxyethyl group, 2-propoxyethyl group, 2-isopropoxyethyl group, 2-butoxy C 2 -C 6 alkoxyalkyl groups such as ethyl group, 3-methoxypropyl group, 4-methoxybutyl group and 5-methoxypentyl group;

메틸티오메틸기, 에틸티오메틸기, 프로필티오메틸기, 이소프로필티오메틸기, 부틸티오메틸기, 2-(메틸티오)에틸기, 2-(메틸티오)에틸기, 2-(프로필티오)에틸기, 2-(이소프로필티오)에틸기, 2-(부틸티오)에틸기, 3-(메틸티오)프로필기, 4-(메틸티오)부틸기, 5-(메틸티오)펜틸기 등의 C2-C6의 알킬티오알킬기;Methylthiomethyl group, ethylthiomethyl group, propylthiomethyl group, isopropylthiomethyl group, butylthiomethyl group, 2- (methylthio) ethyl group, 2- (methylthio) ethyl group, 2- (propylthio) ethyl group, 2- (isopropyl thio) ethyl, 2- (butylthio) ethyl group, 3- (methylthio) propyl, 4- (methylthio) butyl group, 5- (methylthio) pentanoic alkylthio group such as alkyl group of C 2 -C 6;

메틸설포닐메틸기, 에틸설포닐메틸기, 프로필설포닐메틸기, 이소프로필설포닐메틸기, 부틸설포닐메틸기, 2-(메틸설포닐)에틸기, 2-(에틸설포닐)에틸기, 2-(프로필설포닐)에틸기, 2-(이소프로필설포닐)에틸기, 2-(부틸설포닐)에틸기, 3-(메틸설포닐)프로필기, 4-(메틸설포닐)부틸기, 5-(메틸설포닐)펜틸기 등의 C2-C6의 알킬설포닐알킬기;Methylsulfonylmethyl group, ethylsulfonylmethyl group, propylsulfonylmethyl group, isopropylsulfonylmethyl group, butylsulfonylmethyl group, 2- (methylsulfonyl) ethyl group, 2- (ethylsulfonyl) ethyl group, 2- (propylsulfonyl ) Ethyl group, 2- (isopropylsulfonyl) ethyl group, 2- (butylsulfonyl) ethyl group, 3- (methylsulfonyl) propyl group, 4- (methylsulfonyl) butyl group, 5- (methylsulfonyl) phen alkyl sulfonic group and the like of the C 2 -C 6 alkyl sulfonyl;

2-옥소프로필기, 1-메틸-2-옥소프로필기, 1-메틸-2-옥소부틸기, 1-에틸-2-옥소부틸기, 1-프로필-2-옥소프로필기 등의 C3-C6의 옥소알킬기;C 3 -such as 2-oxopropyl group, 1-methyl-2-oxopropyl group, 1-methyl-2-oxobutyl group, 1-ethyl-2-oxobutyl group, 1-propyl-2-oxopropyl group, etc. An oxoalkyl group of C 6 ;

2-(아세틸옥시)에틸기, 2-(프로피오닐옥시)에틸기, 2-(부티릴옥시)에틸기, 2-(이소부티릴옥시)에틸기, 2-(발레릴옥시)에틸기, 2-(이소발레릴옥시)에틸기, 2-(피발로일옥시)에틸기, 2-(아크릴로일옥시)에틸기, 2-(프로피오로일옥시)에틸기, 2-(메타크릴로일옥시)에틸기, 2-(크로토노일옥시)에틸기, 3-(아세틸옥시)프로필기, 4-(아세틸옥시)부틸기, 5-(아세틸옥시)펜틸기 등의 C3-C7의 아실옥시알킬기;2- (acetyloxy) ethyl group, 2- (propionyloxy) ethyl group, 2- (butyryloxy) ethyl group, 2- (isobutyryloxy) ethyl group, 2- (valeryloxy) ethyl group, 2- (isovalle Ryloxy) ethyl group, 2- (pivaloyloxy) ethyl group, 2- (acryloyloxy) ethyl group, 2- (propioyloxy) ethyl group, 2- (methacryloyloxy) ethyl group, 2- ( C 3 -C 7 acyloxyalkyl groups such as crotonoyloxy) ethyl group, 3- (acetyloxy) propyl group, 4- (acetyloxy) butyl group and 5- (acetyloxy) pentyl group;

메톡시카보닐메틸기, 에톡시카보닐메틸기, 프로폭시카보닐메틸기, 이소프로폭시카보닐메틸기, 부톡시카보닐메틸기, 이소부톡시카보닐메틸기, 2급-부톡시카보닐메틸기, 3급-부톡시카보닐메틸기, 펜틸옥시카보닐메틸기, 이소펜틸옥시카보닐메틸기, 헥실옥시카보닐메틸기, 2-(메톡시카보닐)에틸기, 2-(에톡시카보닐)에틸기, 2-(프로폭시카보닐)에틸기, 2-(이소프로폭시카보닐)에틸기, 2-(부톡시카보닐)에틸기, 2-(이소부톡시카보닐)에틸기, 2-(2급-부톡시카보닐)에틸기, 2-(3급-부톡시카보닐)에틸기, 2-(펜틸옥시카보닐)에틸기, 2-(이소펜틸옥시카보닐)에틸기, 1-(메톡시카보닐)에틸기, 1-(에톡시카보닐)에틸기, 1-(프로폭시카보닐)에틸기, 1-(이소프로폭시카보닐)에틸기, 1-(부톡시카보닐)에틸기, 1-(이소부톡시카보닐)에틸기, 1-(2급-부톡시카보닐)에틸기, 1-(3급-부톡시카보닐)에틸기, 1-(펜틸옥시카보닐)에틸기, 1-(이소펜틸옥시카보닐)에틸기, 3-(메톡시카보닐)프로필기, 3-(에톡시카보닐)프로필기, 3-(프로폭시카보닐)프로필기, 3-(이소프로폭시카보닐)프로필기, 3-(부톡시카보닐)프로필기, 1-(메톡시카보닐)프로필기, 1-(에톡시카보닐)프로필기, 1-(프로폭시카보닐)프로필기, 1-(이소프로폭시카보닐)프로필기, 1-(부톡시카보닐)프로필기, 1-(메톡시카보닐)-1-메틸에틸기, 1-(에톡시카보닐)-1-메틸에틸기, 1-메틸-1-(프로폭시카보닐)에틸기, 1-(이소프로폭시카보닐)-1-메틸에틸기, 1-(부톡시카보닐)-1-메틸에틸기, 4-(메톡시카보닐)부틸기, 4-(에톡시카보닐)부틸기, 4-(프로폭시카보닐)부틸기, 3-(이소프로폭시카보닐)부틸기 등의 C3-C7의 알콕시카보닐알킬기;Methoxycarbonylmethyl group, ethoxycarbonylmethyl group, propoxycarbonylmethyl group, isopropoxycarbonylmethyl group, butoxycarbonylmethyl group, isobutoxycarbonylmethyl group, secondary-butoxycarbonylmethyl group, tertiary-part A methoxycarbonylmethyl group, a pentyloxycarbonylmethyl group, isopentyloxycarbonylmethyl group, hexyloxycarbonylmethyl group, 2- (methoxycarbonyl) ethyl group, 2- (ethoxycarbonyl) ethyl group, 2- (propoxycarbon) Yl) ethyl group, 2- (isopropoxycarbonyl) ethyl group, 2- (butoxycarbonyl) ethyl group, 2- (isobutoxycarbonyl) ethyl group, 2- (secondary-butoxycarbonyl) ethyl group, 2- (Tert-butoxycarbonyl) ethyl group, 2- (pentyloxycarbonyl) ethyl group, 2- (isopentyloxycarbonyl) ethyl group, 1- (methoxycarbonyl) ethyl group, 1- (ethoxycarbonyl) Ethyl group, 1- (propoxycarbonyl) ethyl group, 1- (isopropoxycarbonyl) ethyl group, 1- (butoxycarbonyl) ethyl group, 1- (isobutoxycarbonyl) ethyl group, 1- (secondary-part Methoxycarbonyl) ethyl group, 1- (tert-butoxide Cicarbonyl) ethyl group, 1- (pentyloxycarbonyl) ethyl group, 1- (isopentyloxycarbonyl) ethyl group, 3- (methoxycarbonyl) propyl group, 3- (ethoxycarbonyl) propyl group, 3- (Propoxycarbonyl) propyl group, 3- (isopropoxycarbonyl) propyl group, 3- (butoxycarbonyl) propyl group, 1- (methoxycarbonyl) propyl group, 1- (ethoxycarbonyl ) Propyl group, 1- (propoxycarbonyl) propyl group, 1- (isopropoxycarbonyl) propyl group, 1- (butoxycarbonyl) propyl group, 1- (methoxycarbonyl) -1-methyl Ethyl group, 1- (ethoxycarbonyl) -1-methylethyl group, 1-methyl-1- (propoxycarbonyl) ethyl group, 1- (isopropoxycarbonyl) -1-methylethyl group, 1- (butoxy Carbonyl) -1-methylethyl group, 4- (methoxycarbonyl) butyl group, 4- (ethoxycarbonyl) butyl group, 4- (propoxycarbonyl) butyl group, 3- (isopropoxycarbonyl C 3 -C 7 alkoxycarbonylalkyl groups such as) butyl group;

페닐기;Phenyl group;

페닐기로 치환된 메틸기, 에틸기, 프로필기, 이소프로필기 등의 C1-C3의 알킬기;A substituted methyl group with a phenyl group, an ethyl group, a propyl group, an isopropyl group an alkyl group of C 1 -C 3, and the like;

1 또는 2개의 산소원자, 황원자 및/또는 질소원자를 함유하는 3원 내지 6원의 복소환기;3- to 6-membered heterocyclic groups containing one or two oxygen atoms, sulfur atoms and / or nitrogen atoms;

또는 1 또는 2개의 산소원자, 황원자 및/또는 질소원자를 함유하는 3원 내지 6원의 복소환기로 치환된 메틸기, 에틸기, 프로필기, 이소프로필기 등의 C1-C3의 알킬기를 들 수 있다.Or C 1 -C 3 alkyl groups such as methyl, ethyl, propyl and isopropyl groups substituted with 3 to 6 membered heterocyclic groups containing one or two oxygen atoms, sulfur atoms and / or nitrogen atoms. have.

1 또는 2개의 산소원자, 황원자 및/또는 질소원자를 함유하는 3원 내지 6원의 복소환기로서는 옥시라닐기, 옥세타닐기, 테트라하이드로푸릴기, 푸릴기, 티에닐기, 피롤릴기, 피롤리디닐기, 옥사졸릴기, 티아졸릴기, 이미다졸릴기, 이속사졸릴기, 이소티아졸릴기, 피라졸릴기, 테트라하이드로피라닐기, 피리딜기, 피페리딜기, 피리미디닐기, 피리다지닐기, 모르폴리닐기, 피페라디닐기를 들 수 있으며, 이들은 치환기를 가질 수 있다.Examples of the 3- to 6-membered heterocyclic group containing one or two oxygen atoms, sulfur atoms and / or nitrogen atoms include an oxiranyl group, an oxetanyl group, a tetrahydrofuryl group, a furyl group, a thienyl group, a pyrrolyl group and a pyrrolidy Nyl group, oxazolyl group, thiazolyl group, imidazolyl group, isoxazolyl group, isothiazolyl group, pyrazolyl group, tetrahydropyranyl group, pyridyl group, piperidyl group, pyrimidinyl group, pyridazinyl group, A morpholinyl group and a piperadinyl group are mentioned, These may have a substituent.

또한, R15는 W가 -NR16-인 경우에는 W와 함께 환을 형성할 수 있다. R15가 W와 환을 형성하는 경우란 R15가 W와 함께 1 또는 2개의 질소원자 및/또는 0 또는 1개의 산소원자를 함유하는 5원 또는 6원의 복소환기를 형성하는 것을 나타낸다. 1 또는 2개의 질소원자 및/또는 0 또는 1개의 산소원자를 함유하는 5원 또는 6원의 복소환기는 1-피롤리디닐기, 1-피롤릴기, 2-이속사졸리디닐기, 1-피라졸릴기, 1-이미다졸릴기, 1-피페리딜기, 4-모르폴리닐기, 퍼하이드로-1,2-옥사진-2-일기, 1-피페라디닐기 등을 들 수 있으며, 이들은 치환기를 가질 수 있다.In addition, R <15> can form a ring with W, when W is -NR <16> -. R 15 represents the formation of a heterocyclic group of 5 or 6 members, which contain the R 15 is 1 or 2 nitrogen atoms and / or zero or one oxygen atom with W when forming a W and the ring. 5- or 6-membered heterocyclic groups containing 1 or 2 nitrogen atoms and / or 0 or 1 oxygen atom are 1-pyrrolidinyl group, 1-pyrrolyl group, 2-isoxazolidinyl group, 1-pyrazolyl Group, 1-imidazolyl group, 1-piperidyl group, 4-morpholinyl group, perhydro-1,2-oxazin-2-yl group, 1-piperidinyl group, etc., and these have a substituent Can be.

상기 R12, R13또는 R15가 페닐기, 페닐기로 치환된 C1-C3의 알킬기, 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자, 황원자 및/또는 질소원자를 함유한다) 또는 3원 내지 6원 환의 복소환기(당해 환은 1 또는 2개의 산소원자, 황원자 및/또는 질소원자를 함유한다)로 치환된 C1-C3의 알킬기인 경우에는, 당해 페닐기 및 복소환기는 치환기를 가질 수 있다. 당해 치환기로서는 구체적으로 1 내지 3개의 동일하거나 상이한 불소원자, 염소원자, 브롬원자, 요오드 원자 등의 할로겐 원자; 메틸기, 에틸기, 프로필기, 이소프로필기, 부틸기, 이소부틸기, 2급-부틸기, 3급-부틸기 등의 C1-C4의 알킬기; 트리플루오로메틸기; 메톡시기, 에톡시기, 프로폭시기, 이소프로폭시기, 부톡시기, 이소부톡시기, 2급-부톡시기, 3급-부톡시기 등의 C1-C4의 알콕시기; 아세틸옥시기, 프로피오닐옥시기, 부티릴옥시기, 이소부티릴옥시기, 발레릴옥시기, 이소발레릴옥시기, 피발로일옥시기, 아크릴로일옥시기, 프로피올로일옥시기, 메타크릴로일옥시기, 크로토노일옥시기 등의 C2-C5의 아실옥시기; 메틸티오기, 에틸티오기, 프로필티오기, 이소프로필티오기, 부틸티오기, 이소부틸티오기, 2급-부틸티오기, 3급-부틸티오기 등의 C1-C4의 알킬티오기; 메틸설포닐기, 에틸설포닐기, 프로필설포닐기, 이소프로필설포닐기, 부틸설포닐기, 이소부틸설포닐기, 2급-부틸설포닐기, 3급-부틸설포닐기 등의 C1-C4의 알킬설포닐기; 니트로기; 시아노기; 또는 메톡시카보닐기, 에톡시카보닐기, 프로폭시카보닐기, 이소프로폭시카보닐기, 부톡시카보닐기, 이소부톡시카보닐기, 2급-부톡시카보닐기, 3급-부톡시카보닐기 등의 C2-C5의 알콕시카보닐기 등을 들 수 있다.The R 12 , R 13 or R 15 is a phenyl group, a C 1 -C 3 alkyl group substituted with a phenyl group, a 3- to 6-membered heterocyclic group (the ring contains one or two oxygen atoms, sulfur atoms and / or nitrogen atoms) Or a C 1 -C 3 alkyl group substituted with a 3 to 6 membered heterocyclic group (the ring contains one or two oxygen atoms, sulfur atoms and / or nitrogen atoms), the phenyl group and the heterocyclic group May have a substituent. Specific examples of the substituent include one to three halogen atoms such as fluorine, chlorine, bromine and iodine atoms; C 1 -C 4 alkyl groups such as methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, secondary-butyl group and tert-butyl group; Trifluoromethyl group; C 1 -C 4 alkoxy groups such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, secondary-butoxy and tert-butoxy groups; Acetyloxy group, propionyloxy group, butyryloxy group, isobutyryloxy group, valeryloxy group, isovaleryloxy group, pivaloyloxy group, acryloyloxy group, propioloyloxy group, methacryloyloxy group, chloro an acyloxy group of C 2 -C 5, such as the buttocks acryloyloxy group; Import-methylthiophene, ethyl come tea, tea come propyl, isopropyl come tea, thio-butyl, iso-butyl thio group, sec-butyl thio group, t-alkylthio-butyl thio group such as a C 1 -C 4 ; Methyl sulfonyl group, ethyl sulfonyl, propyl sulfonyl, isopropyl sulfonyl, butyl sulfonyl group, isobutyl-sulfonyl, sec-butyl sulfonyl group, t-butyl sulfonyl group such as alkylsulfonyl group of C 1 -C 4 ; Nitro group; Cyano group; Or C such as methoxycarbonyl group, ethoxycarbonyl group, propoxycarbonyl group, isopropoxycarbonyl group, butoxycarbonyl group, isobutoxycarbonyl group, secondary-butoxycarbonyl group, tert-butoxycarbonyl group And alkoxycarbonyl groups of 2 -C 5 .

이 중에서 R3으로서 바람직하게는 수소원자, 니트로기 또는 -QR12{여기서, Q는 산소원자 또는 -NR13-(여기서, R13은 수소원자, C2-C6의 아실기, C1-C6의 알킬설포닐기 또는 C2-C6의 알콕시카보닐기이다)이고, R12는 수소원자, C1-C10의 알킬기, C2-C10의 알케닐기, C2-C10의 알키닐기, C3-C8의 사이클로알킬기, C3-C8의 사이클로알케닐기, C1-C10의 할로알킬기, C2-C10의 할로알케닐기, C2-C10의 할로사이클로알킬기, C2-C7의 시아노알킬기, C2-C10의 알콕시알킬기, C3-C6의 옥소알킬기, C1-C6의 알킬설포닐기, 페닐기로 치환된 C1-C6의 알킬기, 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자를 함유한다), 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자를 함유한다)로 치환된 C1-C3의 알킬기, 화학식(II)의 기 또는 화학식(III)의 기[여기서, R14는 수소원자 또는 C1-C4의 알킬기이고, W는 산소원자 또는 -NR16-(여기서, R16은 수소원자 또는 C1-C4의 알킬기이다)이고, R15는 수소원자 또는 C1-C6의 알킬기이다]이다}이다.Of these, R 3 is preferably a hydrogen atom, a nitro group or -QR 12 {wherein Q is an oxygen atom or -NR 13- (wherein R 13 is a hydrogen atom, an acyl group of C 2 -C 6 , C 1- C is an alkylsulfonyl group or an alkoxy carbonyl group of C 2 -C 6 of 6), and, R 12 is a hydrogen atom, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl of the group, a halo-cycloalkyl group of C 3 -C 8 cycloalkyl group, C 3 -C 8 cycloalkyl alkenyl, C 1 -C 10 haloalkyl group, C 2 -C 10 haloalkenyl group, C 2 -C 10 of the, C 2 -C 7 cyanoalkyl group, an alkyl group of C 2 -C 10 alkoxyalkyl group, C 3 -C 6 oxoalkyl group, C 1 a C 1 -C 6 substituted by alkylsulfonyl group, phenyl group -C 6 of the, C 1 -C substituted with 3- to 6-membered heterocyclic groups (wherein the rings contain 1 or 2 oxygen atoms), with 3 to 6-membered heterocyclic groups (where the rings contain 1 or 2 oxygen atoms) 3 , alkyl group, chemical formula Group or formula of (II) Group of (III) wherein R 14 is a hydrogen atom or an alkyl group of C 1 -C 4 , W is an oxygen atom or -NR 16- (wherein R 16 is a hydrogen atom or an alkyl group of C 1 -C 4 ) R 15 is a hydrogen atom or an alkyl group of C 1 -C 6 ].

R3로서 특히 바람직하게는 수소원자, 니트로기 또는 -QR12{여기서, Q는 산소원자 또는 -NR13-(여기서, R13은 수소원자, C1-C6의 알킬설포닐기 또는 C2-C6의 알콕시카보닐기이다)이고, R12는 수소원자, C1-C10의 알킬기, C2-C10의 알케닐기, C2-C10의 알키닐기, C3-C8의 사이클로알킬기, C1-C10의 할로알킬기, C2-C10의 할로알케닐기, C2-C7의 시아노알킬기, C2-C10의 알콕시알킬기, C3-C6의 옥소알킬기, C1-C6의 알킬설포닐기, 페닐기로 치환된 C1-C3의 알킬기, 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자를 함유한다), 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자를 함유한다)로 치환된 C1-C3의 알킬기, 상기 화학식 II의 기 또는 상기 화학식 III의 기이다}이고,R 3 is particularly preferably a hydrogen atom, a nitro group or —QR 12 {wherein Q is an oxygen atom or —NR 13 —, where R 13 is a hydrogen atom, an alkylsulfonyl group of C 1 -C 6 or C 2- an alkoxycarbonyl group of C 6), and, R 12 is a hydrogen atom, an alkynyl group, a cycloalkyl group of C 3 -C 8 of the C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 of the , C 1 -C 10 haloalkyl group, C 2 -C 10 haloalkenyl group, C 2 -C 7 cyanoalkyl group, C 2 -C 10 alkoxyalkyl group, C 3 -C 6 oxoalkyl group, C 1 An alkylsulfonyl group of -C 6 , a C 1 -C 3 alkyl group substituted with a phenyl group, a 3- to 6-membered heterocyclic group (the ring contains one or two oxygen atoms), a 3- to 6-membered heterocyclic group Wherein the ring contains one or two oxygen atoms and is an alkyl group of C 1 -C 3 , a group of formula II or a group of formula III

보다 바람직하게는 R3는 -QR12[여기서, Q는 산소원자이고, R12는 C1-C10의 알킬기, C2-C10의 알케닐기, C2-C10의 알키닐기, C3-C8의 사이클로알킬기, C1-C10의 할로알킬기, C2-C10의 할로알케닐기, C2-C7의 시아노알킬기, C2-C10의 알콕시알킬기, C3-C6의 옥소알킬기, 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자를 함유한다), 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자를 함유한다)로 치환된 C1-C3의 알킬기 또는 상기 화학식 II의 기이다]이다.More preferably R 3 is -QR 12 [wherein Q is an oxygen atom, R 12 is an alkynyl group of the alkenyl group, C 2 -C 10 alkyl group C 1 -C 10, C 2 -C 10, C 3 -C 8 cycloalkyl group, C 1 -C 10 haloalkyl group, C 2 -C 10 haloalkenyl group, C 2 -C 7 cyanoalkyl group, C 2 -C 10 alkoxyalkyl group, C 3 -C 6 Substituted with an oxoalkyl group, a 3-6 membered heterocyclic group (wherein the ring contains one or two oxygen atoms), a 3-6 membered heterocyclic group (where the ring contains one or two oxygen atoms) C 1 -C 3 alkyl group or the above formula (II).

또한, 치환기의 조합으로서 바람직하게는 R1및 R2가 함께 결합하여 환을 형성하고 R3이 수소원자, 니트로기 또는 -QR12{여기서, Q는 산소원자 또는 -NR13-(여기서, R13은 수소원자, C1-C6의 알킬설포닐기 또는 C2-C6의 알콕시카보닐기이다)이고, R12는 수소원자, C1-C10의 알킬기, C2-C10의 알케닐기, C2-C10의 알키닐기, C3-C8의 사이클로알킬기, C1-C10의 할로알킬기, C2-C10의 할로알케닐기, C2-C7의 시아노알킬기, C2-C10의 알콕시알킬기, C3-C6의 옥소알킬기, C1-C6의 알킬설포닐기, 페닐기로 치환된 C1-C3의 알킬기, 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자를 함유한다), 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자를 함유한다)로 치환된 C1-C3의 알킬기, 화학식(II)의 기 또는 화학식(III)의 기[여기서, R14는 수소원자 또는 C1-C4의 알킬기이고, W는 산소원자 또는 -NR16-(여기서, R16은 수소원자 또는 C1-C6의 알킬기이다)이고, R15는 수소원자 또는 C1-C6의 알킬기이다]이다}인 경우이고,Further, as a combination of substituents, preferably R 1 and R 2 are bonded together to form a ring, and R 3 is a hydrogen atom, a nitro group or -QR 12 {where Q is an oxygen atom or -NR 13- (where R 13 is an alkoxycarbonyl group of a hydrogen atom, C 1 -C 6 alkylsulfonyl group or a C 2 -C 6), and, R 12 is an alkyl group of a hydrogen atom, C 1 -C 10, alkenyl of C 2 -C 10 , Alkynyl group of C 2 -C 10 , cycloalkyl group of C 3 -C 8 , haloalkyl group of C 1 -C 10 , haloalkenyl group of C 2 -C 10 , cyanoalkyl group of C 2 -C 7 , C 2 alkoxyalkyl group -C 10, C 3 -C 6 heterocyclic group of the oxo group, a C 1 -C 6 alkylsulfonyl group, a C 1 -C 3 alkyl group, a 3-to 6-substituted phenyl group in the (Current ring 1 Or a C 1 -C 3 alkyl group substituted with a three to six member heterocyclic group, the ring containing one or two oxygen atoms, containing two oxygen atoms, Group or formula of (II) Group of (III), wherein R 14 is a hydrogen atom or an alkyl group of C 1 -C 4 , W is an oxygen atom or -NR 16- (wherein R 16 is a hydrogen atom or an alkyl group of C 1 -C 6 ) R 15 is a hydrogen atom or an alkyl group of C 1 -C 6 ], and

특히 바람직하게는 R1및 R2가 함께 결합하여 탄소 환을 형성하고 R3이 -QR12[여기서, Q는 산소원자이고, R12는 C1-C10의 알킬기, C2-C10의 알케닐기, C2-C10의 알키닐기, C3-C8의 사이클로알킬기, C1-C10의 할로알킬기, C2-C10의 할로알케닐기, C2-C7의 시아노알킬기, C2-C10의 알콕시알킬기, C3-C6의 옥소알킬기, 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자를 함유한다), 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자를 함유한다)로 치환된 C1-C3의 알킬기 또는 상기 화학식 II의 기이다]인 경우이다.Especially preferably, R 1 and R 2 are bonded together to form a carbocyclic ring and R 3 is -QR 12 , wherein Q is an oxygen atom, R 12 is an alkyl group of C 1 -C 10 , C 2 -C 10 Alkenyl group, C 2 -C 10 alkynyl group, C 3 -C 8 cycloalkyl group, C 1 -C 10 haloalkyl group, C 2 -C 10 haloalkenyl group, C 2 -C 7 cyanoalkyl group, C 2 -C 10 alkoxyalkyl group, C 3 -C 6 oxoalkyl group, 3- to 6-membered heterocyclic group (the ring contains 1 or 2 oxygen atoms), 3- to 6-membered heterocyclic group Ring is a C 1 -C 3 alkyl group substituted with 1 or 2 oxygen atoms or a group represented by the above formula (II).

이 중에서 더욱 바람직하게는 Y가 할로겐 원자인 경우이다.Among these, More preferably, Y is a halogen atom.

상기 화학식 I의 화합물은 피리다진환 부분 및, 치환기 R3중에 수산기 또는 질소원자를 함유하는 경우에는 그 부분에서 염을 형성하는 것이 있다.When the compound of the formula (I) contains a pyridazine ring moiety and a hydroxyl group or a nitrogen atom in the substituent R 3 , a salt may be formed at the moiety.

구체적으로는 나트륨염, 칼륨염 또는 칼슘염 등의 알칼리 금속염, 또는 알칼리 토금속염, 플루오르화수소산염, 염산염, 브롬화수소산염, 요오드화수소산염 같은 할로겐화수소산염; 질산염, 과염소산염, 황산염, 인산염같은 무기산염; 메탄설폰산염, 트리플루오로메탄설폰산염, p-톨루엔설폰산염과 같은 설폰산염을 들 수 있다.Specific examples thereof include alkali metal salts such as sodium salts, potassium salts, and calcium salts, or halogenated metal salts such as alkaline earth metal salts, hydrofluoric acid salts, hydrochlorides, hydrobromide salts, and iodide hydrochlorides; Inorganic acid salts such as nitrates, perchlorates, sulfates, and phosphates; Sulfonates such as methanesulfonic acid salts, trifluoromethanesulfonic acid salts, and p-toluenesulfonic acid salts.

또한, 화학식 V 또는 화학식 V'의 화합물은 본 발명의 화학식 I의 화합물을 합성하기 위한 중요한 중간체로서 신규 화합물이다.In addition, compounds of formula V or formula V ′ are novel compounds as important intermediates for the synthesis of compounds of formula I of the present invention.

위의 화학식 V와 V'에서,In the above formulas V and V ',

Y, Z, R1, R2및 R3은 청구의 범위의 제1항에서 정의한 바와 같다.Y, Z, R 1 , R 2 and R 3 are as defined in claim 1 of the claims.

한편, 화학식 V의 화합물과 화학식 V'의 화합물은 구조 이성체이고 산 또는 알칼리의 존재하에 용이하게 이성화한다. 예를 들면, 옥시염화인 등의 시약에 의하여 염소화되는 경우는 화학식 V의 화합물을 경유하여 반응은 진행하며 수소화나트륨 등의 염기 존재 알킬화을 행하는 경우는 화학식 V'의 화합물을 경유하여 반응이 진행된다.On the other hand, the compound of formula V and the compound of formula V 'are structural isomers and readily isomerize in the presence of an acid or an alkali. For example, when chlorination is carried out by a reagent such as phosphorus oxychloride, the reaction proceeds through the compound of formula (V), and when the base is alkylated such as sodium hydride, the reaction proceeds through the compound of formula (V ').

다음에 본 발명의 신규한 3-치환된 페닐-4-할로피리다진, 이의 유도체 및 이의 중간체의 제조방법에 관해서 설명한다. 상기 화학식 I의 본 발명의 화합물은 예를 들면, 하기 제조방법(1)-(13) 중의 어느 하나의 방법에 의해 제조할 수 있다.Next, the novel tri-substituted phenyl-4-halopyridazine, derivatives thereof and intermediates thereof of the present invention will be described. The compound of the present invention of formula (I) can be produced, for example, by any one of the following production methods (1) to (13).

제조방법(1)Manufacturing method (1)

상기 반응식에서,In the above scheme,

X, Y, Z, R1및 R2는 위에서 정의한 바와 동일하며,X, Y, Z, R 1 and R 2 are the same as defined above,

R3'는 수소원자, 니트로기, 알콕시기, 알킬티오기, 디알킬아미노기 등의 본 반응 및 하기의 원료[VII]의 합성에 영향을 받지 않는 불활성 기이고,R 3 ' is an inert group which is not affected by the present reaction such as a hydrogen atom, a nitro group, an alkoxy group, an alkylthio group, a dialkylamino group and the synthesis of the following raw material [VII],

R17은 메틸기, 에틸기 등의 저급 알킬기이다.R <17> is lower alkyl groups, such as a methyl group and an ethyl group.

상기 반응은 용매를 사용하지 않거나 용매 속에서, 염기의 존재하에서 통상적으로 0 내지 200℃, 바람직하게는 50 내지 100℃의 온도의 범위에서 행하여진다. 반응에 사용되는 화합물의 양은 통상적으로 화합물[VII] 1당량에 대해 화합물[VIII]가 1.0 내지 3.0당량, 바람직하게는 1.0 내지 1.5당량, 염기가 1.0 내지 3.0당량, 바람직하게는 1.0 내지 1.5당량이다.The reaction is carried out in the presence of a base, in the absence of a solvent or in a solvent, at a temperature in the range of usually 0 to 200 ° C, preferably 50 to 100 ° C. The amount of the compound used in the reaction is usually 1.0 to 3.0 equivalents, preferably 1.0 to 1.5 equivalents, base 1.0 to 3.0 equivalents, preferably 1.0 to 1.5 equivalents of compound [VIII] to 1 equivalent of compound [VII] .

용매를 사용하는 경우, 적당한 용매로서는 지방족 탄화수소류(헥산, 헵탄 등), 방향족 탄화수소류(벤젠, 톨루엔, 크실렌 등), 할로겐화탄화수소류(디클로로메탄, 클로로포름, 1,2-디클로로에탄, 클로로벤젠, 디클로로벤젠 등), 에테르류(디에틸에테르, 테트라하이드로푸란, 디옥산 등), 에스테르류(에틸 아세테이트, 부틸 아세테이트 등), 케톤류(아세톤, 메틸 에틸 케톤 등), 비양성자성 극성 용매류(N,N-디메틸포름아미드, N-메틸피롤리돈, 디메틸설폭사이드, 설폴란, 아세토니트릴 등), 알콜류(메탄올, 에탄올, 2-프로판올 등), 유기산류(포름산, 아세트산 등), 물 및 이들의 혼합물 등을 들 수 있다.When a solvent is used, suitable solvents include aliphatic hydrocarbons (hexane, heptane, etc.), aromatic hydrocarbons (benzene, toluene, xylene, etc.), halogenated hydrocarbons (dichloromethane, chloroform, 1,2-dichloroethane, chlorobenzene, Dichlorobenzene, etc.), ethers (diethyl ether, tetrahydrofuran, dioxane, etc.), esters (ethyl acetate, butyl acetate, etc.), ketones (acetone, methyl ethyl ketone, etc.), aprotic polar solvents (N , N-dimethylformamide, N-methylpyrrolidone, dimethylsulfoxide, sulfolane, acetonitrile, etc., alcohols (methanol, ethanol, 2-propanol, etc.), organic acids (formic acid, acetic acid, etc.), water and these And mixtures thereof.

사용되는 염기로서는 트리에틸아민, 디이소프로필에틸아민, 피리딘, 피콜린, N,N-디에틸아닐린, 4-(디메틸아미노)피리딘, 1,8-디아지비사이클로[5,4,0]-7-운데센, 1,5-디아자비사이클로[4,3,0]-5-노넨, 1,4-디아자비사이클로[2,2,2]옥탄 등의 유기 염기, 및 수소화나트륨, 수소화칼륨, 수산화나트륨, 수산화칼륨, 탄산나트륨, 탄산칼륨, 탄산수소나트륨, 탄산수소칼륨, 아세트산나트륨, 아세트산칼륨, 플루오르화나트륨, 플루오르화칼륨 등의 무기 염기를 들 수 있다.Bases used may include triethylamine, diisopropylethylamine, pyridine, picoline, N, N-diethylaniline, 4- (dimethylamino) pyridine, 1,8-diazabicyclo [5,4,0]- Organic bases such as 7-undecene, 1,5-diazabicyclo [4,3,0] -5-nonene, 1,4-diazabicyclo [2,2,2] octane, and sodium hydride and potassium hydride And inorganic bases such as sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogencarbonate, potassium hydrogencarbonate, sodium acetate, potassium acetate, sodium fluoride and potassium fluoride.

제조방법(2)Manufacturing method (2)

상기 반응식에서,In the above scheme,

X, Y, Z, R1및 R2는 위에서 정의한 바와 같으며,X, Y, Z, R 1 and R 2 are as defined above,

R3"는 수소원자, 니트로기, 알콕시기, 알킬티오기, 디알킬아미노기 등의 본 반응 및 하기에 나타낸 중간체[V]의 합성에 영향을 받지 않는 불활성 기이다.R 3 ″ is an inert group which is not affected by the present reaction of hydrogen atom, nitro group, alkoxy group, alkylthio group, dialkylamino group and the like and the synthesis of intermediate [V] shown below.

상기 반응은 용매를 사용하지 않거나 용매 속에서, 할로겐화제 존재하에 통상적으로 0 내지 200℃, 바람직하게는 10 내지 100℃의 온도의 범위에서 행하여진다. 반응에 사용되는 화합물의 양은 통상적으로 [V] 1당량에 대하여 할로겐화제가 1.0 내지 3.0당량, 바람직하게는 1.5 내지 2.0당량이다.The reaction is usually carried out in the range of a temperature of 0 to 200 캜, preferably 10 to 100 캜 in the presence of a halogenating agent in the absence of a solvent or in a solvent. The amount of the compound used in the reaction is usually 1.0 to 3.0 equivalents, preferably 1.5 to 2.0 equivalents, of halogenating agent relative to 1 equivalent of [V].

용매를 사용하는 경우, 적당한 용매로서는 지방족 탄화수소류(헥산, 헵탄 등), 방향족 탄화수소류(벤젠, 톨루엔, 크실렌 등), 할로겐화탄화수소류(디클로로메탄, 클로로포름, 1,2-디클로로에탄, 클로로벤젠, 디클로로벤젠 등), 에테르류(디에틸에테르, 테트라하이드로푸란, 디옥산 등) 및 이들의 혼합물 등을 들 수 있다. 사용되는 할로겐화제로서는 3염화인, 옥시염화인, 5염화인, 염화수소, 3브롬화인, 브롬화수소, 설파트리플루오라이드 디에틸아민 착물, 테트라부틸암모늄플루오라이드, 플루오르화수소 등을 들 수 있다.When a solvent is used, suitable solvents include aliphatic hydrocarbons (hexane, heptane, etc.), aromatic hydrocarbons (benzene, toluene, xylene, etc.), halogenated hydrocarbons (dichloromethane, chloroform, 1,2-dichloroethane, chlorobenzene, Dichlorobenzene etc.), ethers (diethyl ether, tetrahydrofuran, dioxane etc.), mixtures thereof, etc. are mentioned. Examples of the halogenating agent to be used include phosphorus trichloride, phosphorus oxychloride, phosphorus pentachloride, hydrogen chloride, phosphorus tribromide, hydrogen bromide, sulfatrifluoride diethylamine complex, tetrabutylammonium fluoride, hydrogen fluoride and the like.

제조방법(3)Manufacturing Method (3)

상기 반응식에서,In the above scheme,

X, Y, Z, R1, R2및 Q는 위에서 정의한 바와 같다(단, [Ia]에 있어서 R12는 수소원자를 제외한다).X, Y, Z, R 1 , R 2 and Q are as defined above, except that R 12 in [Ia] excludes a hydrogen atom.

상기 반응은 용매를 사용하지 않거나 용매 속에서, 산의 존재하에 통상적으로 -20 내지 200℃, 바람직하게는 10 내지 100℃의 온도의 범위에서 행하여진다. 용매를 사용하는 경우, 적당한 용매로서는 지방족 탄화수소류(헥산, 헵탄 등), 방향족 탄화수소류(벤젠, 톨루엔, 크실렌 등), 할로겐화탄화수소류(디클로로메탄, 클로로포름, 1,2-디클로로에탄, 클로로벤젠, 디클로로벤젠 등), 에테르류(디에틸에테르, 테트라하이드로푸란, 디옥산 등), 비양성자성 극성 용매류(N,N-디메틸포름아미드, N-메틸피롤리돈, 디메틸설폭사이드, 설폴란, 아세토니트릴 등), 알콜류(메탄올, 에탄올, 2-프로판올 등), 물 및 이들의 혼합물 등을 들 수 있다.The reaction is carried out in the absence of a solvent or in a solvent, in the presence of an acid, usually at a temperature in the range of -20 to 200 ° C, preferably 10 to 100 ° C. When a solvent is used, suitable solvents include aliphatic hydrocarbons (hexane, heptane, etc.), aromatic hydrocarbons (benzene, toluene, xylene, etc.), halogenated hydrocarbons (dichloromethane, chloroform, 1,2-dichloroethane, chlorobenzene, Dichlorobenzene, etc.), ethers (diethyl ether, tetrahydrofuran, dioxane, etc.), aprotic polar solvents (N, N-dimethylformamide, N-methylpyrrolidone, dimethyl sulfoxide, sulfolane, Acetonitrile, etc.), alcohols (methanol, ethanol, 2-propanol, etc.), water, and mixtures thereof.

사용되는 산으로서는 포름산, 아세트산, 트리플루오로아세트산, 염산, 브롬화수소산, 요오드화수소산, 황산, 인산, 메탄설폰산, p-톨루엔설폰산 등의 산류를 들 수 있다. 또한, 원료 화합물인 [Ia]는 상기 제조방법(1) 또는 제조방법(2)에 의해 합성할 수 있다. [Ia]에 있어서 R12는 알킬기, 사이클로알킬기, 아실기 또는 알콕시알킬기 등이 바람직하다.Examples of the acid used include acids such as formic acid, acetic acid, trifluoroacetic acid, hydrochloric acid, hydrobromic acid, hydroiodic acid, sulfuric acid, phosphoric acid, methanesulfonic acid, and p-toluenesulfonic acid. In addition, [Ia] which is a raw material compound can be synthesized by the production method (1) or the production method (2). In [Ia], R 12 is preferably an alkyl group, a cycloalkyl group, an acyl group or an alkoxyalkyl group.

R12가 상기 화학식 III과 같이 상기 제조방법(1)에 기재된 환화 반응(環化反應)에 영향을 준다고 예상되는 경우에는 상기 제조방법(3)으로 얻어지는 화합물을 하기 제조방법(4) 또는 (5)에 의해서 유도체화함으로써 제조할 수 있다.When it is expected that R 12 affects the cyclization reaction described in the above Preparation Method (1) as in Formula III, the compound obtained by the above Preparation Method (3) may be prepared by the following Preparation Method (4) or (5). By derivatization).

제조방법(4)Manufacturing method (4)

상기 반응식에서,In the above scheme,

X, Y, Z, R1, R2, R12및 Q는 위에서 정의한 바와 같으며(단, R12는 수소원자를 제외한다),X, Y, Z, R 1 , R 2 , R 12 and Q are as defined above (where R 12 excludes hydrogen atoms),

V는 염소원자, 브롬원자, 요오드 원자 등의 할로겐 원자; 메틸설포닐옥시기 등의 저급 알킬설포닐옥시기; 또는 p-톨루엔설포닐옥시기 등의 아릴설포닐옥시기이다.V is a halogen atom such as chlorine atom, bromine atom or iodine atom; Lower alkylsulfonyloxy groups such as methylsulfonyloxy group; Or arylsulfonyloxy groups such as p-toluenesulfonyloxy group.

상기 반응은 용매를 사용하지 않거나 용매 속에서, 염기의 존재하에 통상적으로 0 내지 200℃, 바람직하게는 10 내지 100℃의 온도의 범위에서 행하여진다. 반응에 사용되는 화합물의 양은 통상적으로 [Ib] 1당량에 대하여 R12-V가 1.0 내지 3.0당량, 바람직하게는 1.0 내지 1.5당량이고, 염기가 1.0 내지 3.0당량, 바람직하게는 1.0 내지 1.5당량이다.The reaction is carried out in the presence of a base, in the absence of a solvent or in a solvent, at a temperature in the range of usually 0 to 200 ° C, preferably 10 to 100 ° C. The amount of the compound used in the reaction is usually 1.0 to 3.0 equivalents, preferably 1.0 to 1.5 equivalents, and 1.0 to 3.0 equivalents, preferably 1.0 to 1.5 equivalents, of R 12 -V relative to 1 equivalent of [Ib]. .

용매를 사용하는 경우, 적당한 용매로서는 지방족 탄화수소류(헥산, 헵탄 등), 방향족 탄화수소류(벤젠, 톨루엔, 크실렌 등), 할로겐화탄화수소류(디클로로메탄, 클로로포름, 1,2-디클로로에탄, 클로로벤젠, 디클로로벤젠 등), 에테르류(디에틸에테르, 테트라하이드로푸란, 디옥산 등), 에스테르류(에틸 아세테이트, 부틸 아세테이트 등), 케톤류(아세톤, 메틸에틸케톤 등), 비양성자성 극성 용매류(N,N-디메틸포름아미드, N-메틸피롤리돈, 디메틸설폭사이드, 설폴란, 아세토니트릴 등), 알콜류(메탄올, 에탄올, 2-프로판올 등), 유기산류(포름산, 아세트산 등), 물 및 이들의 혼합물 등을 들 수 있다. 사용되는 염기로서는 트리에틸아민, 피리딘, 피콜린, N,N-디에틸아닐린, 4-(디메틸아미노)피리딘, 1,8-디아자비사이클로[5,4,0]-7-운데센, 1,5-디아자비사이클로[4,3,0]-5-노넨, 1,4-디아자비사이클로[2,2,2]옥탄 등의 유기 염기, 및 수소화나트륨, 수소화칼륨, 수산화나트륨, 수산화칼륨, 탄산나트륨, 탄산칼륨, 탄산수소나트륨, 탄산수소칼륨, 아세트산나트륨, 아세트산칼륨, 플루오르화나트륨, 플루오르화칼륨 등의 무기 염기를 들 수 있다.When a solvent is used, suitable solvents include aliphatic hydrocarbons (hexane, heptane, etc.), aromatic hydrocarbons (benzene, toluene, xylene, etc.), halogenated hydrocarbons (dichloromethane, chloroform, 1,2-dichloroethane, chlorobenzene, Dichlorobenzene, etc.), ethers (diethyl ether, tetrahydrofuran, dioxane, etc.), esters (ethyl acetate, butyl acetate, etc.), ketones (acetone, methyl ethyl ketone, etc.), aprotic polar solvents (N , N-dimethylformamide, N-methylpyrrolidone, dimethylsulfoxide, sulfolane, acetonitrile, etc., alcohols (methanol, ethanol, 2-propanol, etc.), organic acids (formic acid, acetic acid, etc.), water and these And mixtures thereof. Bases used include triethylamine, pyridine, picoline, N, N-diethylaniline, 4- (dimethylamino) pyridine, 1,8-diazabicyclo [5,4,0] -7-undecene, 1 Organic bases such as, 5-diazabicyclo [4,3,0] -5-nonene, 1,4-diazabicyclo [2,2,2] octane, and sodium hydride, potassium hydride, sodium hydroxide, potassium hydroxide And inorganic bases such as sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate, sodium acetate, potassium acetate, sodium fluoride and potassium fluoride.

제조방법(5)Manufacturing Method (5)

상기 반응식에서,In the above scheme,

X, Y, Z, R1, R2, R12및 Q는 위에서 정의한 바와 같으며(단, R12는 수소원자를 제외한다),X, Y, Z, R 1 , R 2 , R 12 and Q are as defined above (where R 12 excludes hydrogen atoms),

R18은 메틸기, 에틸기 등의 저급 알킬기이다.R <18> is lower alkyl groups, such as a methyl group and an ethyl group.

상기 반응은 용매를 사용하지 않거나 용매 속에서, 트리페닐포스핀과 아조디카복실산 디알킬의 존재하에 통상적으로 0 내지 100℃, 바람직하게는 0 내지 50℃의 온도의 범위에서 행하여진다. 반응에 사용되는 화합물의 양은 통상적으로 [1b] 1당량에 대하여 R12-OH가 1.0 내지 3.0당량, 바람직하게는 1.0 내지 1.5당량, 트리페닐포스핀이 1.0 내지 3.0당량, 바람직하게는 1.0 내지 1.5당량, 아조디카복실산 디알킬이 1.0 내지 3.0당량, 바람직하게는 1.0 내지 1.5당량이다.The reaction is usually carried out at a temperature in the range of 0 to 100 ° C., preferably 0 to 50 ° C., in the presence of triphenylphosphine and azodicarboxylic acid dialkyl in the absence of a solvent or in a solvent. The amount of the compound used in the reaction typically [1b] 1 equivalent of R 12 -OH is 1.0 to 3.0 equivalents per equivalent, preferably 1.0 to 1.5 equivalents, of triphenylphosphine is 1.0 to 3.0 equivalents, preferably 1.0 to 1.5 The equivalent, azodicarboxylic acid dialkyl is 1.0 to 3.0 equivalents, preferably 1.0 to 1.5 equivalents.

용매를 사용하는 경우, 적당한 용매로서는 지방족 탄화수소류(헥산, 헵탄 등), 방향족 탄화수소류(벤젠, 톨루엔, 크실렌 등), 할로겐화탄화수소류(디클로로메탄, 클로로포름, 1,2-디클로로에탄, 클로로벤젠, 디클로로벤젠 등), 에테르류(디에틸에테르, 테트라하이드로푸란, 디옥산 등), 에스테르류(에틸 아세테이트, 부틸 아세테이트 등), 케톤류(아세톤, 메틸에틸케톤 등), 비양성자성 극성 용매류(N,N-디메틸포름아미드, N-메틸피롤리돈, 디메틸설폭사이드, 설폴란, 아세토니트릴 등) 및 이들의 혼합물 등을 들 수 있다.When a solvent is used, suitable solvents include aliphatic hydrocarbons (hexane, heptane, etc.), aromatic hydrocarbons (benzene, toluene, xylene, etc.), halogenated hydrocarbons (dichloromethane, chloroform, 1,2-dichloroethane, chlorobenzene, Dichlorobenzene, etc.), ethers (diethyl ether, tetrahydrofuran, dioxane, etc.), esters (ethyl acetate, butyl acetate, etc.), ketones (acetone, methyl ethyl ketone, etc.), aprotic polar solvents (N , N-dimethylformamide, N-methylpyrrolidone, dimethyl sulfoxide, sulfolane, acetonitrile and the like) and mixtures thereof.

제조방법(6)Manufacturing Method (6)

상기 반응식에서,In the above scheme,

X, Y, Z, R1및 R2는 위에서 정의한 바와 같다.X, Y, Z, R 1 and R 2 are as defined above.

상기 반응은 용매를 사용하지 않거나 용매 속에서, 통상적으로 -10 내지 150℃, 바람직하게는 20 내지 60℃의 온도의 범위에서 행하여진다. 반응에 사용되는 화합물의 양은 통상적으로 [Ic] 1당량에 대하여 1.0 내지 3.0당량, 바람직하게는 1.5 내지 2.0당량의 니트로화제를 사용한다.The reaction is carried out in the range of -10 to 150 캜, preferably 20 to 60 캜, in the absence of a solvent or in a solvent. The amount of the compound used in the reaction is usually 1.0 to 3.0 equivalents, preferably 1.5 to 2.0 equivalents of a nitrating agent relative to 1 equivalent of [Ic].

용매를 사용하는 경우, 적당한 용매로서는 무기산류(황산, 염산 등), 유기산류(포름산, 아세트산 등), 유기 무수산류(무수 아세트산 등) 등을 들 수 있다. 사용되는 니트로화제로서는 무기산류(황산, 염산)와 질산 또는 질산염(질산나트륨, 질산칼륨 등)과의 혼합물, 질산, 니트로늄테트라플루오로보레이트, 니트로늄트리플루오로메탄설포네이트 등을 들 수 있다.When using a solvent, a suitable solvent includes inorganic acids (sulfuric acid, hydrochloric acid, etc.), organic acids (formic acid, acetic acid, etc.), organic anhydrides (acetic anhydride, etc.), and the like. Examples of the nitrating agent used include mixtures of inorganic acids (sulfuric acid, hydrochloric acid) with nitric acid or nitrates (sodium nitrate, potassium nitrate, etc.), nitric acid, nitronium tetrafluoroborate, nitronium trifluoromethanesulfonate, and the like. .

제조방법(7)Manufacturing method (7)

상기 반응식에서,In the above scheme,

X, Y, Z, R1및 R2는 위에서 정의한 바와 같다.X, Y, Z, R 1 and R 2 are as defined above.

상기 환원 반응은 용매를 사용하지 않거나 용매 속에서, 금속 또는 금속 화합물 및 산의 존재하에 통상적으로 50 내지 100℃의 온도 범위에서 행하여진다. 사용되는 금속 또는 금속 화합물의 양은 통상적으로 [Id] 1당량에 대하여 1 내지 20당량, 바람직하게는 2 내지 10당량이다. 사용되는 산의 양은 통상적으로 [Id]가 1당량에 대하여 0.01 내지 20당량, 바람직하게는 0.01 내지 10당량이다.The reduction reaction is usually performed at a temperature in the range of 50 to 100 ° C. in the absence of a solvent or in the presence of a metal or a metal compound and an acid. The amount of the metal or metal compound used is usually 1 to 20 equivalents, preferably 2 to 10 equivalents, relative to 1 equivalent of [Id]. The amount of acid used is usually 0.01 to 20 equivalents, preferably 0.01 to 10 equivalents, relative to 1 equivalent of [Id].

용매를 사용하는 경우, 적당한 용매로서는 지방족 탄화수소류(헥산, 헵탄 등), 방향족 탄화수소류(벤젠, 톨루엔, 크실렌 등), 할로겐화탄화수소류(디클로로메탄, 클로로포름, 1,2-디클로로에탄, 클로로벤젠, 디클로로벤젠 등), 에테르류(디에틸에테르, 테트라하이드로푸란, 디옥산 등), 에스테르류(에틸 아세테이트, 부틸 아세테이트 등), 케톤류(아세톤, 메틸에틸케톤 등), 비양성자성 극성 용매류(N,N-디메틸포름아미드, N-메틸피롤리돈, 디메틸설폭사이드, 설폴란, 아세토니트릴 등), 유기산류(포름산, 아세트산), 물 및 이들의 혼합물 등을 들 수 있다. 사용되는 용매의 양은 통상적으로 [Id]의 중량의 1 내지 100배, 바람직하게는 1 내지 20배이다. 사용되는 금속 또는 금속 화합물로서는 철, 아연, 주석, 염화주석(II) 등을 들 수 있다. 사용되는 산으로서는 염산, 황산, 아세트산 등을 들 수 있다. 또한, 상기 반응은 환원제로서, 황화나트륨, 나트륨하이드로설파이드, 아2티온산나트륨, 황화암모늄, 수소/금속 촉매(팔라듐-탄소, 백금-탄소, 로듐-알루미나, 백금, 라니 니켈 등) 등을 사용하는 것도 가능하다.When a solvent is used, suitable solvents include aliphatic hydrocarbons (hexane, heptane, etc.), aromatic hydrocarbons (benzene, toluene, xylene, etc.), halogenated hydrocarbons (dichloromethane, chloroform, 1,2-dichloroethane, chlorobenzene, Dichlorobenzene, etc.), ethers (diethyl ether, tetrahydrofuran, dioxane, etc.), esters (ethyl acetate, butyl acetate, etc.), ketones (acetone, methyl ethyl ketone, etc.), aprotic polar solvents (N , N-dimethylformamide, N-methylpyrrolidone, dimethyl sulfoxide, sulfolane, acetonitrile, and the like), organic acids (formic acid, acetic acid), water, and mixtures thereof. The amount of solvent used is usually 1 to 100 times, preferably 1 to 20 times the weight of [Id]. Examples of the metal or metal compound to be used include iron, zinc, tin, tin chloride (II) and the like. Examples of the acid used may include hydrochloric acid, sulfuric acid, acetic acid, and the like. In addition, the reaction uses sodium sulfide, sodium hydrosulfide, sodium dithionate, ammonium sulfide, hydrogen / metal catalyst (palladium-carbon, platinum-carbon, rhodium-alumina, platinum, Raney nickel, etc.) as a reducing agent. It is also possible.

제조방법(8)Manufacturing Method (8)

상기 반응식에서,In the above scheme,

X, Y, Z, R1, R2, R12및 R13은 위에서 정의한 바와 같으며(단, R12는 수소원자를 제외한다),X, Y, Z, R 1 , R 2 , R 12 and R 13 are as defined above, except R 12 excludes hydrogen atoms,

V는 염소원자, 브롬원자, 요오드 원자 등의 할로겐 원자; 메틸설포닐옥시기 등의 저급 알킬설포닐옥시기; 또는 p-톨루엔설포닐옥시기 등의 아릴설포닐옥시기이다.V is a halogen atom such as chlorine atom, bromine atom or iodine atom; Lower alkylsulfonyloxy groups such as methylsulfonyloxy group; Or arylsulfonyloxy groups such as p-toluenesulfonyloxy group.

상기 반응은 용매를 사용하지 않거나 용매 속에서, 염기의 존재하에 통상적으로 0 내지 200℃, 바람직하게는 10 내지 100℃의 온도의 범위에서 행하여진다. 반응에 사용되는 화합물의 양은 통상적으로 [If] 1당량에 대하여 R13-V가 1.0 내지 3.0당량, 바람직하게는 1.5 내지 2.0당량이고, 염기가 1.0 내지 3.0당량, 바람직하게는 1.5 내지 2.0당량이다.The reaction is carried out in the presence of a base, in the absence of a solvent or in a solvent, at a temperature in the range of usually 0 to 200 ° C, preferably 10 to 100 ° C. The amount of the compound used in the reaction is usually 1.0 to 3.0 equivalents, preferably 1.5 to 2.0 equivalents, and 1.0 to 3.0 equivalents, preferably 1.5 to 2.0 equivalents, of R 13 -V to 1 equivalent of [If]. .

용매를 사용하는 경우, 적당한 용매로서는 지방족 탄화수소류(헥산, 헵탄 등), 방향족 탄화수소류(벤젠, 톨루엔, 크실렌 등), 할로겐화탄화수소류(디클로로메탄, 클로로포름, 1,2-디클로로에탄, 클로로벤젠, 디클로로벤젠 등), 에테르류(디에틸에테르, 테트라하이드로푸란, 디옥산 등), 에스테르류(에틸 아세테이트, 부틸 아세테이트 등), 케톤류(아세톤, 메틸에틸케톤 등), 비양성자성 극성 용매류(N,N-디메틸포름아미드, N-메틸피롤리돈, 디메틸설폭사이드, 설폴란, 아세토니트릴 등), 알콜류(메탄올, 에탄올, 2-프로판올 등), 유기산류(포름산, 아세트산 등), 물 및 이들의 혼합물 등을 들 수 있다. 사용되는 염기로서는 트리에틸아민, 피리딘, 피콜린, N,N-디에틸아닐린, 4-(디메틸아미노)피리딘, 1,8-디아자비사이클로[5,4,0]-7-운데센, 1,5-디아자비사이클로[4,3,0]-5-노넨, 1,4-디아자비사이클로[2,2,2]옥탄 등의 유기 염기, 및 수소화나트륨, 수소화칼륨, 수산화나트륨, 수산화칼륨, 탄산나트륨, 탄산칼륨, 탄산수소나트륨, 탄산수소칼륨, 아세트산나트륨, 아세트산칼륨, 플루오르화나트륨, 플루오르화칼륨 등의 무기 염기를 들 수 있다.When a solvent is used, suitable solvents include aliphatic hydrocarbons (hexane, heptane, etc.), aromatic hydrocarbons (benzene, toluene, xylene, etc.), halogenated hydrocarbons (dichloromethane, chloroform, 1,2-dichloroethane, chlorobenzene, Dichlorobenzene, etc.), ethers (diethyl ether, tetrahydrofuran, dioxane, etc.), esters (ethyl acetate, butyl acetate, etc.), ketones (acetone, methyl ethyl ketone, etc.), aprotic polar solvents (N , N-dimethylformamide, N-methylpyrrolidone, dimethylsulfoxide, sulfolane, acetonitrile, etc., alcohols (methanol, ethanol, 2-propanol, etc.), organic acids (formic acid, acetic acid, etc.), water and these And mixtures thereof. Bases used include triethylamine, pyridine, picoline, N, N-diethylaniline, 4- (dimethylamino) pyridine, 1,8-diazabicyclo [5,4,0] -7-undecene, 1 Organic bases such as, 5-diazabicyclo [4,3,0] -5-nonene, 1,4-diazabicyclo [2,2,2] octane, and sodium hydride, potassium hydride, sodium hydroxide, potassium hydroxide And inorganic bases such as sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate, sodium acetate, potassium acetate, sodium fluoride and potassium fluoride.

제조방법(9)Manufacturing Method (9)

상기 반응식에서,In the above scheme,

X, Y, R1, R2및 R3은 위에서 정의한 바와 같고,X, Y, R 1 , R 2 and R 3 are as defined above,

X'는 할로겐 원자이고,X 'is a halogen atom,

Met는 금속 원자이다.Met is a metal atom.

상기 반응은 용매를 사용하지 않거나 용매 속에서, 통상적으로 0 내지 250℃, 바람직하게는 100 내지 200℃의 온도의 범위에서 행하여진다. 반응에 사용되는 화합물의 양은 통상적으로 [Ih] 1당량에 대하여 시아노화제(Met-CN)가 1.0 내지 3.0당량, 바람직하게는 1.5 내지 2.0당량이다.The reaction is carried out in a solvent-free or in a solvent, usually at a temperature of 0 to 250 캜, preferably 100 to 200 캜. The amount of the compound used for the reaction is usually 1.0 to 3.0 equivalents, preferably 1.5 to 2.0 equivalents of cyanolating agent (Met-CN) to 1 equivalent of [Ih].

용매를 사용하는 경우, 적당한 용매로서는 지방족 탄화수소류(헥산, 헵탄 등), 방향족 탄화수소류(벤젠, 톨루엔, 크실렌 등), 할로겐화탄화수소류(디클로로메탄, 클로로포름, 1,2-디클로로에탄, 클로로벤젠, 디클로로벤젠 등), 에테르류(디에틸에테르, 테트라하이드로푸란, 디옥산 등), 에스테르류(에틸 아세테이트, 부틸 아세테이트 등), 케톤류(아세톤, 메틸에틸케톤 등), 비양성자성 극성 용매류(N,N-디메틸포름아미드, N-메틸피롤리돈, 디메틸설폭사이드, 설폴란, 아세토니트릴 등), 알콜류(메탄올, 에탄올, 2-프로판올 등), 유기산류(포름산, 아세트산 등), 물 및 이들의 혼합물 등을 들 수 있다. 사용되는 시아노화제로서는 시안화구리, 시안화칼륨, 시안화나트륨 등을 들 수 있다.When a solvent is used, suitable solvents include aliphatic hydrocarbons (hexane, heptane, etc.), aromatic hydrocarbons (benzene, toluene, xylene, etc.), halogenated hydrocarbons (dichloromethane, chloroform, 1,2-dichloroethane, chlorobenzene, Dichlorobenzene, etc.), ethers (diethyl ether, tetrahydrofuran, dioxane, etc.), esters (ethyl acetate, butyl acetate, etc.), ketones (acetone, methyl ethyl ketone, etc.), aprotic polar solvents (N , N-dimethylformamide, N-methylpyrrolidone, dimethylsulfoxide, sulfolane, acetonitrile, etc., alcohols (methanol, ethanol, 2-propanol, etc.), organic acids (formic acid, acetic acid, etc.), water and these And mixtures thereof. Copper cyanide, potassium cyanide, sodium cyanide, etc. are mentioned as a cyanoating agent used.

제조방법(10)Manufacturing Method (10)

상기 반응식에서,In the above scheme,

X, Y, Z, R1, R2, R3, n 및 m은 위에서 정의한 바와 같다(단, n+m>0).X, Y, Z, R 1 , R 2 , R 3 , n and m are as defined above (where n + m> 0).

상기 반응은 용매를 사용하지 않거나 용매 속에서, 산화제의 존재하에 금속 또는 금속 착물의 존재하에 또는 부재하에 통상적으로 0 내지 200℃, 바람직하게는 10 내지 100℃의 온도의 범위에서 행하여진다. 반응에 사용되는 화합물의 양은 통상적으로 [I]이 1당량에 대하여 산화제가 1.0 내지 3.0당량, 바람직하게는 1.5 내지 2.5당량이고, 금속 또는 금속 착물이 필요할 때는 0.05 내지 1.5당량, 바람직하게는 0.1 내지 1.0당량이다.The reaction is usually carried out at a temperature in the range of 0 to 200 ° C., preferably 10 to 100 ° C., without or using a solvent, in the presence of an oxidant, in the presence or absence of a metal or metal complex. The amount of the compound used in the reaction is typically 1.0 to 3.0 equivalents, preferably 1.5 to 2.5 equivalents of oxidizing agent relative to 1 equivalent of [I], and 0.05 to 1.5 equivalents, preferably 0.1 to 0.1, when a metal or metal complex is required. 1.0 equivalent.

용매를 사용하는 경우, 적당한 용매로서는 지방족 탄화수소류(헥산, 헵탄 등), 방향족 탄화수소류(벤젠, 톨루엔, 크실렌 등), 할로겐화탄화수소류(디클로로메탄, 클로로포름, 1,2-디클로로에탄, 클로로벤젠, 디클로로벤젠 등), 비양성자성 극성 용매류(N,N-디메틸포름아미드, N-메틸피롤리돈, 디메틸설폭사이드, 설폴란, 아세토니트릴 등), 알콜류(메탄올, 에탄올, 2-프로판올 등), 유기산류(포름산, 아세트산 등), 물 및 이들의 혼합물 등을 들 수 있다. 사용되는 산화제로서는 m-클로로벤조산, 과아세트산, 과산화수소, 3급-부틸하이드로퍼옥사이드 등을 들 수 있다. 사용되는 금속 또는 금속 착물로서는 바나듐, 몰리브덴, 티탄테트라이소프로폭사이드-타르타르산디이소프로필 착물 등을 들 수 있다.When a solvent is used, suitable solvents include aliphatic hydrocarbons (hexane, heptane, etc.), aromatic hydrocarbons (benzene, toluene, xylene, etc.), halogenated hydrocarbons (dichloromethane, chloroform, 1,2-dichloroethane, chlorobenzene, Dichlorobenzene, etc.), aprotic polar solvents (N, N-dimethylformamide, N-methylpyrrolidone, dimethylsulfoxide, sulfolane, acetonitrile, etc.), alcohols (methanol, ethanol, 2-propanol, etc.) , Organic acids (formic acid, acetic acid, and the like), water, and mixtures thereof. Examples of the oxidizing agent used include m-chlorobenzoic acid, peracetic acid, hydrogen peroxide, tert-butyl hydroperoxide and the like. As a metal or metal complex used, a vanadium, molybdenum, a titanium tetraisopropoxide- diiso tartrate complex, etc. are mentioned.

제조방법(11)Manufacturing Method (11)

상기 반응식에서,In the above scheme,

X, Y, Z, R1, R2및 R3은 위에서 정의한 바와 동일하며,X, Y, Z, R 1 , R 2 and R 3 are the same as defined above,

H-U는 본원 화합물과 염을 형성하는 산이고 구체적으로는 플루오르화수소산, 염산, 브롬화수소산, 요오드화수소산과 같은 할로겐화수소산; 질산, 과염소산, 황산, 인산과 같은 무기산; 메탄설폰산, 트리플루오로메탄설폰산, p-톨루엔설폰산과 같은 설폰산이다.H-U is an acid which forms a salt with the compound of the present application, and specifically, hydrofluoric acid such as hydrofluoric acid, hydrochloric acid, hydrobromic acid, hydroiodic acid; Inorganic acids such as nitric acid, perchloric acid, sulfuric acid, phosphoric acid; Sulfonic acids such as methanesulfonic acid, trifluoromethanesulfonic acid, p-toluenesulfonic acid.

상기 반응은 용매를 사용하지 않거나 용매 속에서, H-U의 존재하에 통상적으로 0 내지 200℃, 바람직하게는 10 내지 100℃의 온도의 범위에서 행하여진다. 반응에 사용되는 화합물의 양은 통상적으로 [I] 1당량에 대하여 H-U가 1.0 내지 3.0당량, 바람직하게는 1.0 내지 1.5당량이다.The reaction is carried out in the absence of a solvent or in a solvent, in the presence of H-U, at a temperature in the range of usually 0 to 200 ° C, preferably 10 to 100 ° C. The amount of the compound used in the reaction is usually 1.0 to 3.0 equivalents, preferably 1.0 to 1.5 equivalents of H-U, based on 1 equivalent of [I].

용매를 사용하는 경우, 적당한 용매로서는 지방족 탄화수소류(헥산, 헵탄 등), 방향족 탄화수소류(벤젠, 톨루엔, 크실렌 등), 할로겐화탄화수소류(디클로로메탄, 클로로포름, 1,2-디클로로에탄, 클로로벤젠, 디클로로벤젠 등), 에테르류(디에틸에테르, 테트라하이드로푸란, 디옥산 등), 에스테르류(에틸 아세테이트, 부틸 아세테이트 등), 케톤류(아세톤, 메틸에틸케톤 등), 비양성자성 극성 용매류(N,N-디메틸포름아미드, N-메틸피롤리돈, 디메틸설폭사이드, 설폴란, 아세토니트릴 등), 알콜류(메탄올, 에탄올, 2-프로판올 등), 물 및 이들의 혼합물 등을 들 수 있다.When a solvent is used, suitable solvents include aliphatic hydrocarbons (hexane, heptane, etc.), aromatic hydrocarbons (benzene, toluene, xylene, etc.), halogenated hydrocarbons (dichloromethane, chloroform, 1,2-dichloroethane, chlorobenzene, Dichlorobenzene, etc.), ethers (diethyl ether, tetrahydrofuran, dioxane, etc.), esters (ethyl acetate, butyl acetate, etc.), ketones (acetone, methyl ethyl ketone, etc.), aprotic polar solvents (N , N-dimethylformamide, N-methylpyrrolidone, dimethyl sulfoxide, sulfolane, acetonitrile and the like), alcohols (methanol, ethanol, 2-propanol and the like), water and mixtures thereof and the like.

제조방법(12)Manufacturing Method (12)

상기 반응식에서,In the above scheme,

X, Y, Z, R1, R2및 R3은 위에서 정의한 바와 같으며,X, Y, Z, R 1 , R 2 and R 3 are as defined above,

X'는 할로겐 원자이고,X 'is a halogen atom,

P는 -B(OH)2또는 -Met'-X"(여기서, Met'는 마그네슘, 아연 등의 금속이고, X"는 할로겐 원자이다)이다.P is a -B (OH) 2 or -Met'-X "(Here, the metal such as Met 'is magnesium, zinc, X" is a halogen atom).

상기 반응은 용매를 사용하지 않거나 용매 속에서, 금속 또는 금속 착물의 존재하에 또는 부재하에 0 내지 200℃, 바람직하게는 10 내지 100℃의 온도의 범위에서 행하여진다. 반응에 사용되는 화합물의 양은 통상적으로 [IX] 1당량에 대하여 [X]가 1.0 내지 3.0당량, 바람직하게는 1.0 내지 1.5당량, 금속 또는 금속 착물이 0.01 내지 1.0당량, 바람직하게는 0.05 내지 0.5당량이다.The reaction is carried out at a temperature in the range of 0 to 200 ° C., preferably 10 to 100 ° C., with or without a solvent, in the presence or absence of a metal or metal complex. The amount of the compound used in the reaction is usually 1.0 to 3.0 equivalents, preferably 1.0 to 1.5 equivalents, preferably 0.01 to 1.0 equivalents, preferably 0.05 to 0.5 equivalents of metal or metal complex, relative to 1 equivalent of [IX] to be.

용매를 사용하는 경우, 적당한 용매로서는 지방족 탄화수소류(헥산, 헵탄 등), 방향족 탄화수소류(벤젠, 톨루엔, 크실렌 등), 할로겐화탄화수소류(디클로로메탄, 클로로포름, 1,2-디클로로에탄, 클로로벤젠, 디클로로벤젠 등), 에테르류(디에틸에테르, 테트라하이드로푸란, 디옥산 등), 비양성자성 극성 용매류(N,N-디메틸포름아미드, N-메틸피롤리돈, 디메틸설폭사이드, 설폴란, 아세토니트릴 등) 및 이들의 혼합물 등을 들 수 있다. 금속 또는 금속 착물을 사용하는 경우, 적당한 금속 또는 금속 착물로서는 니켈, 철, 루테늄, 코발트, 로듐, 이리듐, 팔라듐, 백금 등의 금속이나, 테트라키스(트리페닐포스핀)팔라듐, 트리스(디벤질리덴아세톤)디팔라듐, 디클로로비스(트리페닐포스핀)팔라듐, 디클로로[1,3-비스(디페닐포스피노)프로판]니켈, 비스(아세틸아세토네이트)니켈, 디클로로[1,1'-비스(디페닐포스피노)페로센]팔라듐 등과 같은 상술한 금속, 또는 상술한 금속의 염화물과 트리페닐포스핀, 트리(o-톨릴)포스핀, 1,2-비스(디페닐포스프피노)에탄, 1,2-비스(디페닐포스프피노)프로판, 1,1'-비스(디페닐포스프피노)페로센, 디벤질리덴아세톤, 아세틸아세톤 등의 배위자로 형성된 금속 착물 등을 들 수 있다.When a solvent is used, suitable solvents include aliphatic hydrocarbons (hexane, heptane, etc.), aromatic hydrocarbons (benzene, toluene, xylene, etc.), halogenated hydrocarbons (dichloromethane, chloroform, 1,2-dichloroethane, chlorobenzene, Dichlorobenzene, etc.), ethers (diethyl ether, tetrahydrofuran, dioxane, etc.), aprotic polar solvents (N, N-dimethylformamide, N-methylpyrrolidone, dimethyl sulfoxide, sulfolane, Acetonitrile), and mixtures thereof. In the case of using a metal or metal complex, suitable metals or metal complexes include metals such as nickel, iron, ruthenium, cobalt, rhodium, iridium, palladium, and platinum, tetrakis (triphenylphosphine) palladium, and tris (dibenzylidene). Acetone) dipalladium, dichlorobis (triphenylphosphine) palladium, dichloro [1,3-bis (diphenylphosphino) propane] nickel, bis (acetylacetonate) nickel, dichloro [1,1'-bis (di The above-mentioned metals such as phenylphosphino) ferrocene] palladium, or the chlorides and triphenylphosphines, tri (o-tolyl) phosphine, 1,2-bis (diphenylphosphino) ethane, And metal complexes formed with ligands such as 2-bis (diphenylphosphino) propane, 1,1'-bis (diphenylphosphino) ferrocene, dibenzylideneacetone, and acetylacetone.

제조방법(13)Manufacturing Method (13)

상기 반응식에서,In the above scheme,

X, Y, Z, R1, R2및 R3은 위에서 정의한 바와 같으며,X, Y, Z, R 1 , R 2 and R 3 are as defined above,

W는 염소원자, 브롬원자, 요오드 원자 등의 할로겐 원자; 메틸설포닐옥시기; 등의 저급 알킬설포닐옥시기; 트리플루오로메틸설포닐옥시기 등의 저급 할로알킬설포닐옥시기; 또는 p-톨루엔설포닐옥시기 등의 아릴설포닐옥시기이다.W is a halogen atom such as chlorine atom, bromine atom or iodine atom; Methylsulfonyloxy group; Lower alkylsulfonyloxy groups such as; Lower haloalkylsulfonyloxy groups such as trifluoromethylsulfonyloxy group; Or arylsulfonyloxy groups such as p-toluenesulfonyloxy group.

상기 반응은 용매를 사용하지 않거나 용매 속에서, 염기의 존재하에 금속 또는 금속 착물의 존재하에 또는 부재하에 -50 내지 200℃, 바람직하게는 0 내지 100℃의 온도의 범위에서 행하여진다. 반응에 사용되는 화합물의 양은 통상적으로 [XII] 1당량에 대하여 [XI]가 1.0 내지 3.0당량, 바람직하게는 1.0 내지 1.5당량, 염기가 1.0 내지 3.0당량, 바람직하게는 1.0 내지 1.5당량, 금속 또는 금속 착물이 0.01 내지 1.0당량, 바람직하게는 0.05 내지 0.5당량이다.The reaction is carried out at a temperature in the range of −50 to 200 ° C., preferably 0 to 100 ° C., with or without solvent, in the presence of a base, in the presence or absence of a metal or metal complex. The amount of the compound used in the reaction is usually 1.0-3.0 equivalents, preferably 1.0-1.5 equivalents, 1.0-3.0 equivalents, preferably 1.0-1.5 equivalents, metal or [XI] based on 1 equivalent of [XII] The metal complex is 0.01 to 1.0 equivalent, preferably 0.05 to 0.5 equivalent.

용매를 사용하는 경우, 적당한 용매로서는 지방족 탄화수소류(헥산, 헵탄 등), 방향족 탄화수소류(벤젠, 톨루엔, 크실렌 등), 할로겐화탄화수소류(디클로로메탄, 클로로포름, 1,2-디클로로에탄, 클로로벤젠, 디클로로벤젠 등), 에테르류(디에틸에테르, 테트라하이드로푸란, 디옥산 등), 비양성자성 극성 용매류(N,N-디메틸포름아미드, N-메틸피롤리돈, 디메틸설폭사이드, 설폴란, 아세토니트릴 등) 및 이들의 혼합물 등을 들 수 있다. 사용되는 염기로서는 트리에틸아민, 피리딘, 피콜린, N,N-디에틸아닐린, 4-(디메틸아미노)피리딘, 1,8-디아자비사이클로[5,4,0]-7-운데센, 1,5-디아자비사이클로[4,3,0]-5-노넨, 1,4-디아자비사이클로[2,2,2]옥탄 등의 유기 염기, 및 수소화나트륨, 수소화칼륨, 부틸리튬, 2급-부틸리튬, 3급-부틸리튬, 페닐리튬, 나트륨메톡사이드, 칼륨메톡사이드, 나트륨에톡사이드, 칼륨에톡사이드, 리튬디이소프로필아미드, 3급-부톡시칼륨, 수산화나트륨, 수산화칼륨, 탄산나트륨, 탄산칼륨, 탄산수소나트륨, 탄산수소칼륨, 아세트산나트륨, 아세트산칼륨, 플루오르화나트륨, 플루오르화칼륨 등의 무기 염기를 들 수 있다. 사용되는 금속 또는 금속 착물로서는 염화구리, 브롬화구리, 요오드화구리, 염화철, 브롬화철, 요오드화철 등을 들 수 있다.When a solvent is used, suitable solvents include aliphatic hydrocarbons (hexane, heptane, etc.), aromatic hydrocarbons (benzene, toluene, xylene, etc.), halogenated hydrocarbons (dichloromethane, chloroform, 1,2-dichloroethane, chlorobenzene, Dichlorobenzene, etc.), ethers (diethyl ether, tetrahydrofuran, dioxane, etc.), aprotic polar solvents (N, N-dimethylformamide, N-methylpyrrolidone, dimethyl sulfoxide, sulfolane, Acetonitrile), and mixtures thereof. Bases used include triethylamine, pyridine, picoline, N, N-diethylaniline, 4- (dimethylamino) pyridine, 1,8-diazabicyclo [5,4,0] -7-undecene, 1 Organic bases such as, 5-diazabicyclo [4,3,0] -5-nonene, 1,4-diazabicyclo [2,2,2] octane, and sodium hydride, potassium hydride, butyllithium, secondary -Butyllithium, tert-butyllithium, phenyllithium, sodium methoxide, potassium methoxide, sodium ethoxide, potassium ethoxide, lithium diisopropylamide, tert-butoxy potassium, sodium hydroxide, potassium hydroxide, Inorganic bases such as sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate, sodium acetate, potassium acetate, sodium fluoride and potassium fluoride. Copper chloride, copper bromide, copper iodide, iron chloride, iron bromide, iron iodide, etc. are mentioned as a metal or metal complex used.

또한, 상기 제조방법(1)에 있어서의 원료 화합물[VII]는 예를 들면, 하기 반응식에 따라서 제조할 수 있다.In addition, the raw material compound [VII] in the said manufacturing method (1) can be manufactured according to following Reaction Formula, for example.

상기 반응식에서,In the above scheme,

X, Y, Z, R3및 R17은 위에서 정의한 바와 같다.X, Y, Z, R 3 and R 17 are as defined above.

또한, 상기 제조방법(2)에서 원료 화합물[V]은 예를 들면, 하기 반응식에 따라서 제조할 수 있다.In addition, in the said manufacturing method (2), raw material compound [V] can be manufactured according to following Reaction Formula, for example.

상기 반응식에서,In the above scheme,

X, Y, Z, R1, R2및 R3는 위에서 정의한 바와 같으며,X, Y, Z, R 1 , R 2 and R 3 are as defined above,

V와 W는 동일하거나 상이한 염소원자, 브롬원자, 요오드 원자 등의 할로겐 원자이다.V and W are the same or different halogen atoms such as chlorine, bromine and iodine atoms.

본 발명의 화합물은 그 구조에 따라서는 광학 이성체나 디아스테레오머 등의 이성체가 존재하고 본 발명의 화합물은 이들을 전부 포함한다. 본 발명의 화합물을 제초제로서 사용하는 경우, 공지된 방법에 따라서 분리한 각 이성체를 단독으로 사용하여도 좋지만 이성체의 혼합물로서 사용할 수 있다.According to the structure of the compound of the present invention, isomers such as optical isomers and diastereomers exist, and the compounds of the present invention include all of them. When using the compound of this invention as a herbicide, each isomer separated according to a well-known method may be used independently, but can be used as a mixture of isomers.

본 발명의 화합물을 제초제로서 사용하는 경우, 본 발명의 화합물(이하, 「원체」라고 지칭하기도 함)를 그대로 시용하여도 좋지만, 통상적으로 적당한 보조제를 사용하여 수화제, 과립제, 유제, 유동화제 등의 형태로 사용한다. 보조제로서는 예를 들면, 카올린, 벤토나이트, 탈크, 규조토, 화이트 카본, 전분 등의 고체 담체; 물, 알콜류(메탄올, 에탄올, 프로판올, 부탄올, 에틸렌 글리콜 등), 케톤류(아세톤, 메틸에틸케톤, 사이클로헥사논 등), 에테르류(디에틸 에테르, 디옥산, 셀로솔브류 등), 지방족 탄화수소류(케로신, 등유 등), 방향족 탄화수소류(벤젠, 톨루엔, 크실렌, 용제 나프타, 메틸나프탈렌 등), 할로겐화탄화수소류(디클로로에탄, 사염화탄소, 트리클로로벤젠 등), 산 아미드류(디메틸포름아미드 등), 에스테르류(에틸 아세테이트, 부틸 아세테이트, 지방산 글리세린 에스테르류 등), 니트릴류(아세토니트릴 등) 등의 용매; 비이온계 계면활성제(폴리옥시에틸렌 알킬 알릴 에테르, 폴리옥시에틸렌소르비탄 모노라우레이트 등), 양이온계 계면활성제(알킬디메틸벤질암모늄 클로라이드, 알킬피리디늄 클로라이드 등), 음이온계 계면활성제(알킬벤젠설폰산염, 리그닌설폰산염, 고급 알콜황산염 등), 양성계 계면활성제(알킬디메틸베타인, 도데실아미노에틸글리신 등) 등의 계면활성제 등을 들 수 있다. 이들의 고체 담체, 용매, 계면활성제 등은 각각 필요에 따라서 하나 이상의 혼합물로서 사용된다.When the compound of the present invention is used as a herbicide, the compound of the present invention (hereinafter, also referred to as "element") may be applied as it is, but generally, a suitable adjuvant may be used, such as a hydrating agent, a granule, an emulsion, a fluidizing agent, or the like. Use in form. As an adjuvant, For example, solid carriers, such as kaolin, bentonite, talc, diatomaceous earth, white carbon, starch; Water, alcohols (methanol, ethanol, propanol, butanol, ethylene glycol, etc.), ketones (acetone, methyl ethyl ketone, cyclohexanone, etc.), ethers (diethyl ether, dioxane, cellosolves, etc.), aliphatic hydrocarbons (Kerosine, kerosene, etc.), aromatic hydrocarbons (benzene, toluene, xylene, solvent naphtha, methylnaphthalene, etc.), halogenated hydrocarbons (dichloroethane, carbon tetrachloride, trichlorobenzene, etc.), acid amides (dimethylformamide, etc.) Solvents such as esters (ethyl acetate, butyl acetate, fatty acid glycerin esters and the like), nitriles (acetonitrile and the like); Nonionic surfactants (polyoxyethylene alkyl allyl ether, polyoxyethylene sorbitan monolaurate, etc.), cationic surfactants (alkyldimethylbenzyl ammonium chloride, alkylpyridinium chloride, etc.), anionic surfactants (alkylbenzenesulfon Acid salts, lignin sulfonates, higher alcohol sulfates and the like), and surfactants such as amphoteric surfactants (alkyldimethylbetaine, dodecylaminoethylglycine, etc.). These solid carriers, solvents, surfactants, etc. are each used as one or more mixture as needed.

본 발명의 화합물의 시용량은 화합물의 구조나 대상 잡초, 처리 시기, 처리 방법, 토양의 성질 등의 조건에 따라서 다르지만, 통상적으로 1헥타르 당의 유효 성분량으로서는 2 내지 2000g, 바람직하게는 5 내지 1000g의 범위가 적당하다.The dosage of the compound of the present invention varies depending on the conditions of the structure, the target weeds, the treatment time, the treatment method, the soil properties, etc., but the amount of the active ingredient per hectare is usually in the range of 2 to 2000 g, preferably 5 to 1000 g. Is suitable.

본 발명의 화합물의 대상 잡초로서는 밭에서는 예를 들면, 흰명아주, 명아주, 개여뀌, 바늘여뀌, 개비름, 청비름, 별꽃, 광대나물, 어저귀, 도꼬마리, 야생 나팔꽃, 흰독말풀, 야생 갓, 갈퀴덩쿨, 서양 제비꽃, 족제비쑥, 털고사리, 바랭이, 왕바랭이, 개피, 강아지풀 등을 들 수 있다.As a target weed of the compound of the present invention, in the field, for example, white hyacinth, hyacinth, perilla, perilla, perilla, green amaranth, chickweed, vast greens, mother-of-pearl, wild horse, wild morning glory, datura, wild mustard, rake, Western violets, weasel, hairy ferns, bees, king burrows, kelp, ragweed, and the like.

또한, 논에서는 예를 들면, 마디꽃, 외풀, 물달개비, 등에풀, 물볕, 택사, 돌피, 알방동사니, 올미, 벗풀, 올챙고랭이, 너도방도사니 등을 들 수 있다. 본 발명의 화합물은 발아전 토양 처리 및 생육기 경엽 처리의 어느 경우에 있어서도, 상기 잡초를 방제하는 것이 가능하다. 또한, 본 발명의 화합물은 예를 들면, 옥수수, 밀, 보리, 벼, 콩 등의 재배 작물에 대하여 발아전 토양 처리 및 생육기 경엽 처리의 어느 경우에 있어서도 영향이 적으며 선택적 제초제로서 사용할 수 있다.Moreover, in a rice paddy, a knotweed flower, a single flower, a watering cane, a back grass, a water sun, a taxi, a peeling, an egg shell, a snare, a peel, a tadpole, a beech, etc. are mentioned, for example. The compound of the present invention can control the weeds in any case of pre-germination soil treatment and growing foliage treatment. In addition, the compound of the present invention has little effect on cultivated crops such as corn, wheat, barley, rice and soybeans in any case of pre-germination soil treatment and growing foliage treatment, and can be used as a selective herbicide.

본 발명의 화합물을 유효 성분으로 하는 제초제는 동일 분야에 사용하는 다른 농약, 예를 들면, 살충제, 살균제, 식물 성장 조절제 및 비료 등과 혼합 시용할 수 있다. 또한, 다른 제초제와 혼합 시용함으로써 제초 효과를 보다 안정화하는 것도 가능하다. 본 발명의 화합물과 다른 제초제를 혼합 시용하는 경우, 양자의 각각의 제제를 시용시에 혼합하여도 좋지만 미리 양자를 함유하는 제제로서 시용할 수 있다. 본 발명의 화합물과 적합하게 혼합 시용할 수 있는 제초제로서는, 예를 들면, 하기의 것을 들 수 있다.Herbicides containing the compound of the present invention as an active ingredient may be mixed with other pesticides used in the same field, such as insecticides, fungicides, plant growth regulators and fertilizers. It is also possible to stabilize the herbicidal effect by mixing with other herbicides. When the compound of this invention and another herbicide are mixed and applied, each formulation may be mixed at the time of application, but can be applied as a preparation containing both. As a herbicide which can be mixed and used suitably with the compound of this invention, the following are mentioned, for example.

카바메이트계 제초제:Carbamate Herbicides:

2-클로로알릴 디에틸디티오카바메이트,2-chloroallyl diethyldithiocarbamate,

S-2,3-디클로로알릴 디이소프로필티오카바메이트,S-2,3-dichloroallyl diisopropylthiocarbamate,

S-2,2,3-트리클로로알릴 디이소프로필티오카바메이트,S-2,2,3-trichloroallyl diisopropylthiocarbamate,

S-에틸 디프로필티오카바메이트,S-ethyl dipropylthiocarbamate,

S-에틸 디이소부틸티오카바메이트,S-ethyl diisobutylthiocarbamate,

S-벤질 1,2-디메틸프로필(에틸)티오카바메이트,S-benzyl 1,2-dimethylpropyl (ethyl) thiocarbamate,

S-4-클로로벤질 디에틸티오카바메이트,S-4-chlorobenzyl diethylthiocarbamate,

S-에틸 퍼하이드로아제핀-1-티오카복실레이트,S-ethyl perhydroazepine-1-thiocarboxylate,

S-이소프로필 퍼하이드로아제핀-1-티오카복실레이트,S-isopropyl perhydroazepine-1-thiocarboxylate,

S-1-메틸-1-페닐에틸 피페리딘-1-티오카복실레이트,S-1-methyl-1-phenylethyl piperidine-1-thiocarboxylate,

0-3-3급-부틸페닐 6-메톡시-2-피리딜(메틸)티오카바메이트,0-3-tert-butylphenyl 6-methoxy-2-pyridyl (methyl) thiocarbamate,

3-(메톡시카보닐아미노)페닐 3'-메틸페닐카바메이트,3- (methoxycarbonylamino) phenyl 3'-methylphenylcarbamate,

이소프로필 3'-클로로페닐카바메이트,Isopropyl 3'-chlorophenylcarbamate,

메틸 (4-아미노페닐설포닐)카바메이트 등Methyl (4-aminophenylsulfonyl) carbamate and the like

우레아계 제초제:Urea herbicides:

3-(3,4-디클로로페닐)-1,1-디메틸우레아,3- (3,4-dichlorophenyl) -1,1-dimethylurea,

3-(3,4-디클로로페닐)-1-메톡시-1-메틸우레아,3- (3,4-dichlorophenyl) -1-methoxy-1-methylurea,

1,1-디메틸-3-[3-(트리플루오로메틸)페닐]우레아,1,1-dimethyl-3- [3- (trifluoromethyl) phenyl] urea,

3-[4-(4-메톡시페녹시)페닐)-1,1-디메틸우레아,3- [4- (4-methoxyphenoxy) phenyl) -1,1-dimethylurea,

1-(1-메틸-1-페닐에틸)-3-p-톨릴우레아,1- (1-methyl-1-phenylethyl) -3-p-tolylurea,

3-(4-이소프로필페닐)-1,1-디메틸우레아,3- (4-isopropylphenyl) -1,1-dimethylurea,

3-(5-3급-부틸이속사졸-3-일)-1,1-디메틸우레아,3- (5-tert-butylisoxazol-3-yl) -1,1-dimethylurea,

1-(5-3급-부틸-1,3,4-티아디아졸-2-일)-1,3-디메틸우레아,1- (5-tert-butyl-1,3,4-thiadiazol-2-yl) -1,3-dimethylurea,

1-(벤조티아졸-2-일)-1,3-디메틸우레아 등1- (benzothiazol-2-yl) -1,3-dimethylurea and the like

아미드계 제초제:Amide herbicides:

2-클로로-2',6'-디에틸-N-(메톡시메틸)아세트아닐리드,2-chloro-2 ', 6'-diethyl-N- (methoxymethyl) acetanilide,

N-(부톡시메틸)-2-클로로-2',6'-디에틸아세트아닐리드,N- (butoxymethyl) -2-chloro-2 ', 6'-diethylacetanilide,

2-클로로-2',6'-디에틸-N-(2-프로폭시에틸)아세트아닐리드,2-chloro-2 ', 6'-diethyl-N- (2-propoxyethyl) acetanilide,

2-클로로-N-(에톡시메틸)-6'-에틸아세트-o-톨이미드,2-chloro-N- (ethoxymethyl) -6'-ethylacet-o-tolimide,

2-클로로-6'-에틸-N-(2-메톡시-1-메틸에틸)아세트-o-톨이미드,2-chloro-6'-ethyl-N- (2-methoxy-1-methylethyl) acet-o-tolimide,

2-클로로-N-(3-메톡시-2-테닐)-2',6'-디메틸아세트아닐리드,2-chloro-N- (3-methoxy-2-tenyl) -2 ', 6'-dimethylacetanilide,

N-(클로로아세틸)-N-(2,6-디에틸페닐)글리신에틸에스테르,N- (chloroacetyl) -N- (2,6-diethylphenyl) glycineethyl ester,

2-클로로-N-(2,4-디메틸-3-티에닐)-N-(2-메톡시-1-메틸에틸)아세아미드,2-chloro-N- (2,4-dimethyl-3-thienyl) -N- (2-methoxy-1-methylethyl) aceamide,

3',4'-디클로로프로피온아닐리드,3 ', 4'-dichloropropionanilide,

2',4'-디플루오로-2-[3-(트리플루오로메틸)페녹시]니코틴아닐리드,2 ', 4'-difluoro-2- [3- (trifluoromethyl) phenoxy] nicotinanilide,

2-(1,3-벤조티아졸-2-일옥시)-N-메틸아세트아닐리드,2- (1,3-benzothiazol-2-yloxy) -N-methylacetanilide,

2-브로모-N-(a,a-디메틸벤질)-3,3-디메틸부틸아미드,2-bromo-N- (a, a-dimethylbenzyl) -3,3-dimethylbutylamide,

N-[3-(에틸-1-메틸프로필)이속사졸-5-일]-2,6-디메톡시벤즈아미드 등N- [3- (ethyl-1-methylpropyl) isoxazol-5-yl] -2,6-dimethoxybenzamide and the like

디니트로아닐린계 제초제:Dinitroaniline herbicides:

2,6-디니트로-N,N-디프로필-4-(트리플루오로메틸)아닐린,2,6-dinitro-N, N-dipropyl-4- (trifluoromethyl) aniline,

N-부틸-N-에틸-2.6-디니트로-4-(트리플루오로메틸)아닐린,N-butyl-N-ethyl-2.6-dinitro-4- (trifluoromethyl) aniline,

2,6-디니트로-N', N'-디프로필-4-(트리플루오로메틸)-m-페닐렌디아민,2,6-dinitro-N ', N'-dipropyl-4- (trifluoromethyl) -m-phenylenediamine,

4-(디프로필아미노)-3,5-디니트로벤젠설폰아미드,4- (dipropylamino) -3,5-dinitrobenzenesulfonamide,

N-2급-부틸-4-3급-부틸-2,6-디니트로아닐린,N-tert-butyl-4-tert-butyl-2,6-dinitroaniline,

N-(1-에틸프로필)-2,6-디니트로-3,4-크실리딘 등N- (1-ethylpropyl) -2,6-dinitro-3,4-xyldine and the like

카복실산계 제초제:Carboxylic Acid Herbicides:

(2,4-디클로로페녹시)아세트산 및 이의 유도체,(2,4-dichlorophenoxy) acetic acid and derivatives thereof,

(2,4,5-트리클로로페녹시)아세트산 및 이의 유도체,(2,4,5-trichlorophenoxy) acetic acid and derivatives thereof,

(4-클로로-2-메틸페녹시)아세트산 및 이의 유도체,(4-chloro-2-methylphenoxy) acetic acid and derivatives thereof,

2-(2,4-디클로로페녹시)프로피온산 및 이의 유도체,2- (2,4-dichlorophenoxy) propionic acid and derivatives thereof,

4-(2,4-디클로로페녹시)부티르산 및 이의 유도체,4- (2,4-dichlorophenoxy) butyric acid and its derivatives,

2,3,6-트리클로로벤조산 및 이의 유도체,2,3,6-trichlorobenzoic acid and derivatives thereof,

3,6-디클로로-2-메톡시벤조산 및 이의 유도체,3,6-dichloro-2-methoxybenzoic acid and derivatives thereof,

3,7-디클로로퀴놀린-8-카복실산,3,7-dichloroquinoline-8-carboxylic acid,

7-클로로-3-메틸퀴놀린-8-카복실산,7-chloro-3-methylquinoline-8-carboxylic acid,

3,6-디클로로피리딘-2-카복실산 및 그의 염,3,6-dichloropyridine-2-carboxylic acid and salts thereof,

4-아미노-3,5,6-트리클로로피리딘-2-카복실산 및 이의 염,4-amino-3,5,6-trichloropyridine-2-carboxylic acid and salts thereof,

(3,5,6-트리클로로-2-피리딜옥시)아세트산 및 이의 유도체,(3,5,6-trichloro-2-pyridyloxy) acetic acid and derivatives thereof,

(4-아미노-3,5-디클로로-6-플루오로-2-피리딜옥시)아세트산 및 이의 유도체,(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetic acid and derivatives thereof,

(4-클로로-2-옥소벤조티아졸린-3-일)아세트산 및 이의 유도체,(4-chloro-2-oxobenzothiazolin-3-yl) acetic acid and derivatives thereof,

2-[4-(2,4-디클로로페녹시)페녹시]프로피온산 및 이의 유도체,2- [4- (2,4-dichlorophenoxy) phenoxy] propionic acid and derivatives thereof,

2-[4-[5-(트리플루오로메틸)-2-피리딜옥시]페녹시]프로피온산 및 이의 유도체,2- [4- [5- (trifluoromethyl) -2-pyridyloxy] phenoxy] propionic acid and derivatives thereof,

2-[4-[3-클로로-5-(트리플루오로메틸)-2-피리딜옥시]페녹시]프로피온산 및 이의 유도체,2- [4- [3-chloro-5- (trifluoromethyl) -2-pyridyloxy] phenoxy] propionic acid and derivatives thereof,

2-[4-(6-클로로-1,3-벤조옥사졸-2-일옥시)페녹시]프로피온산 및 이의 유도체,2- [4- (6-chloro-1,3-benzooxazol-2-yloxy) phenoxy] propionic acid and derivatives thereof,

2-[4-(6-클로로퀴녹살린-2-일옥시)페녹시]프로피온산 및 이의 유도체,2- [4- (6-chloroquinoxalin-2-yloxy) phenoxy] propionic acid and derivatives thereof,

2-[4-(4-시아노-2-플루오로페녹시)페녹시]프로피온산 및 이의 유도체 등2- [4- (4-cyano-2-fluorophenoxy) phenoxy] propionic acid and derivatives thereof, and the like

페놀계 제초제:Phenolic Herbicides:

3,5-디브로모-4-하이드록시벤조니트릴 및 이의 염,3,5-dibromo-4-hydroxybenzonitrile and salts thereof,

4-하이드록시-3,5-디요오도벤조니트릴 및 이의 염,4-hydroxy-3,5-diiodobenzonitrile and salts thereof,

2-3급-부틸-4,6-디니트로페놀 및 이의 염 등2-tert-butyl-4,6-dinitrophenol and salts thereof

사이클로헥산디온계 제초제:Cyclohexanedione Herbicides:

메틸 3-[1-(알릴옥시이미노)부틸]-4-하이드록시-6,6-디메틸-2-옥소-3-사이클로헥센-1-카복실레이트 및 이의 염,Methyl 3- [1- (allyloxyimino) butyl] -4-hydroxy-6,6-dimethyl-2-oxo-3-cyclohexene-1-carboxylate and salts thereof,

2-[1-(에톡시이미노)부틸]-5-[2-(에틸티오)프로필]-3-하이드록시-2-사이클로헥센-1-온,2- [1- (ethoxyimino) butyl] -5- [2- (ethylthio) propyl] -3-hydroxy-2-cyclohexen-1-one,

2-[1-(에톡시이미노)부틸]-3-하이드록시-5-(티안-3-일)-2-사이클로헥센-1-온,2- [1- (ethoxyimino) butyl] -3-hydroxy-5- (thian-3-yl) -2-cyclohexen-1-one,

2-[1-(에톡시이미노)프로필]-3-하이드록시-5-(2,4,6-트리메틸페닐)-2-사이클로헥센-1-온,2- [1- (ethoxyimino) propyl] -3-hydroxy-5- (2,4,6-trimethylphenyl) -2-cyclohexen-1-one,

2-[1-(3-클로로알릴옥시이미노)프로필]-5-[2-(에틸티오)프로필]-3-하이드록시-2-사이클로헥센-1-온,2- [1- (3-chloroallyloxyimino) propyl] -5- [2- (ethylthio) propyl] -3-hydroxy-2-cyclohexen-1-one,

2-[2-클로로-4-(메틸설포닐)벤조일]사이클로헥산-1,3-디온 등2- [2-chloro-4- (methylsulfonyl) benzoyl] cyclohexane-1,3-dione, etc.

디페닐에테르계 제초제:Diphenyl ether herbicides:

4-니트로페닐 2,4,6-트리클로로페닐 에테르,4-nitrophenyl 2,4,6-trichlorophenyl ether,

2-(2,4-디클로로페녹시)-2-니트로아니솔,2- (2,4-dichlorophenoxy) -2-nitroanisole,

2-클로로-4-(트리플루오로메틸)페닐 3-에톡시-4-니트로페닐에테르,2-chloro-4- (trifluoromethyl) phenyl 3-ethoxy-4-nitrophenyl ether,

메틸 5-(2,4-디클로로페녹시)-2-니트로벤조에이트,Methyl 5- (2,4-dichlorophenoxy) -2-nitrobenzoate,

5-[2-클로로-4-(트리플루오로메틸)페녹시]-2-니트로벤조산 및 이의 염,5- [2-chloro-4- (trifluoromethyl) phenoxy] -2-nitrobenzoic acid and salts thereof,

0-[5-[2-클로로-4-(트리플루오로메틸)페녹시]-2-니트로벤조일]글리콜산에틸,0- [5- [2-chloro-4- (trifluoromethyl) phenoxy] -2-nitrobenzoyl] ethyl glycolate,

에틸 0-[5-[2-클로로-4-(트리플루오로메틸)페녹시]-2-니트로벤조일]-DL-락테이트,Ethyl 0- [5- [2-chloro-4- (trifluoromethyl) phenoxy] -2-nitrobenzoyl] -DL-lactate,

5-[2-클로로-4-(트리플루오로메틸)페녹시]-N-(메틸설포닐)-2-니트로벤즈아미드,5- [2-chloro-4- (trifluoromethyl) phenoxy] -N- (methylsulfonyl) -2-nitrobenzamide,

2-클로로-6-니트로-3-페녹시아닐린 등2-chloro-6-nitro-3-phenoxyaniline, etc.

설포닐우레아계 제초제:Sulfonylurea herbicides:

에틸 2-(4-클로로-6-메톡시피리미딘-2-일카바모일설파모일)벤조에이트,Ethyl 2- (4-chloro-6-methoxypyrimidin-2-ylcarbamoylsulfamoyl) benzoate,

메틸 2-(4,6-디메틸피리미딘-2-일카바모일설파모일)벤조에이트,Methyl 2- (4,6-dimethylpyrimidin-2-ylcarbamoylsulfamoyl) benzoate,

메틸 2-[4,6-비스(디플루오로메톡시)피리미딘-2-일카바모일설파모일]벤조에이트,Methyl 2- [4,6-bis (difluoromethoxy) pyrimidin-2-ylcarbamoylsulfamoyl] benzoate,

메틸 2-(4,6-디메톡시피리미딘-2-일카바모일설파모일메틸)벤조에이트,Methyl 2- (4,6-dimethoxypyrimidin-2-ylcarbamoylsulfamoylmethyl) benzoate,

1-(2-클로로페닐설포닐)-3-(4-메톡시-6-메틸-1,3,5-트리아진-2-일)우레아,1- (2-chlorophenylsulfonyl) -3- (4-methoxy-6-methyl-1,3,5-triazin-2-yl) urea,

메틸 2-(4-메톡시-6-메틸-1,3,5-트리아진-2-일카바모일설파모일)벤조에이트,Methyl 2- (4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl) benzoate,

메틸 2-[4-메톡시-6-메틸-1,3,5-트리아진-2-일(메틸)카바모일설파모일]벤조에이트,Methyl 2- [4-methoxy-6-methyl-1,3,5-triazin-2-yl (methyl) carbamoylsulfamoyl] benzoate,

1-[2-(2-클로로에톡시)페닐설포닐]-3-(4-메톡시-6-메틸-1,3,5-트리아진-2-일)우레아,1- [2- (2-chloroethoxy) phenylsulfonyl] -3- (4-methoxy-6-methyl-1,3,5-triazin-2-yl) urea,

1-(4,6-디메톡시-1,3,5-트리아진-2-일)-3-[2-(2-메톡시에톡시)페닐설포닐]우레아,1- (4,6-dimethoxy-1,3,5-triazin-2-yl) -3- [2- (2-methoxyethoxy) phenylsulfonyl] urea,

메틸 2-[4-에톡시-6-(메틸아미노)-1,3,5-트리아진-2-일카바모일설파모일]벤조에이트,Methyl 2- [4-ethoxy-6- (methylamino) -1,3,5-triazin-2-ylcarbamoylsulfamoyl] benzoate,

메틸 3-(4-메톡시-6-메틸-1,3,5-트리아진-2-일카바모일설파모일)티오펜-2-카복실레이트,Methyl 3- (4-methoxy-6-methyl-1,3,5-triazine-2-ylcarbamoylsulfamoyl) thiophene-2-carboxylate,

에틸 5-(4,6-디메톡시피리미딘-2-일카바모일설파모일)-1-메틸피라졸-4-카복실레이트,Ethyl 5- (4,6-dimethoxypyrimidin-2-ylcarbamoylsulfamoyl) -1-methylpyrazole-4-carboxylate,

메틸 3-클로로-5-(4,6-디메톡시피리미딘-2-일카바모일설파모일)-1-메틸피라졸-4-카복실레이트,Methyl 3-chloro-5- (4,6-dimethoxypyrimidin-2-ylcarbamoylsulfamoyl) -1-methylpyrazole-4-carboxylate,

1-(4,6-디메톡시피리미딘-2-일)-3-[3-(트리플루오로메틸)-2-피리딜설포닐]우레아,1- (4,6-dimethoxypyrimidin-2-yl) -3- [3- (trifluoromethyl) -2-pyridylsulfonyl] urea,

1-(4,6-디메톡시피리미딘-2-일)-3-[3-(에틸설포닐)-2-피리딜설포닐]우레아,1- (4,6-dimethoxypyrimidin-2-yl) -3- [3- (ethylsulfonyl) -2-pyridylsulfonyl] urea,

2-(4,6-디메톡시피리미딘-2-일카바모일설파모일)-N,N-디메틸니코틴아미노,2- (4,6-dimethoxypyrimidin-2-ylcarbamoylsulfamoyl) -N, N-dimethylnicotinamino,

1-(2-클로로이미다조[1,2-a]피리딘-3-일설포닐)-3-(4,6-디메톡시피리미딘-2-일)우레아,1- (2-chloroimidazo [1,2-a] pyridin-3-ylsulfonyl) -3- (4,6-dimethoxypyrimidin-2-yl) urea,

1-[2-(사이클로프로필카보닐)페닐설파모일)-3-(4,6-디메톡시피리미딘-2-일)우레아,1- [2- (cyclopropylcarbonyl) phenylsulfamoyl) -3- (4,6-dimethoxypyrimidin-2-yl) urea,

1-(4-메톡시-6-메틸-1,3,5-트리아진-2-일)-3-[2-(3,3,3-트리플루오로프로필)페닐설포닐]우레아 등1- (4-methoxy-6-methyl-1,3,5-triazin-2-yl) -3- [2- (3,3,3-trifluoropropyl) phenylsulfonyl] urea and the like

비피리디늄계 제초제:Bipyridinium-based herbicides:

1,1'-디메틸-4,4'-비피리디늄 디클로라이드,1,1'-dimethyl-4,4'-bipyridinium dichloride,

1,1'-에틸렌-2,2'-비피리디늄 디브로마이드 등1,1'-ethylene-2,2'-bipyridinium dibromide, etc.

피라졸계 제초제:Pyrazole herbicides:

4-(2,4-디클로로벤조일)-1,3-디메틸피라졸-5-일 톨루엔-4-설포네이트,4- (2,4-dichlorobenzoyl) -1,3-dimethylpyrazol-5-yl toluene-4-sulfonate,

2-[4-(2,4-디클로로벤조일)1,3-디메틸피라졸-5-일옥시]아세트페논,2- [4- (2,4-dichlorobenzoyl) 1,3-dimethylpyrazol-5-yloxy] acetphenone,

2-[4-(2,4-디클로로-3-메틸벤조일)-1,3-디메틸피라졸-5-일옥시]-4'-메틸아세트페논 등2- [4- (2,4-dichloro-3-methylbenzoyl) -1,3-dimethylpyrazol-5-yloxy] -4'-methylacetphenone, etc.

트리아진계 제초제:Triazine Herbicides:

6-클로로-N2,N4-디에틸-1,3,5-트리아진-2,4-디아민,6-chloro-N 2 , N 4 -diethyl-1,3,5-triazine-2,4-diamine,

6-클로로-N2-에틸-N4-이소프로필-1,3,5-트리아진-2,4-디아민,6-chloro-N 2 -ethyl-N 4 -isopropyl-1,3,5-triazine-2,4-diamine,

2-[4-클로로-6-(에틸아미노)-1,3,5-트리아진-2-일아미노]-2-메틸프로피오니트릴,2- [4-chloro-6- (ethylamino) -1,3,5-triazin-2-ylamino] -2-methylpropionitrile,

N2,N4-디에틸-6-(메틸티오)-1,3,5-트리아진-2,4-디아민,N 2 , N 4 -diethyl-6- (methylthio) -1,3,5-triazine-2,4-diamine,

N2-(1,2-디메틸프로필)-N4-에틸-6-(메틸티오)-1,3,5-트리아진-2,4-디아민,N 2- (1,2-dimethylpropyl) -N 4 -ethyl-6- (methylthio) -1,3,5-triazine-2,4-diamine,

4-아미노-6-3급-부틸-3-(메틸티오)-1,2,4-트리아진-5(4H)-온 등4-amino-6-tert-butyl-3- (methylthio) -1,2,4-triazine-5 (4H) -one and the like

이미다졸리논계 제초제:Imidazolinone herbicides:

메틸 2-(4-이소프로필-4-메틸-5-옥소-2-이미다졸린-2-일)-4(5)-메틸벤조에이트,Methyl 2- (4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl) -4 (5) -methylbenzoate,

2-(4-이소프로필-4-메틸-5-옥소-2-이미다졸린-2-일)피리딘-3-카복실산 및 이의 염,2- (4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl) pyridine-3-carboxylic acid and salts thereof,

2-(4-이소프로필-4-메틸-5-옥소-2-이미다졸린-2-일)퀴놀린-3-카복실산 및 이의 염,2- (4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl) quinoline-3-carboxylic acid and salts thereof,

5-에틸-2-(4-이소프로필-4-메틸-5-옥소-2-이미다졸린-2-일)피리딘-3-카복실산 및 이의 염,5-ethyl-2- (4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl) pyridine-3-carboxylic acid and salts thereof,

2-(4-이소프로필-4-메틸-5-옥소-2-이미다졸린-2-일)-5-(메톡시메틸)피리딘-3-카복실산 및 이의 염 등2- (4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl) -5- (methoxymethyl) pyridine-3-carboxylic acid and salts thereof

기타 제초제:Other herbicides:

1-메틸-3-페닐-5-[3-(트리플루오로메틸)페닐]-4-피리돈,1-methyl-3-phenyl-5- [3- (trifluoromethyl) phenyl] -4-pyridone,

3-클로로-4-(클로로메틸)-1-[3-(트리플루오로메틸)페닐]-2-피롤리디논,3-chloro-4- (chloromethyl) -1- [3- (trifluoromethyl) phenyl] -2-pyrrolidinone,

5-(메틸아미노)-2-페닐-4-[3-(트리플루오로메틸)페닐]푸란-3(2H)-온,5- (methylamino) -2-phenyl-4- [3- (trifluoromethyl) phenyl] furan-3 (2H) -one,

4-클로로-5-(메틸아미노)-2-[3-(트리플루오로메틸)페닐]피라진-3(2H)-온,4-chloro-5- (methylamino) -2- [3- (trifluoromethyl) phenyl] pyrazine-3 (2H) -one,

N,N-디에틸-3-(2,4,6-트리메틸페닐설포닐)-1H-1,2,4-트리아졸-1-카복스아미드,N, N-diethyl-3- (2,4,6-trimethylphenylsulfonyl) -1H-1,2,4-triazole-1-carboxamide,

N-[2,4-디클로로-5-[4-(디플루오로메틸)-4,5-디하이드로-3-메틸-5-옥소-1H-1,2,4-트리아졸-1-일]페닐]메탄설폰아미드,N- [2,4-dichloro-5- [4- (difluoromethyl) -4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl ] Phenyl] methanesulfonamide,

1-[4-클로로-3-(2,2,3,3,3-펜타플루오로프로폭시메틸)페닐]-5-페닐-1H-1,2,4-트리아졸-3-카복스아미드,1- [4-chloro-3- (2,2,3,3,3-pentafluoropropoxymethyl) phenyl] -5-phenyl-1H-1,2,4-triazole-3-carboxamide ,

2-(클로로벤질)-4,4-디메틸이속사졸리딘-3-온,2- (chlorobenzyl) -4,4-dimethylisoxazolidin-3-one,

5-사이클로프로필-4-[2-(메틸설포닐)-4-(트리플루오로메틸)벤조일]이속사졸,5-cyclopropyl-4- [2- (methylsulfonyl) -4- (trifluoromethyl) benzoyl] isoxazole,

5-3급-부틸-3-(2,4-디클로로-5-이소프로폭시페닐)-1,3,4-옥사디아졸-2(3H)-온,5-tert-butyl-3- (2,4-dichloro-5-isopropoxyphenyl) -1,3,4-oxadiazole-2 (3H) -one,

에틸 [2-클로로-5-[4-클로로-5-(디플루오로메톡시)-1-메틸피라졸-3-일]-4-플루오로페녹시]아세테이트,Ethyl [2-chloro-5- [4-chloro-5- (difluoromethoxy) -1-methylpyrazol-3-yl] -4-fluorophenoxy] acetate,

S,S'-디메틸 2-(디플루오로메틸)-4-이소부틸-6-(트리플루오로메틸)피리딘-3,5-디카보티오에이트,S, S'-dimethyl 2- (difluoromethyl) -4-isobutyl-6- (trifluoromethyl) pyridine-3,5-dicarbothioate,

메틸 2-(디플루오로메틸)-5-(4,5-디하이드로-1,3-티아졸-2-일)-4-이소부틸-6-(트리플루오로메틸)피리딘-3-카복실레이트,Methyl 2- (difluoromethyl) -5- (4,5-dihydro-1,3-thiazol-2-yl) -4-isobutyl-6- (trifluoromethyl) pyridine-3-carboxyl Rate,

2-클로로-6-(4,6-디메톡시피리미딘-2-일티오)벤조산 및 이의 염,2-chloro-6- (4,6-dimethoxypyrimidin-2-ylthio) benzoic acid and salts thereof,

메틸 2-(4,6-디메톡시피리미딘-2-일옥시)-6-[1-(메톡시이미노)에틸]벤조에이트,Methyl 2- (4,6-dimethoxypyrimidin-2-yloxy) -6- [1- (methoxyimino) ethyl] benzoate,

2,6-비스(4,6-디메톡시피리미딘-2-일옥시)벤조산 및 이의 염,2,6-bis (4,6-dimethoxypyrimidin-2-yloxy) benzoic acid and salts thereof,

5-브로모-3-2급-부틸-6-메틸피리미딘-2,4(1H, 3H)-디온,5-bromo-3-secondary-butyl-6-methylpyrimidine-2,4 (1H, 3H) -dione,

3-3급-부틸-5-클로로-6-메틸피리미딘-2,4(1H, 3H)-디온,Tert-butyl-5-chloro-6-methylpyrimidine-2,4 (1H, 3H) -dione,

3-사이클로헥실-1,5,6,7-테트라하이드로사이클로펜타피리미딘-2,4(3H)-디온,3-cyclohexyl-1,5,6,7-tetrahydrocyclopentapyrimidine-2,4 (3H) -dione,

이소프로필 2-클로로-5-[1,2,3,6-테트라하이드로-3-메틸-2,6-디옥소-4-(트리플루오로메틸)피리미딘-1-일]벤조에이트,Isopropyl 2-chloro-5- [1,2,3,6-tetrahydro-3-methyl-2,6-dioxo-4- (trifluoromethyl) pyrimidin-1-yl] benzoate,

1-메틸-4-이소프로필-2-[(2-메틸페닐)메톡시]-7-옥사비사이클로[2.2.1]헵탄,1-methyl-4-isopropyl-2-[(2-methylphenyl) methoxy] -7-oxabicyclo [2.2.1] heptane,

N-(4-클로로페닐)-3,4,5,6-테트라하이드로프탈이미드,N- (4-chlorophenyl) -3,4,5,6-tetrahydrophthalimide,

펜틸 [2-클로로-4-플루오로-5-(1,3,4,5,6,7-헥사하이드로-1,3-디옥소-2H-이소인돌-2-일)페녹시]아세테이트,Pentyl [2-chloro-4-fluoro-5- (1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl) phenoxy] acetate,

2-[7-플루오로-3,4-디하이드로-3-옥소-4-(2-프로피닐)-2H-1,4-벤조옥사진-6-일]-4,5,6,7-테트라하이드로-1H-이소인돌-1,3(2H)-디온,2- [7-fluoro-3,4-dihydro-3-oxo-4- (2-propynyl) -2H-1,4-benzooxazin-6-yl] -4,5,6,7 Tetrahydro-1H-isoindole-1,3 (2H) -dione,

N-(2,6-디플루오로페닐)-5-메틸[1,2,4]트리아졸로[1,5-a]피리미딘-2-설폰아미드,N- (2,6-difluorophenyl) -5-methyl [1,2,4] triazolo [1,5-a] pyrimidine-2-sulfonamide,

N-(2,6-디클로로-3-메틸페닐)-5,7-디메톡시[1,2,4]트리아졸로[1,5-a]피리미딘-2-설폰아미드,N- (2,6-dichloro-3-methylphenyl) -5,7-dimethoxy [1,2,4] triazolo [1,5-a] pyrimidine-2-sulfonamide,

2,3-디하이드로-3,3-디메틸벤조푸란-5-일 에탄설포네이트,2,3-dihydro-3,3-dimethylbenzofuran-5-yl ethanesulfonate,

2-에톡시-2,3-디하이드로-3,3-디메틸벤조푸란-5-일 메탄설포네이트,2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-yl methanesulfonate,

메틸 [[2-클로로-4-플루오로-5-[(테트라하이드로-3-옥소-1H,3H-[1,3,4]티아디아졸로[3,4a]피리다진-1-일리덴)아미노]페닐]티오]아세테이트,Methyl [[2-chloro-4-fluoro-5-[(tetrahydro-3-oxo-1H, 3H- [1,3,4] thiadiazolo [3,4a] pyridazine-1-ylidene) Amino] phenyl] thio] acetate,

2-[2-(3-클로로페닐)-2,3-에폭시프로필]-2-에틸인단-1,3-디온 등.2- [2- (3-chlorophenyl) -2,3-epoxypropyl] -2-ethyl indan-1,3-dione and the like.

실시예Example

다음에 실시예를 들어 본 발명을 더욱 구체적으로 설명한다. 단, 본 발명은 그 요지를 벗어나지 않는 한, 하기의 실시예에 한정되는 것은 아니다.Next, an Example is given and this invention is demonstrated further more concretely. However, this invention is not limited to the following Example, unless the summary is exceeded.

참고예 1Reference Example 1

에틸 1-[4-클로로-5-(사이클로펜틸옥시)-2-플루오로페닐]에틸리덴카바제이트Ethyl 1- [4-chloro-5- (cyclopentyloxy) -2-fluorophenyl] ethylidenecarbazate

4'-클로로-5'-(사이클로펜틸옥시)-2'-플루오로아세토페논 6.1g, 카바딘산에틸 2.5g 및 톨루엔 20㎖의 혼합물을 10시간 동안 가열 환류시키면서 에스테르관을 사용하여 상시 물을 계외로 제거한다. 하룻 밤 방치한 후에 농축시켜 조 생성물을 수득한다. 컬럼 크로마토그래피(전개 용매 헥산:에틸 아세테이트/7:1)에 의해서 정제하고 표제 화합물 4.2g을 수득한다. 물성치 및 NMR 스펙트럼 데이터는 하기와 같다.The mixture of 6.1 g of 4'-chloro-5 '-(cyclopentyloxy) -2'-fluoroacetophenone, 2.5 g of ethyl carbadate and 20 ml of toluene was heated under reflux for 10 hours, and the water was constantly Remove to system. After standing overnight, it is concentrated to give the crude product. Purification by column chromatography (developing solvent hexane: ethyl acetate / 7: 1) affords 4.2 g of the title compound. Physical properties and NMR spectral data are as follows.

1H-NMR(CDCl3) δ(ppm): 7.93(1H, br), 7.22(1H, d, J=6.0Hz), 7.10(1H, d, J=10.5Hz), 4.84(1H, m), 4.32(2H, q, J=6.9Hz), 2.22(3H, s), 1.98-1.80(4H, m), 1.75-1.59(2H, m), 1.35(3H, t, J=6.9Hz). 1 H-NMR (CDCl 3 ) δ (ppm): 7.93 (1H, br), 7.22 (1H, d, J = 6.0 Hz), 7.10 (1H, d, J = 10.5 Hz), 4.84 (1H, m) , 4.32 (2H, q, J = 6.9 Hz), 2.22 (3H, s), 1.98-1.80 (4H, m), 1.75-1.59 (2H, m), 1.35 (3H, t, J = 6.9 Hz).

참고예 2Reference Example 2

에틸 2,2,2-트리클로로-1-[4-클로로-5-(사이클로펜틸옥시)-2-플루오로페닐]에틸리덴카바제이트Ethyl 2,2,2-trichloro-1- [4-chloro-5- (cyclopentyloxy) -2-fluorophenyl] ethylidenecarbazate

참고예 1에서 수득된 에틸 1-[4-클로로-5-(사이클로펜틸옥시)-2-플루오로페닐]에틸리덴카바제이트 1.8g, N-클로로석신이미드 2.4g, 사염화탄소 30㎖의 혼합물을 28시간 동안 가열 환류시킨다. 실온에서 하룻 밤 방치하여 석출한 결정을 여과분별하고 결정을 에틸 아세테이트로 세정한다. 수득된 여과액을 농축시키고 에틸 2,2-디클로로-1-[4-클로로-5-(사이클로펜틸옥시)-2-플루오로페닐]에틸리덴카바제이트 2.6g을 수득한다. 이 조 생성물과 설푸릴클로라이드 4.5g의 혼합물을 50℃에서 17시간 동안 교반시킨다. 이후에 반응액을 교반중인 빙수에 천천히 적하한다. 석출한 결정을 여과분별하고 에틸 아세테이트에 용해시켜 포화 식염수로 세정하고, 무수 황산나트륨으로 건조시켜 여과한 후 농축시킨다. 수득된 결정을 여과하고 헥산으로 세정하여 건조시키고 표제 화합물 1.8g을 수득한다. 물성치 및 NMR 스펙트럼 데이터는 하기와 같다.A mixture of 1.8 g of ethyl 1- [4-chloro-5- (cyclopentyloxy) -2-fluorophenyl] ethylidenecarbazate, 2.4 g of N-chlorosuccinimide, and 30 ml of carbon tetrachloride obtained in Reference Example 1 Heated to reflux for 28 h. The precipitated crystals were separated by filtration at room temperature overnight and the crystals were washed with ethyl acetate. The filtrate obtained is concentrated to give 2.6 g of ethyl 2,2-dichloro-1- [4-chloro-5- (cyclopentyloxy) -2-fluorophenyl] ethylidenecarbazate. The mixture of crude product and 4.5 g of sulfyl chloride is stirred at 50 ° C. for 17 hours. Thereafter, the reaction solution is slowly added dropwise to the stirring ice water. The precipitated crystals were separated by filtration, dissolved in ethyl acetate, washed with saturated brine, dried over anhydrous sodium sulfate, filtered and concentrated. The crystals obtained are filtered off, washed with hexane and dried to give 1.8 g of the title compound. Physical properties and NMR spectral data are as follows.

융점. 230.0-231.0℃Melting point. 230.0-231.0 ℃

1H-NMR(CDCl3) δ(ppm): 7.58(1H, br), 7.32(1H, d, J=9.3Hz), 6.94(1H, d, J=5.7Hz), 4.75(1H, m), 4.29(2H, q, J=6.9Hz), 1.98-1.80(4H, m), 1.75-1.59(2H, m), 1.33(3H, t, J=6.9Hz). 1 H-NMR (CDCl 3 ) δ (ppm): 7.58 (1H, br), 7.32 (1H, d, J = 9.3 Hz), 6.94 (1H, d, J = 5.7 Hz), 4.75 (1H, m) 4.29 (2H, q, J = 6.9 Hz), 1.98-1.80 (4H, m), 1.75-1.59 (2H, m), 1.33 (3H, t, J = 6.9 Hz).

IR(KBr)ν(cm-1): 2965, 1630, 1490, 1450, 1402, 1341, 1190.IR (KBr) ν (cm −1 ): 2965, 1630, 1490, 1450, 1402, 1341, 1190.

참고예 3Reference Example 3

에틸 4-클로로-5-사이클로펜틸옥시-2-플루오로페닐글리옥실레이트Ethyl 4-chloro-5-cyclopentyloxy-2-fluorophenylglyoxylate

100㎖의 4구 플라스크에 스터러 바를 넣고 지무로 냉각관 및 온도계를 설치한다. 금속 마그네슘 0.49g, 한 조각의 요오드 및 THF 2㎖의 혼합물을 질소 기류하에 요오드의 색이 사라질 때까지 15분 동안 교반시켜 마그네슘을 활성화시킨다. 여기에 1-브로모-4-클로로-5-사이클로펜틸옥시-2-플루오로벤젠 2.0g, 디브로모에탄 0.1㎖의 THF 6㎖ 용액을 15분간에 걸쳐 내부 온도 35℃ 이하로 유지하면서 천천히 적하한다. 적하 종료후, 다시 디브로모에탄 0.1㎖의 THF 2㎖ 용액을 5분간에 걸쳐 내부 온도 35℃ 이하로 유지하면서 천천히 적하하고 그리냐르 시약을 조정한다.Put a stirrer bar in a 100 ml four-necked flask and install the cooling tube and thermometer with a dial. A mixture of 0.49 g of metal magnesium, one piece of iodine and 2 ml of THF is stirred under a stream of nitrogen for 15 minutes until the color of iodine disappears to activate the magnesium. Here, a solution of THF 6 ml of 2.0 g of 1-bromo-4-chloro-5-cyclopentyloxy-2-fluorobenzene and 0.1 ml of dibromoethane was kept slowly at an internal temperature of 35 ° C. or lower for 15 minutes. Dropping After completion of the dropwise addition, 2 ml of a solution of 0.1 ml of THF in 0.1 ml of dibromoethane was slowly added dropwise while maintaining the internal temperature at 35 ° C. or lower over 5 minutes to adjust the Grignard reagent.

2000㎖의 4구 플라스크에 스터러 바를 투입하고 지무로 냉각관 및 온도계를 설치한다. 금속 마그네슘 30.0g, 약숟갈 1분량의 요오드 및 THF 150㎖의 혼합물을 질소 기류하에 요오드의 색이 사라질 때까지 15분 동안 교반시켜 마그네슘을 활성화시킨다. 여기에 먼저 조정한 그리냐르 시약을 실린지로 첨가하여 THF 220㎖를 가한 후에 1-브로모-4-클로로-5-사이클로펜틸옥시-2-플루오로벤젠 181.94g, 디브로모에탄 10.8㎖의 THF 180㎖ 용액을 2시간에 걸쳐서 내부 온도 30 내지 36℃로 유지하면서 천천히 적하한다. 적하 종료후, 추가로 디브로모에탄 2.7㎖의 THF 용액 15㎖를 30분간에 걸쳐 내부 온도 35℃ 이하로 유지하면서 천천히 적하한다.Put a stirrer bar into a 2000 ml four-necked flask and install a cooling tube and a thermometer with jiru. A mixture of 30.0 grams of metal magnesium, about one minute of iodine and 150 ml of THF is stirred under a stream of nitrogen for 15 minutes until the color of iodine disappears to activate magnesium. The Grignard reagent adjusted first was added to the syringe and 220 ml of THF was added thereto, followed by 181.94 g of 1-bromo-4-chloro-5-cyclopentyloxy-2-fluorobenzene and 10.8 ml of dibromoethane. The 180 ml solution is slowly added dropwise while maintaining the internal temperature at 30 to 36 ° C. over 2 hours. After completion of the dropwise addition, 15 ml of a THF solution of 2.7 ml of dibromoethane was slowly added dropwise while maintaining the internal temperature at 35 ° C or lower over 30 minutes.

3000㎖의 4구 플라스크에 스터러 바를 투입하고 지무로 냉각관 및 온도계를 설치한다. 여기에 디에틸옥살레이트 184.0g의 에테르 800㎖ 용액을 첨가하여 질소 기류하 -30℃로 냉각시킨다. 여기에 먼저 조정한 그리냐르 시약을 -30℃ 이하로 유지하면서 1.5시간에 걸쳐 천천히 적하한다. 또한 -20℃로 승온시켜 1시간 동안 교반시킨다. 반응 혼합물에 포화 염화암모늄 수용액을 천천히 첨가하여 반응을 종료시켜 실온으로 승온시킨다. 반응 혼합물을 에틸 아세테이트로 추출하여 수득된 유기상을 포화 식염수로 세정하고 무수 황산나트륨으로 건조시켜 여과한 후 농축시킨다. 조 생성물 중의 미반응 디에틸옥살레이트를 0.5mmHg에서 욕 온도 70℃에서 증류 제거하여 수득된 조 생성물을 섬광 컬럼 크로마토그래피(전개용매 헥산:에틸 아세테이트/20:1-15:1)로 정제하고 표제 화합물 101.1g을 수득한다. 물성치 및 NMR 스펙트럼 데이터는 하기와 같다.Put a stirrer bar into a 3000 ml four-necked flask and install a cooling tube and a thermometer with jiru. A 800 ml solution of 184.0 g of diethyloxalate was added thereto and cooled to -30 ° C under a stream of nitrogen. The Grignard reagent adjusted first is dripped slowly over 1.5 hours, keeping below -30 degreeC. Furthermore, it heated up at -20 degreeC and stirred for 1 hour. Saturated aqueous ammonium chloride solution is slowly added to the reaction mixture to terminate the reaction, and the temperature is raised to room temperature. The reaction mixture is extracted with ethyl acetate and the organic phase is washed with saturated brine, dried over anhydrous sodium sulfate, filtered and concentrated. The crude product obtained by distilling off unreacted diethyloxalate in the crude product at a bath temperature of 70 ° C. at 0.5 mmHg was purified by flash column chromatography (developing solvent hexane: ethyl acetate / 20: 1-15: 1) and titled 101.1 g of compound is obtained. Physical properties and NMR spectral data are as follows.

융점 54.5-55.1℃Melting Point 54.5-55.1 ℃

1H-NMR(CDCl3) δ(ppm): 7.40(1H, d, J=6.0Hz), 7.22(1H, d, J=10.2Hz), 4.85(1H, m), 4.43(2H, q, J=6.9Hz), 1.98-1.80(4H, m), 1.75-1.59(2H, m), 1.40(3H, t, J=6.9Hz). 1 H-NMR (CDCl 3 ) δ (ppm): 7.40 (1H, d, J = 6.0 Hz), 7.22 (1H, d, J = 10.2 Hz), 4.85 (1H, m), 4.43 (2H, q, J = 6.9 Hz), 1.98-1.80 (4H, m), 1.75-1.59 (2H, m), 1.40 (3H, t, J = 6.9 Hz).

참고예 4Reference Example 4

4-클로로-5-사이클로펜틸옥시-2-플루오로페닐글리옥실산4-Chloro-5-cyclopentyloxy-2-fluorophenylglyoxylic acid

2000㎖의 3구 플라스크에 기계 교반기와 온도계를 설치하고 여기에 수산화나트륨 40.00g과 물 500㎖을 첨가하여 2N 수산화나트륨 수용액을 조정한다. 실온까지 냉각한 후에 참고예 3에서 수득된 에틸 4-클로로-5-사이클로펜틸옥시-2-플루오로페닐글리옥실레이트 109.8g을 천천히 첨가하고 1.5시간 동안 교반한다. 반응 종료후, 1N 염산 수용액 1000㎖를 천천히 첨가하여 반응 용액을 산성으로 한다. 반응 혼합물을 에테르로 3회 추출하여 수득된 유기상을 포화 식염수로 2회 세정하고, 무수 황산나트륨으로 건조시켜 여과한 후 농축시키고 표제 화합물 99.8g을 수득한다. 물성치 및 NMR 스펙트럼 데이터는 하기와 같다.A mechanical stirrer and thermometer are installed in a 2000 ml three-necked flask, and 40.00 g of sodium hydroxide and 500 ml of water are added to adjust the 2N aqueous sodium hydroxide solution. After cooling to room temperature, 109.8 g of ethyl 4-chloro-5-cyclopentyloxy-2-fluorophenylglyoxylate obtained in Reference Example 3 was slowly added and stirred for 1.5 hours. After completion of the reaction, 1000 ml of 1N aqueous hydrochloric acid solution was slowly added to make the reaction solution acidic. The reaction mixture was extracted three times with ether, and the organic phase obtained was washed twice with saturated brine, dried over anhydrous sodium sulfate, filtered and concentrated to give 99.8 g of the title compound. Physical properties and NMR spectral data are as follows.

융점 94.2-96.7℃Melting Point 94.2-96.7 ℃

1H-NMR(CDCl3) δ(ppm): 7.99(1H, t, J=7.8Hz), 7.33(1H, dd, J=1.5, 8.4Hz), 7.26(1H, dd, J=1.5, 9.9Hz), 7.03(1H, br). 1 H-NMR (CDCl 3 ) δ (ppm): 7.99 (1H, t, J = 7.8 Hz), 7.33 (1H, dd, J = 1.5, 8.4 Hz), 7.26 (1H, dd, J = 1.5, 9.9 Hz), 7.03 (1H, broad singlet).

IR(KBr)ν(cm-1): 2985, 1720, 1692, 1606, 1408, 1250, 1215, 1080, 990, 900, 861, 540.IR (KBr) ν (cm −1 ): 2985, 1720, 1692, 1606, 1408, 1250, 1215, 1080, 990, 900, 861, 540.

실시예 1Example 1

3-(4-클로로-2-플루오르-5-사이클로펜틸옥시페닐)-6,7-디하이드로-4-하이드록시-[5H]-사이클로펜타[c]피리다진3- (4-chloro-2-fluoro-5-cyclopentyloxyphenyl) -6,7-dihydro-4-hydroxy- [5H] -cyclopenta [c] pyridazine

1000㎖의 플라스크에 스터러 바 및 염 컬관과 알칼리 트랩을 설치한다. 여기에 참고예 4에서 수득된 4-클로로-5-사이클로펜틸옥시-2-플루오로페닐글리옥실산 99.8g과 염화티오닐 122.0㎖를 첨가하고 60℃에서 2.5시간 동안 가열교반한다. 이후에 증류 세트를 설치하여 욕 온도를 110℃까지 승온시켜 미반응의 염화티오닐을 증류 제거한다. 추가로 벤젠 120㎖를 첨가하여 남은 염화티오닐과 함께 증류 제거한 후, 진공 펌프로 감압 건조시켜 조 글리옥실산클로라이드를 수득한다.A 1000 ml flask is equipped with a stirrer bar, a salt curl tube and an alkali trap. To this, 99.8 g of 4-chloro-5-cyclopentyloxy-2-fluorophenylglyoxylic acid obtained in Reference Example 4 and 122.0 ml of thionyl chloride were added thereto, and the mixture was stirred by heating at 60 ° C. for 2.5 hours. Thereafter, a distillation set is installed to raise the bath temperature to 110 ° C. to distill off unreacted thionyl chloride. Further 120 ml of benzene was added and distilled off with the remaining thionyl chloride, followed by drying under reduced pressure with a vacuum pump to obtain crude glyoxylic acid chloride.

2000㎖의 4구 플라스크에 스터러 바와 염 컬관 및 온도계를 설치한다. 여기에 N-(1-사이클로펜텐-1-일)-모르폴린 54.2g과 트리에틸아민 66.6g 및 염화메틸렌 500㎖를 첨가하여 질소 기류하 -5℃까지 냉각시킨다. 여기에 먼저 조정한 글리옥실산클로라이드의 염화메틸렌(200㎖) 용액을 1시간에 걸쳐, 용액 온도를 1℃ 이하로 유지하면서 천천히 적하한다. 다시, 반응 혼합물을 1 내지 10℃에서 1시간 동안 교반한다. 반응 혼합물을 여과하여 잔사(트리에틸아민염산염)를 염화메틸렌 150㎖로 세정한다. 여과액을 2000㎖ 플라스크에 옮겨, 2-프로판올 500㎖를 첨가하여 교반시키면서 하이드라진 수화물 19.8g을 적하하고 실온에서 1시간 동안 교반시킨 후, 밤새 방치한다. 반응 혼합물을 감압 농축시켜 잔사를 에탄올로 현탁시킨다. 현탁 용액을 여과하여 잔사를 에탄올 및 헥산으로 세정하고 감압건조시켜 표제 화합물 55.5g을 수득한다. 여과액을 감압농축시켜 수득된 잔사를 또 한번 에탄올로 현탁시켜 동일하게 여과한 후 세정, 건조를 거쳐 추가로 표제 화합물 13.6g을 수득한다. 물성치 및 NMR 스펙트럼 데이터는 하기와 같다.A stirrer bar, salt curl tube and thermometer are installed in a 2000 ml four neck flask. 54.2 g of N- (1-cyclopenten-l-yl) -morpholine, 66.6 g of triethylamine, and 500 ml of methylene chloride were added thereto, followed by cooling to -5 DEG C under a nitrogen stream. The methylene chloride (200 mL) solution of the glyoxylic acid chloride adjusted first here is dripped slowly, maintaining solution temperature at 1 degrees C or less over 1 hour. Again, the reaction mixture is stirred at 1-10 ° C. for 1 hour. The reaction mixture was filtered to wash the residue (triethylamine hydrochloride) with 150 ml of methylene chloride. The filtrate was transferred to a 2000 ml flask, 19.8 g of hydrazine hydrate was added dropwise while 500 ml of 2-propanol was added and stirred, and the mixture was stirred at room temperature for 1 hour, and then left overnight. The reaction mixture is concentrated under reduced pressure and the residue is suspended with ethanol. The suspension solution is filtered, the residue is washed with ethanol and hexane and dried under reduced pressure to give 55.5 g of the title compound. The residue obtained by concentrating the filtrate under reduced pressure was once again suspended in ethanol, filtered in the same manner, washed, dried and further obtained 13.6 g of the title compound. Physical properties and NMR spectral data are as follows.

융점 300℃ 이상Melting point 300 ℃ or more

1H-NMR(DMSO-d6) δ(ppm): 7.23(1H, d, J=6.3Hz), 7.18(1H, d, J=9.6Hz), 4.79(1H, m), 3.05(2H, t, J=7.5Hz), 2.96(2H, t, J=7.5Hz), 2.17(2H, qui, J=7.5Hz), 1.95-1.53(8H, m). 1 H-NMR (DMSO-d 6 ) δ (ppm): 7.23 (1H, d, J = 6.3 Hz), 7.18 (1H, d, J = 9.6 Hz), 4.79 (1H, m), 3.05 (2H, t, J = 7.5 Hz), 2.96 (2H, t, J = 7.5 Hz), 2.17 (2H, qui, J = 7.5 Hz), 1.95-1.53 (8H, m).

IR(KBr)ν(cm-1): 3050, 2920, 1580, 1560, 1492, 1465, 1401, 1187.IR (KBr) ν (cm −1 ): 3050, 2920, 1580, 1560, 1492, 1465, 1401, 1187.

실시예 2Example 2

4-클로로-3-[4-클로로-5-(사이클로펜틸옥시)-2-플루오로페닐]-6,7-디하이드로-5H-사이클로펜타[c]피리다진4-chloro-3- [4-chloro-5- (cyclopentyloxy) -2-fluorophenyl] -6,7-dihydro-5H-cyclopenta [c] pyridazine

참고예 2에서 수득된 에틸 2,2,2-트리클로로-1-[4-클로로-5-(사이클로펜틸옥시)-2-플루오로페닐]에틸리덴카바제이트 1.50g의 디클로로메탄 10㎖ 용액에 트리에틸아민 0.42g을 천천히 적하한다. 그 혼합물 중에 1-모르폴리노-1-사이클로펜텐 0.64g을 첨가하여 7시간 동안 가열 환류시킨다. 하룻 밤 방치한 후, 반응 혼합물로부터 에틸 아세테이트로 추출하여 포화 염화암모늄 수용액, 포화 중조수, 이어서 포화 식염수로 순서대로 세정하고 무수 황산나트륨으로 건조시켜 여과한 후 농축시킨다. 조 생성물을 섬광 컬럼 크로마토그래피(헥산:에틸 아세테이트/9:1-3:1)로 정제하고 표제 화합물(표 1, No.18) 0.50g을 수득한다.10 ml solution of 1.50 g of ethyl 2,2,2-trichloro-1- [4-chloro-5- (cyclopentyloxy) -2-fluorophenyl] ethylidenecarbazate obtained in Reference Example 2 0.42 g of triethylamine was slowly added dropwise to the mixture. 0.64 g of 1-morpholino-1-cyclopentene is added to the mixture and heated to reflux for 7 hours. After standing overnight, the mixture was extracted with ethyl acetate from the reaction mixture, washed sequentially with saturated aqueous ammonium chloride solution, saturated aqueous sodium bicarbonate and then with saturated brine, dried over anhydrous sodium sulfate, filtered and concentrated. The crude product is purified by flash column chromatography (hexane: ethyl acetate / 9: 1-3: 1) to afford 0.50 g of the title compound (Table 1, No. 18).

실시예 3Example 3

4-클로로-3-(4-클로로-2-플루오로-5-하이드록시페닐)-6,7-디하이드로-5H-사이클로펜타[c]피리다진4-chloro-3- (4-chloro-2-fluoro-5-hydroxyphenyl) -6,7-dihydro-5H-cyclopenta [c] pyridazine

75% 황산 4㎖에 4-클로로-3-(4-클로로-5-사이클로펜틸옥시-2-플루오로페닐)-6,7-디하이드로-5H-사이클로펜타[c]피리다진 2.4g의 메틸렌 클로라이드 2㎖ 용액을 천천히 적하한다. 실온에서 30분 동안 교반후, 반응 혼합물을 파쇄 빙수에 적하하고 에틸 아세테이트로 추출한다. 또한, 수층을 포화 중조수로 중성으로 한 후, 에틸 아세테이트로 추출한다. 합친 유기층을 포화 식염수로 세정하고 무수 황산나트륨으로 건조시켜 여과한 후 농축시킨다. 조 생성물을 소량의 에틸 아세테이트와 헥산으로 세정하고 표제 화합물(표 1, No.12) 1.68g을 결정으로서 수득한다.Methylene of 2.4 g of 4-chloro-3- (4-chloro-5-cyclopentyloxy-2-fluorophenyl) -6,7-dihydro-5H-cyclopenta [c] pyridazine in 4 ml of 75% sulfuric acid 2 ml solution of chloride is slowly added dropwise. After stirring for 30 minutes at room temperature, the reaction mixture is added dropwise to crushed ice water and extracted with ethyl acetate. The aqueous layer is further neutralized with saturated sodium bicarbonate water and then extracted with ethyl acetate. The combined organic layers were washed with saturated brine, dried over anhydrous sodium sulfate, filtered and concentrated. The crude product is washed with a small amount of ethyl acetate and hexanes to give 1.68 g of the title compound (Table 1, No. 12) as crystals.

실시예 4Example 4

에틸 2-[2-클로로-4-플루오로-5-(4-클로로-6,7-디하이드로-5H-사이클로펜타[c]피리다진-3-일)페녹시]프로피오네이트Ethyl 2- [2-chloro-4-fluoro-5- (4-chloro-6,7-dihydro-5H-cyclopenta [c] pyridazin-3-yl) phenoxy] propionate

4-클로로-3-(4-클로로-2-플루오로-5-하이드록시페닐)-6,7-디하이드로-5H-사이클로펜타[c]피리다진 0.40g, α-브로모프로피온산에틸 0.29g, 탄산칼륨 0.22g 및 아세톤 5㎖의 혼합물을, 교반하에 5시간 동안 가열 환류시킨다. 반응액을 실온으로 냉각시켜 포화 암모니아 수용액을 가하여 에틸 아세테이트로 추출한다. 유기상을 포화 식염수로 세정하여 황산나트륨으로 건조시킨다. 감압농축시켜 수득된 조 생성물을 섬광 컬럼 크로마토그래피(헥산-에틸 아세테이트/2:1)로 정제하고 표제 화합물(표 2, No.54) 0.44g을 수득한다.0.40 g of 4-chloro-3- (4-chloro-2-fluoro-5-hydroxyphenyl) -6,7-dihydro-5H-cyclopenta [c] pyridazine, 0.29 g of ethyl α-bromopropionate A mixture of 0.22 g of potassium carbonate and 5 ml of acetone was heated to reflux for 5 hours under stirring. The reaction solution was cooled to room temperature, saturated aqueous ammonia solution was added, and extracted with ethyl acetate. The organic phase is washed with saturated brine and dried over sodium sulfate. The crude product obtained by concentration under reduced pressure was purified by flash column chromatography (hexane-ethyl acetate / 2: 1) to give 0.44 g of the title compound (Table 2, No. 54).

실시예 5Example 5

4-클로로-3-[4-클로로-2-플루오로-5-(1-메틸-2-프로피닐옥시)페닐]-6,7-디하이드로-5H-사이클로펜타[c]피리다진4-chloro-3- [4-chloro-2-fluoro-5- (1-methyl-2-propynyloxy) phenyl] -6,7-dihydro-5H-cyclopenta [c] pyridazine

4-클로로-3-(4-클로로-2-플루오로-5-하이드록시페닐)-6,7-디하이드로-5H-사이클로펜타[c]피리다진 0.61g과 트리페닐포스핀(TPP) 0.67g, 1-부텐-3-올 0.21g의 테트라하이드로푸란 5㎖ 용액에 아조디카복실산 디에틸(DEAD) 0.44g을 천천히 적하한다. 이후에 실온에서 하룻 밤 교반시킨다. 반응 용액을 감압 농축시켜 수득된 조 생성물을 섬광 컬럼 크로마토그래피(헥산-에틸 아세테이트/3:1)에 의해서 정제하여 수득된 결정을 열수로 세정하고 표제 화합물(표 1, No.24) 0.46g을 수득한다.0.61 g of 4-chloro-3- (4-chloro-2-fluoro-5-hydroxyphenyl) -6,7-dihydro-5H-cyclopenta [c] pyridazine and triphenylphosphine (TPP) 0.67 0.44 g of azodicarboxylic acid diethyl (DEAD) was slowly added dropwise to 5 ml of tetrahydrofuran solution of 0.21 g of 1-butene-3-ol. Then stir overnight at room temperature. The crude product obtained by concentration of the reaction solution under reduced pressure was purified by flash column chromatography (hexane-ethyl acetate / 3: 1), and the obtained crystals were washed with hot water to obtain 0.46 g of the title compound (Table 1, No. 24). To obtain.

실시예 6Example 6

4-클로로-3-[4-클로로-5-(사이클로펜틸옥시)-2-플루오로페닐]-6,7-디하이드로-5H-사이클로펜타[c]피리다진4-chloro-3- [4-chloro-5- (cyclopentyloxy) -2-fluorophenyl] -6,7-dihydro-5H-cyclopenta [c] pyridazine

실시예 1에서 수득된 3-(4-클로로-2-플루오로-5-사이클로펜틸옥시페닐)-6,7-디하이드로-4-하이드록시-[5H]-사이클로펜타[c]피리다진 1.45g과 옥시염화인 3.00g의 톨루엔 용액(10㎖)을 실온에서 1시간 동안 교반시킨다. 반응 혼합물을 빙냉수(100㎖)에 첨가하고 에틸 아세테이트로 추출하여 수득된 유기상을 포화 중조수, 포화 식염수로 세정하고 무수 황산나트륨으로 건조시켜 여과한 후 농축시킨다. 수득된 조 생성물을 섬광 컬럼 크로마토그래피(헥산-에틸 아세테이트/2:1)로 정제하고 표제 화합물(표 1, No.18) 1.50g을 수득한다.3- (4-Chloro-2-fluoro-5-cyclopentyloxyphenyl) -6,7-dihydro-4-hydroxy- [5H] -cyclopenta [c] pyridazine 1.45 obtained in Example 1. g and 3.00 g of toluene solution (10 ml) of phosphorus oxychloride are stirred at room temperature for 1 hour. The reaction mixture was added to ice-cold water (100 mL) and extracted with ethyl acetate. The organic phase obtained was washed with saturated sodium bicarbonate, saturated brine, dried over anhydrous sodium sulfate, filtered and concentrated. The crude product obtained is purified by flash column chromatography (hexane-ethyl acetate / 2: 1) to afford 1.50 g of the title compound (Table 1, No. 18).

실시예 7Example 7

4-브로모-3-[4-클로로-5-(사이클로펜틸옥시)-2-플루오로페닐]-6,7-디하이드로-5H-사이클로펜타[c]피리다진4-bromo-3- [4-chloro-5- (cyclopentyloxy) -2-fluorophenyl] -6,7-dihydro-5H-cyclopenta [c] pyridazine

실시예 1에서 수득된 3-(4-클로로-2-플루오로-5-사이클로펜틸옥시페닐)-6,7-디하이드로-4-하이드록시-[5H]-사이클로펜타[c]피리다진 9.00g의 삼브롬화인 30㎖ 용액을 80 내지 90℃에서 2 시간 동안 가열 교반한다. 반응 종료후, 실온으로 냉각시켜 반응 혼합물을 빙수에 투입하고 클로로포름으로 추출한다. 수득된 유기층을 포화 중조수, 이어서 포화 식염수로 세정하고 무수 황산나트륨으로 건조시킨 후, 여과한 후 농축시킨다. 조 생성물을 섬광 컬럼 크로마토그래피(전개 용매 헥산:에틸 아세테이트/3:1-5:2)로 정제하고 표제 화합물 3.00g을 수득한다.3- (4-Chloro-2-fluoro-5-cyclopentyloxyphenyl) -6,7-dihydro-4-hydroxy- [5H] -cyclopenta [c] pyridazine 9.00 obtained in Example 1. g 30 ml solution of phosphorus tribromide is heated and stirred at 80 to 90 ° C. for 2 hours. After the reaction was completed, the reaction mixture was cooled to room temperature, poured into ice water, and extracted with chloroform. The organic layer obtained was washed with saturated sodium bicarbonate, followed by saturated brine, dried over anhydrous sodium sulfate, filtered and concentrated. The crude product is purified by flash column chromatography (developing solvent hexane: ethyl acetate / 3: 1-5: 2) to afford 3.00 g of the title compound.

실시예 8Example 8

4-클로로-3-(4-클로로-5-니트로-2-플루오로페닐)-6,7-디하이드로-5H-사이클로펜타[c]피리다진4-chloro-3- (4-chloro-5-nitro-2-fluorophenyl) -6,7-dihydro-5H-cyclopenta [c] pyridazine

4-클로로-3-(4-클로로-2-플루오로페닐)-6,7-디하이드로-5H-사이클로펜타[c]피리다진 7.4g에 진한 황산 35㎖를 첨가하고 7℃로 냉각하면서 교반시켜 균일계로 한다. 이 혼합물에 산 혼합물(진한 황산 2.5㎖, 60% 질산 2.5㎖)을 6 내지 12℃에서 10분 걸어 천천히 적하한다. 반응 혼합물을 빙수(400㎖)에 전개하고 에틸 아세테이트로 추출하여 수득된 유기층을 포화 중조수, 포화 식염수로 순서대로 세정하고 무수 황산나트륨으로 건조시켜 여과한 후 농축시킨다. 조 생성물을 섬광 컬럼 크로마토그래피(헥산-에틸 아세테이트/2:1)로 정제하고 표제 화합물(표 1, No.8) 5.12g을 수득한다.To 7.4 g of 4-chloro-3- (4-chloro-2-fluorophenyl) -6,7-dihydro-5H-cyclopenta [c] pyridazine, 35 ml of concentrated sulfuric acid was added and stirred while cooling to 7 ° C. To obtain a homogeneous system. An acid mixture (2.5 ml of concentrated sulfuric acid, 2.5 ml of 60% nitric acid) was slowly added dropwise to the mixture at 6 to 12 ° C for 10 minutes. The reaction mixture was developed in ice water (400 mL) and extracted with ethyl acetate. The organic layer was washed with saturated sodium bicarbonate and saturated brine in that order, dried over anhydrous sodium sulfate, filtered and concentrated. The crude product is purified by flash column chromatography (hexane-ethyl acetate / 2: 1) to give 5.12 g of the title compound (Table 1, No. 8).

실시예 9Example 9

4-클로로-3-(5-아미노-4-클로로-2-플루오로페닐)-6,7-디하이드로-5H-사이클로펜타[c]피리다진4-chloro-3- (5-amino-4-chloro-2-fluorophenyl) -6,7-dihydro-5H-cyclopenta [c] pyridazine

철분 6.0g, 물 6㎖, 아세트산 1.5㎖의 혼합물을 30분 동안 가열 환류시킨다. 실온까지 냉각한 후에 이소프로판올(20㎖)을 첨가하고 70℃로 가열하면서 4-클로로-3-(4-클로로-2-플루오로-5-니트로페닐)-6,7-디하이드로-5H-사이클로펜타[c]피리다진 5.05g의 N-메틸피롤리돈(NMP) 용액 20㎖를 천천히 첨가한다. 이후에 80℃에서 1.5시간 동안 가열 교반하여 실온까지 냉각시키고 탄산칼륨 수용액(탄산칼륨 1.25g, 물 10㎖)을 첨가한다. 혼합물을 셀라이트 여과하고 잔사를 에틸 아세테이트로 세정한다. 여과액을 농축시켜 수득된 조 생성물을 에틸 아세테이트로 추출하여 수득된 유기층을 포화 중조수, 포화 식염수로 순서대로 세정하고 무수 황산나트륨으로 건조시켜 여과한 후 농축시킨다. 조 생성물을 섬광 컬럼 크로마토그래피(헥산-에틸 아세테이트/2:1)로 정제하고 표제 화합물(표 1, No.61) 4.59g을 수득한다.A mixture of 6.0 g of iron, 6 ml of water and 1.5 ml of acetic acid is heated to reflux for 30 minutes. After cooling to room temperature add isopropanol (20 mL) and heat to 70 ° C. while 4-chloro-3- (4-chloro-2-fluoro-5-nitrophenyl) -6,7-dihydro-5H-cyclo 20 ml of a solution of 5.05 g of N-methylpyrrolidone (NMP) with penta [c] pyridazine are slowly added. Thereafter, the mixture was heated and stirred at 80 ° C. for 1.5 hours, cooled to room temperature, and an aqueous potassium carbonate solution (1.25 g of potassium carbonate and 10 ml of water) was added. The mixture is filtered through Celite and the residue is washed with ethyl acetate. The crude product obtained by concentrating the filtrate was extracted with ethyl acetate, and the organic layer was washed with saturated sodium bicarbonate and saturated brine in that order, dried over anhydrous sodium sulfate, filtered and concentrated. The crude product is purified by flash column chromatography (hexane-ethyl acetate / 2: 1) to afford 4.59 g of the title compound (Table 1, No. 61).

실시예 10Example 10

에틸 N-[4-클로로-5-(4-클로로-6,7-디하이드로-5H-사이클로펜타[c]피리다진-3-일)-2-플루오로페닐]카바메이트Ethyl N- [4-chloro-5- (4-chloro-6,7-dihydro-5H-cyclopenta [c] pyridazin-3-yl) -2-fluorophenyl] carbamate

4-클로로-3-(5-아미노-4-클로로-2-플루오로페닐)-6,7-디하이드로-5H-사이클로펜타[c]피리다진 1.50g, 클로로포름산에틸 0.57g의 피리딘 용액(15㎖)을 8시간 동안 교반시킨다. 반응 혼합물을 에틸 아세테이트로 추출하여 유기층을 1N 염산 수용액, 포화 중조수, 포화 식염수로 순서대로 세정하고 무수 황산나트륨으로 건조시켜 여과한 후 농축시킨다. 조 생성물을 섬광 컬럼 크로마토그래피(헥산-에틸 아세테이트/2:1)로 정제하고 표제 화합물(표 1, No.63) 1.10g을 수득한다.Pyridine solution of 1.50 g of 4-chloro-3- (5-amino-4-chloro-2-fluorophenyl) -6,7-dihydro-5H-cyclopenta [c] pyridazine and 0.57 g of ethyl chloroformate ( 15 ml) is stirred for 8 hours. The reaction mixture was extracted with ethyl acetate, and the organic layer was washed sequentially with 1N aqueous hydrochloric acid solution, saturated sodium bicarbonate and saturated brine, dried over anhydrous sodium sulfate, filtered and concentrated. The crude product is purified by flash column chromatography (hexane-ethyl acetate / 2: 1) to afford 1.10 g of the title compound (Table 1, No. 63).

실시예 11Example 11

에틸 N-[4-클로로-5-(4-클로로-6,7-디하이드로-5H-사이클로펜타[c]피리다진-3-일)-2-플루오로페닐]-N-프로파길카바메이트Ethyl N- [4-chloro-5- (4-chloro-6,7-dihydro-5H-cyclopenta [c] pyridazin-3-yl) -2-fluorophenyl] -N-propargylcarbamate

수소화나트륨 0.12g을 헥산으로 세정하고 오일을 제거한 후에 디메틸포름아미드 5㎖에 현탁시킨다. 그 용액에 에틸 N-[4-클로로-5-(4-클로로-6,7-디하이드로-5H-사이클로펜타[c]피리다진-3-일)-2-플루오로페닐]카바메이트 10g을 첨가하여 실온에서 30분 동안 교반시킨 후에 프로파길브로마이드 0.35g을 첨가하여 다시 2시간 동안 교반시킨다. 반응 혼합물에 물을 첨가하여 에틸 아세테이트로 추출하고 유기층을 포화 염화암모늄 수용액, 포화 중조수, 포화 식염수로 순서대로 세정하고 무수 황산나트륨으로 건조시켜 여과한 후 농축시킨다. 조 생성물을 섬광 컬럼 크로마토그래피(헥산-에틸 아세테이트/2:1)로 정제하고 표제 화합물(표 1, No.68) 0.75g을 수득한다.0.12 g of sodium hydride is washed with hexane and suspended in 5 ml of dimethylformamide after removing the oil. To the solution was added 10 g of ethyl N- [4-chloro-5- (4-chloro-6,7-dihydro-5H-cyclopenta [c] pyridazin-3-yl) -2-fluorophenyl] carbamate. After stirring for 30 minutes at room temperature, 0.35 g of propargyl bromide was added and stirred for another 2 hours. Water was added to the reaction mixture, followed by extraction with ethyl acetate. The organic layer was washed with an aqueous saturated ammonium chloride solution, saturated sodium bicarbonate and saturated brine in that order, dried over anhydrous sodium sulfate, filtered and concentrated. The crude product is purified by flash column chromatography (hexane-ethyl acetate / 2: 1) to afford 0.75 g of the title compound (Table 1, No. 68).

실시예 12Example 12

N-[4-클로로-5-(4-클로로-6,7-디하이드로-5H-사이클로펜타[c]피리다진-3-일)-2-플루오로페닐]프로판설폰아미드N- [4-chloro-5- (4-chloro-6,7-dihydro-5H-cyclopenta [c] pyridazin-3-yl) -2-fluorophenyl] propanesulfonamide

4-클로로-3-(5-아미노-4-클로로-2-플루오르페닐)-6,7-디하이드로-5H-사이클로펜타[c]피리다진 3.00g, n-프로판설포닐클로라이드 2.10g, 피리딘 1.6g의 메틸렌 클로라이드 용액 20㎖를 7시간 동안 교반시킨다. 반응 혼합물을 에틸 아세테이트로 추출하여 유기층을 1N 염산 수용액, 포화 중조수, 포화 식염수로 순서대로 세정하고 무수 황산나트륨으로 건조시켜 여과한 후 농축시킨다. 조 생성물을 섬광 컬럼 크로마토그래피(헥산-에틸 아세테이트/2:1)로 정제하고 표제 화합물(표 1, No.64) 2.95g을 수득한다.4-chloro-3- (5-amino-4-chloro-2-fluorophenyl) -6,7-dihydro-5H-cyclopenta [c] pyridazine 3.00 g, n-propanesulfonylchloride 2.10 g, pyridine 20 ml of 1.6 g methylene chloride solution is stirred for 7 hours. The reaction mixture was extracted with ethyl acetate, and the organic layer was washed sequentially with 1N aqueous hydrochloric acid solution, saturated sodium bicarbonate and saturated brine, dried over anhydrous sodium sulfate, filtered and concentrated. The crude product is purified by flash column chromatography (hexane-ethyl acetate / 2: 1) to afford 2.95 g of the title compound (Table 1, No. 64).

실시예 13Example 13

N-[5-(4-클로로-6,7-디하이드로-5H-사이클로펜타[c]피리다진-3-일)-4-시아노-2-플루오로페닐]에탄설폰아미드N- [5- (4-chloro-6,7-dihydro-5H-cyclopenta [c] pyridazin-3-yl) -4-cyano-2-fluorophenyl] ethanesulfonamide

N-[4-브로모-5-(4-클로로-6,7-디하이드로-5H-사이클로펜타[c]피리다진-3-일)-2-플루오로페닐]에탄설폰아미드 3.69g, 시안화구리 0.91g의 디메틸포름아미드 용액 10㎖를 2.5시간 동안 가열 환류시킨다. 이후에 실온으로 냉각시키고 염화철 수용액(FeCl33.5g, 물 4 ㎖)를 첨가하여 다시 실온에서 20분 동안 교반시킨다. 반응 혼합물에 물을 첨가하여 에틸 아세테이트로 3회 추출하여 수득된 유기층을 포화 식염수로 세정하고 무수 황산나트륨으로 건조시킨 후, 여과, 농축시킨다. 조 생성물을 섬광 컬럼 크로마토그래피(헥산-에틸 아세테이트/2:1)로 정제하고 표제 화합물(표 1, No.86) 0.32g을 수득한다.3.69 g of N- [4-bromo-5- (4-chloro-6,7-dihydro-5H-cyclopenta [c] pyridazin-3-yl) -2-fluorophenyl] ethanesulfonamide, cyanated 10 ml of 0.91 g of copper dimethylformamide solution was heated to reflux for 2.5 hours. After cooling to room temperature, an aqueous solution of iron chloride (3.5 g of FeCl 3 , 4 ml of water) was added thereto, followed by further stirring at room temperature for 20 minutes. Water was added to the reaction mixture, followed by extraction three times with ethyl acetate. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, filtered and concentrated. The crude product is purified by flash column chromatography (hexane-ethyl acetate / 2: 1) to afford 0.32 g of the title compound (Table 1, No.86).

실시예 14Example 14

4-클로로-3-(4-클로로-2-플루오로-5-사이클로펜틸옥시페닐)-6,7-디하이드로-2-옥시-[5H]-사이클로펜타[c]피리다진4-chloro-3- (4-chloro-2-fluoro-5-cyclopentyloxyphenyl) -6,7-dihydro-2-oxy- [5H] -cyclopenta [c] pyridazine

4-클로로-3-(4-클로로-2-플루오로-5-사이클로펜틸옥시페닐)-6,7-디하이드로-1H-사이클로펜타[c]피리다진 1.12g, m-클로로과벤조산(mCPBA) 0.90g의 클로로포름 용액 10㎖를 실온에서 3시간 동안 교반시킨다. 포화 중조수 15㎖를 첨가하여 반응을 종료시킨다. 반응 혼합물을 에틸 아세테이트로 추출하여 수득된 유기층을 포화 식염수로 세정하고 무수 황산나트륨으로 건조시킨 후, 여과한 후 농축시킨다. 조 생성물을 섬광 컬럼 크로마토그래피(헥산-에틸 아세테이트/1:1)로 정제하고 표제 화합물(표 1, No.93) 0.52g을 수득한다.4-chloro-3- (4-chloro-2-fluoro-5-cyclopentyloxyphenyl) -6,7-dihydro-1H-cyclopenta [c] pyridazine 1.12 g, m-chloroperbenzoic acid (mCPBA) 10 ml of 0.90 g chloroform solution is stirred at room temperature for 3 hours. 15 ml of saturated sodium bicarbonate water is added to terminate the reaction. The reaction mixture was extracted with ethyl acetate, and the organic layer obtained was washed with saturated brine, dried over anhydrous sodium sulfate, filtered and concentrated. The crude product is purified by flash column chromatography (hexane-ethyl acetate / 1: 1) to afford 0.52 g of the title compound (Table 1, No.93).

실시예 15Example 15

4-클로로-3-(4-클로로-2-플루오로-5-사이클로펜틸옥시페닐)-6,7-디하이드로-[5H]-사이클로펜타[c]피리다진염산염4-chloro-3- (4-chloro-2-fluoro-5-cyclopentyloxyphenyl) -6,7-dihydro- [5H] -cyclopenta [c] pyridazine hydrochloride

4-클로로-3-(4-클로로-2-플루오로-5-사이클로펜틸옥시페닐)-6,7-디하이드로-1H-사이클로펜타[c]피리다진 0.60g의 5% 염산·메탄올 용액 2.00g 용액을 실온에서 3시간 동안 교반시킨다. 반응 혼합물을 감압 농축시켜 수득된 결정을 여과한다. 결정을 헥산으로 세정하고 건조시켜 (표 1, No.88) 0.59g을 수득한다.4-chloro-3- (4-chloro-2-fluoro-5-cyclopentyloxyphenyl) -6,7-dihydro-1H-cyclopenta [c] pyridazine 0.60 g of a 5% hydrochloric acid methanol solution 2.00 g The solution is stirred for 3 hours at room temperature. The reaction mixture is concentrated under reduced pressure to filter the obtained crystals. The crystals are washed with hexane and dried to give 0.59 g (Table 1, No. 88).

표 1 내지 표 5에 기재된 다른 화합물도 실시예 1 내지 15 중의 어느 하나의 방법에 준하여 제조할 수 있다. 수득된 화합물의 구조는 모두 각종 스펙트럼에 의해 확인한다. 표 1 내지 표 5에 기재된 화합물의 물성 및 스펙트럼 데이터를 표 6에 나타낸다.The other compounds of Tables 1-5 can also be manufactured according to the method in any one of Examples 1-15. The structures of the obtained compounds are all confirmed by various spectra. Table 6 shows the physical and spectral data of the compounds described in Tables 1 to 5.

다음은 본 발명의 화합물의 제제예이다. 또한, 이하에 「부」, 「%」라는 것은 각각 「중량부」, 「중량%」를 의미한다.The following is a formulation example of the compound of the present invention. In addition, below "part" and "%" mean "weight part" and "weight%", respectively.

제제예 1 수화제Formulation Example 1 Hydration

표 1 및 표 2에 기재된 본 발명의 화합물 40부, 카브렉스#80(상표명, 시오노기 세이야쿠사) 20부, 카올린 클레이(상표명, 쓰치야카올린사) 35부 및 고급 알콜황산 에스테르계 계면활성제인 소르볼 8070(상표명, 도호가가쿠사) 5부를 배합한 후, 균일하게 혼합 분쇄하여 유효 성분 40%를 함유하는 수화제를 수득한다.40 parts of the compound of the present invention shown in Tables 1 and 2, 20 parts of Cabrex # 80 (trade name, Shionogi Seiyaku Co., Ltd.), 35 parts of kaolin clay (trade name, Tsuchiya Kaolin Co., Ltd.), and a higher alcohol sulfate ester surfactant. After mixing 5 parts of sorbol 8070 (trade name, Tohogagaku Co., Ltd.), it is mixed and ground uniformly to obtain a hydrating agent containing 40% of the active ingredient.

제제예 2 유제Formulation Example 2 Emulsion

표 1 내지 표 5에 기재된 화합물의 본 발명의 화합물 20부를 크실렌 35부 및 N,N-디메틸포름아미드 30부로 이루어진 혼합 용매에 용해시킨 후, 여기에 폴리옥시에틸렌계 계면활성제인 소르볼 3005X(상표명, 도호가가쿠사) 15부를 가하여 유효 성분 20%을 함유하는 유제를 수득한다.After dissolving 20 parts of the compounds of the present invention of the compounds described in Tables 1 to 5 in a mixed solvent consisting of 35 parts of xylene and 30 parts of N, N-dimethylformamide, sorbol 3005X (polyoxyethylene-based surfactant) was added thereto. 15 parts of Tohogagaku Co., Ltd. was added to obtain an emulsion containing 20% of the active ingredient.

제제예 3 유동화제Formulation Example 3 Fluidizing Agent

표 1 내지 표 5에 기재된 본 발명의 화합물 30부를 미리 혼합하여 놓은 에틸렌글리콜 8부, 소르볼 AC3020(상표명, 도호가가쿠사) 5부를 크산탄검 0.1부 및 물 56.9부에 혼합 분산시킨 후, 이러한 슬러리상 혼합물을 다이노밀(상표명, 신말엔타프라이제스사)로 습식분쇄하여 유효 성분 30%을 함유하는 유동화제를 수득한다.After mixing and dispersing 8 parts of ethylene glycol previously mixed with 30 parts of the compounds of the present invention shown in Tables 1 to 5, 5 parts of sorbol AC3020 (trade name, Tohogagaku Co.), 0.1 part of xanthan gum and 56.9 parts of water, This slurry-like mixture was wet pulverized with Dinomil (trade name, Synmal Enthaprise Co., Ltd.) to obtain a fluidizing agent containing 30% of the active ingredient.

제제예 4 과립제Formulation Example 4 Granules

표 1 내지 표 5에 기재된 본 발명의 화합물 1부, 클레이(니혼탈크사제) 43부, 벤토나이트(도요쥰요코사제) 55부 및 석시네이트계 계면활성제 에야롤 CT-1(상표명, 도호가가쿠사) 1부를 배합하고 혼합 분쇄한 후, 물 20부를 가하여 혼화시킨다. 또한, 이것을 압출 제립기를 사용하여 직경 0.6mm의 구멍으로부터 압출시키고, 60℃에서 2시간 건조시킨 후, 1 내지 2mm의 길이로 절단하여 유효 성분 1%를 함유하는 과립제를 수득한다.1 part of the compounds of the present invention shown in Tables 1 to 5, 43 parts of clay (manufactured by Nihon Talc Co., Ltd.), 55 parts of bentonite (manufactured by Toyoyo Yoko Co., Ltd.), and succinate-based surfactant eyrol CT-1 (trade name, Tohogagaku Corporation) ) 1 part is mixed, mixed and ground, and 20 parts of water is added to mix. Further, this was extruded from a hole having a diameter of 0.6 mm using an extrusion granulator, dried at 60 ° C. for 2 hours, and then cut into lengths of 1 to 2 mm to obtain granules containing 1% of the active ingredient.

다음은 본 발명의 화합물의 시험예이다.The following is a test example of the compound of the present invention.

시험예 1 담수 토양 처리 시험Test Example 1 Freshwater Soil Treatment Test

면적 200㎠의 수지로 제조된 포트에 논 충적 식양토를 충전하여 시비후, 적량의 물을 가하여 써레질을 행하고 토양 표면으로부터 0.5cm 층내에 피, 물달개비, 마디꽃 및 올챙고랭이의 각 잡초 종자를 혼입한다. 그 후 입수(入水)를 행하고 3.5cm의 담수심을 유지한다.After filling and fertilizing non-impact loam into a pot made of a resin with an area of 200 cm 2, fertilize it by adding an appropriate amount of water, and then weed seeds of blood, spruce, knotweed and tadpoles within 0.5 cm from the soil surface. Mix. After that, water is obtained and a fresh water depth of 3.5 cm is maintained.

잡초 파종 5일째에 제제예 3에 의해 수득한 본 발명의 화합물을 유효 성분으로 하는 유동화제를 물로 희석 조정하여 유효 성분의 사용량이 1아르당 10g이 되도록 소정량을 담수면에 적하 처리한다.On the 5th day of weed sowing, the fluidizing agent containing the compound of the present invention obtained in Preparation Example 3 as an active ingredient was diluted and adjusted with water, and a predetermined amount was added dropwise to the fresh water surface so that the amount of the active ingredient used was 10 g per each.

이후에 온실내에서 재배 관리를 계속하여 약제 처리 후 28일째에 제초 효과에 관해서 조사한다. 그 결과를 표 17에 기재한다(표 7의 화합물 번호는 표 1 내지 표 5에 기재된 화합물 번호에 상응한다). 또한, 제초 효과의 평가는 수학식 1에 의해 Y값을 구하고 하기의 기준에 따라 제초 효과 계수로 나타낸다.After that, the cultivation management in the greenhouse is continued and the herbicidal effect is investigated 28 days after the treatment. The results are shown in Table 17 (compound numbers in Table 7 correspond to compound numbers in Tables 1 to 5). In addition, evaluation of the herbicidal effect is obtained by calculating the Y value by the equation (1) and expressed as a herbicidal effect coefficient according to the following criteria.

시험예 2 밭 토양의 토양 처리 시험Test example 2 soil treatment test of the field soil

면적 200㎠의 수지로 배트에 밭 토양 화산재 토양을 충전하여 시비후, 이 토양 표면에 바랭이, 강아지풀, 흰명아주(일본명) 및 큰개여뀌의 각 잡초 종자를 균일하게 혼합한 토양을 투입하고 제제예 1에 의해 얻은 본 발명의 화합물을 유효 성분으로 하는 수화제를 물로 희석 조정하여 유효 성분의 사용량이 1아르당 10g이 되도록 소정량을 소형 동력 가압 분무기로 토양 표면에 균일하게 분무 처리한다.Filling the batter soil with volcanic ash in the batter with an area of 200 cm2, and fertilizing the soil, the soil surface was uniformly mixed with the weed seeds of bark, ragweed, white mallow (Japanese name) and large chickweed. The hydrous agent containing the compound of the present invention obtained in 1 as an active ingredient is diluted and adjusted with water, and a predetermined amount is uniformly sprayed onto the soil surface with a small power pressurized sprayer so that the amount of the active ingredient is 10 g per each are used.

이후에 온실 내에서 재배 관리를 계속하여 약제 처리 후 28일째에 제초 효과에 관해서 조사한다. 그 결과를 표 8에 기재한다(표 8의 화합물 번호는 표 1 내지 표 5에 기재된 화합물 번호에 상응한다)After that, the cultivation management in the greenhouse is continued to investigate the herbicidal effect on the 28th day after the treatment. The results are shown in Table 8 (compound numbers in Table 8 correspond to compound numbers in Tables 1 to 5).

또한, 제초 효과의 평가는 시험예 1의 기준과 동일하게 나타낸다.In addition, evaluation of the herbicidal effect is shown similarly to the criteria of Test Example 1.

시험예 3 밭 경엽 처리시험Test Example 3 Field foliage treatment test

면적 200㎠의 수지로 만든 배트에 밭 토양 화산재 토양을 충전하고 시비후, 서양 갓, 둥근잎나팔꽃, 개피 및 둑새풀을 파종하여 균일하게 복토를 행한다. 이후에 온실 내에서 재배 관리를 계속하고 공시 잡초의 생육엽령이 1.0 내지 2.0엽기에 달할 때, 제제예 1에 의해 얻은 본 발명의 화합물을 유효 성분으로 하는 수화제를 물로 희석 조정하여 유효 성분의 사용량이 1아르당 10g이 되도록 소정량을 소형 동력 가압 분무기로 균일하게 분무 처리한다. 약제 처리 후 21일째에 제초 효과에 관해서 조사를 행한다.A batter made of a resin having an area of 200 cm 2 is filled with a field soil volcanic ash soil, and after application, sowing a western lampshade, round leaf morning glory, open cover, and gingiva grass is uniformly covered. After that, the cultivation management in the greenhouse is continued, and when the weed growth age of the weeds reaches 1.0 to 2.0 leaves, the amount of the active ingredient is adjusted by diluting and adjusting the hydrating agent containing the compound of the present invention obtained in Formulation Example 1 as the active ingredient. A predetermined amount is uniformly sprayed with a small power pressurized spray bottle so that it is 10 g per each ar. At 21 days after drug treatment, the herbicidal effect is investigated.

그 결과를 표 9에 기재한다(표 9의 화합물 번호는 표 1 내지 표 5에 기재된 화합물 번호에 상응한다).The results are shown in Table 9 (compound numbers in Table 9 correspond to compound numbers in Tables 1 to 5).

또한, 제초 효과의 평가는 시험예 1의 기준과 동일하게 나타낸다.In addition, evaluation of the herbicidal effect is shown similarly to the criteria of Test Example 1.

본 발명의 화합물은 적은 사용량으로 높은 제초 효과를 나타내는 동시에 약해 등의 문제가 적으며 제초제로서 유용하다.The compound of the present invention exhibits high herbicidal effect with a small amount of use, has little problem such as weakness and is useful as a herbicide.

Claims (16)

화학식 I의 3-치환된 페닐-4-할로피리다진 유도체.3-substituted phenyl-4-halopyridazine derivatives of formula (I). 위의 화학식 I에서,In Formula I above, X는 할로겐 원자이고,X is a halogen atom, Y는 수소원자 또는 할로겐 원자이고,Y is a hydrogen atom or a halogen atom, Z는 할로겐 원자 또는 시아노기이고,Z is a halogen atom or a cyano group, n 및 m은 각각 독립적으로 0 또는 1이고,n and m are each independently 0 or 1, R1은 수소원자, 할로겐 원자, C1-C6의 알킬기 또는 C1-C6의 할로알킬기이고,R 1 is an alkyl group or a haloalkyl group of C 1 -C 6 a hydrogen atom, a halogen atom, a C 1 -C 6, R2는 수소원자 또는 C1-C6의 알킬기이거나, R1과 함께 -K-L-M-의 환[여기서, K는 CR4R5, CR4R5CR6R7, 산소원자, 황원자 또는 C1-C6의 알킬기로 치환된 질소원자이고, L은 CR8R9, 산소원자, 황원자 또는 C1-C6의 알킬기로 치환된 질소원자이고, M은 CR10R11, 산소원자, 황원자 또는 C1-C6의 알킬기로 치환된 질소원자이고(여기서, 치환기 R4내지 R11은 각각 독립적으로 수소원자 또는 C1-C6의 알킬기이다), 단 K, L 및 M이 동시에 산소원자, 황원자 또는 C1-C6의 알킬기로 치환된 질소원자인 것은 아니다]을 형성하고,R 2 is a hydrogen atom or an alkyl group of C 1 -C 6 , or a ring of -KLM- with R 1 , wherein K is CR 4 R 5 , CR 4 R 5 CR 6 R 7 , oxygen atom, sulfur atom or C 1 A nitrogen atom substituted with an alkyl group of -C 6 , L is CR 8 R 9 , an oxygen atom, a sulfur atom or a nitrogen atom substituted with an alkyl group of C 1 -C 6 , and M is a CR 10 R 11 , an oxygen atom, a sulfur atom or A nitrogen atom substituted with a C 1 -C 6 alkyl group (wherein the substituents R 4 to R 11 are each independently a hydrogen atom or a C 1 -C 6 alkyl group) provided that K, L and M are oxygen atoms at the same time, Not a sulfur atom or a nitrogen atom substituted with a C 1 -C 6 alkyl group; R3은 수소원자, 니트로기 또는 -QR12{여기서, Q는 산소원자, 황원자, 설피닐기, 설포닐기 또는 -NR13-(여기서, R13은 수소원자, C1-C6의 알킬기, C2-C6의 알케닐기, C2-C6의 알키닐기, C1-C6의 할로알킬기, C2-C6의 할로알케닐기, C2-C6의 알콕시알킬기, C2-C6의 아실기, C1-C6의 알킬설포닐기, C1-C6의 할로알킬설포닐기, C2-C6의 알케닐설포닐기, C2-C6의 알콕시카보닐기, 페닐기 또는 페닐기로 치환된 C1-C3의 알킬기이다)이고, R12는 수소원자, C1-C10의 알킬기, C2-C10의 알케닐기, C2-C10의 알키닐기, C3-C8의 사이클로알킬기, C4-C10의 알킬기로 치환된 사이클로알킬기, C4-C10의 (사이클로알킬)알킬기, C3-C8의 사이클로알케닐기, C1-C10의 할로알킬기, C2-C10의 할로알케닐기, C3-C8의 할로사이클로알킬기, C2-C7의 시아노알킬기, C2-C10의 알콕시알킬기, C2-C10의 알킬티오알킬기, C2-C10의 알킬설포닐알킬기, C2-C6의 아실기, C3-C6의 옥소알킬기, C1-C6의 알킬설포닐기, C1-C6의 할로알킬설포닐기, C2-C6의 알케닐설포닐기, 페닐기, 페닐기로 치환된 C1-C3의 알킬기, 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자, 황원자 및/또는 질소원자를 함유한다), 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자, 황원자 및/또는 질소원자를 함유한다)로 치환된 C1-C3의 알킬기, 화학식(II)의 기 또는 화학식(III)의 기[여기서, R14는 수소원자 또는 C1-C4의 알킬기이고, W는 산소원자, 황원자 또는 -NR16-(여기서, R16은 수소원자 또는 C1-C4의 알킬기이다)이고, R15는 수소원자, C1-C6의 알킬기, C2-C6의 알케닐기, C2-C6의 알키닐기, C3-C6의 사이클로알킬기, C4-C10의 알킬기로 치환된 사이클로알킬기, C3-C6의 사이클로알케닐기, C1-C6의 할로알킬기, C2-C6의 할로알케닐기, C3-C6의 할로사이클로알킬기, C2-C5의 시아노알킬기, C2-C6의 알콕시알킬기, C2-C6의 알킬티오알킬기, C2-C6의 알킬설포닐알킬기, C3-C6의 옥소알킬기, C3-C7의 아실옥시알킬기, C3-C7의 알콕시카보닐알킬기, 페닐기, 페닐기로 치환된 C1-C3의 알킬기, 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자, 황원자 및/또는 질소원자를 함유한다) 또는 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자, 황원자 및/또는 질소원자를 함유한다)로 치환된 C1-C3의 알킬기이고, 또한 R15는, W가 -NR16-을 나타내는 경우, W와 함께 1 또는 2개의 질소원자 및/또는 0 또는 1개의 산소원자를 함유하는 5원 또는 6원의 복소환기를 형성할 수 있다]이고, R12, R13또는 R15가 페닐기, 페닐기로 치환된 C1-C3의 알킬기, 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자, 황원자 및/또는 질소원자를 함유한다) 또는 3원 내지 6원 환의 복소환기(당해 환은 1 또는 2개의 산소원자, 황원자 및/또는 질소원자를 함유한다)로 치환된 C1-C3의 알킬기인 경우, 당해 페닐기 및 복소환기는 1 내지 3개의 동일하거나 상이한 할로겐 원자, C1-C4의 알킬기, 트리플루오로메틸기, C1-C4의 알콕시기, C2-C5의 아실옥시기, C1-C4의 알킬티오기, C1-C4의 알킬설포닐기, 니트로기, 시아노기 또는 C2-C5의 알콕시카보닐기로 치환될 수 있다}이다.R 3 is a hydrogen atom, a nitro group or -QR 12 {where Q is an oxygen atom, a sulfur atom, a sulfinyl group, a sulfonyl group or -NR 13- (wherein R 13 is a hydrogen atom, an alkyl group of C 1 -C 6 , C 2 -C 6 alkenyl group, a halo-alkenyl group, an alkoxyalkyl group of C 2 -C 6 C 2 -C 6 alkynyl group, C 1 -C 6 haloalkyl group, C 2 -C 6 of, C 2 -C 6 of an acyl group, a alkoxycarbonyl group, phenyl group or phenyl C 1 -C 6 alkylsulfonyl group, a halo-C 1 -C 6 alkylsulfonyl group, C 2 -C 6 alkenyl sulfonyl group, C 2 -C 6 of the alkyl group substituted by a C 1 -C 3), and, R 12 is an alkynyl group of a hydrogen atom, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 of, C 3 -C 8 a cycloalkyl group, a cycloalkyl group of C 4, C 4 -C 10 a (cycloalkyl) alkyl group, a cyclo alkenyl group of C 3 -C 8, C 1 -C 10 alkyl group substituted with -C 10 haloalkyl group, C 2 -C 10 haloalkenyl group, C 3 -C 8 halocycloalkyl group, C 2 -C 7 cyano Alkyl group, C 2 -C 10 alkoxyalkyl group, C 2 -C 10 alkylthioalkyl group, C 2 -C 10 alkylsulfonylalkyl group, C 2 -C 6 acyl group, C 3 -C 6 oxoalkyl group, C 1 -C 6 alkylsulfonyl group, C 1 -C 6 haloalkylsulfonyl group, C 2 -C 6 alkenylsulfonyl group, phenyl group, C 1 -C 3 alkyl group substituted with phenyl group, 3- to 6 Heterocyclic groups of a member (wherein the ring contains one or two oxygen atoms, sulfur atoms and / or nitrogen atoms), three to six membered heterocyclic groups (wherein the rings contain one or two oxygen atoms, sulfur atoms and / or nitrogen atoms) C 1 -C 3 alkyl group substituted with Group or formula of (II) Group of (III), wherein R 14 is a hydrogen atom or an alkyl group of C 1 -C 4 , W is an oxygen atom, a sulfur atom or -NR 16- , wherein R 16 is a hydrogen atom or an alkyl group of C 1 -C 4 a), and, R 15 is a hydrogen atom, an alkynyl group, a cycloalkyl group of C 3 -C 6 of the C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 of, C 4 -C 10 A cycloalkyl group substituted with an alkyl group of C, a cycloalkenyl group of C 3 -C 6 , a haloalkyl group of C 1 -C 6 , a haloalkenyl group of C 2 -C 6 , a halocycloalkyl group of C 3 -C 6 , C 2- C 5 cyanoalkyl group, C 2 -C 6 alkoxyalkyl group, C 2 -C 6 alkylthioalkyl group, C 2 -C 6 alkylsulfonylalkyl group, C 3 -C 6 oxoalkyl group, C 3 -C 7 acyloxyalkyl group, C 3 -C 7 alkoxycarbonylalkyl group, phenyl group, C 1 -C 3 alkyl group substituted with phenyl group, 3- to 6-membered heterocyclic group (the ring is 1 or 2 oxygen atoms, sulfur atom And / or contains nitrogen atoms) or from 3 to An alkyl group of C 1 -C 3 substituted with a six-membered heterocyclic group (wherein the ring contains one or two oxygen atoms, sulfur atoms and / or nitrogen atoms), and R 15 represents that W represents -NR 16- Can form a 5 or 6 membered heterocyclic group containing 1 or 2 nitrogen atoms and / or 0 or 1 oxygen atom together with W], and R 12 , R 13 or R 15 is a phenyl group, A C 1 -C 3 alkyl group substituted with a phenyl group, a 3- to 6-membered heterocyclic group (the ring contains one or two oxygen atoms, sulfur and / or nitrogen atoms) or a 3- to 6-membered heterocyclic group ( When the ring is a C 1 -C 3 alkyl group substituted with 1 or 2 oxygen atoms, sulfur atoms and / or nitrogen atoms), the phenyl group and heterocyclic group are 1 to 3 identical or different halogen atoms, C 1 -C group with an alkyl group, a trifluoromethyl 4, an alkoxy group, an acyloxy group of C 2 -C 5 in the C 1 -C 4, C 1 -C 4 Alkylthio group, the alkoxycarbonyl may be substituted}, of C 1 -C 4 alkylsulfonyl group, a nitro group, a cyano group or a C 2 -C 5. 제1항에 있어서, R1이 수소원자, C1-C6의 알킬기 또는 C1-C6의 할로알킬기이고, R2가 수소원자, C1-C6의 알킬기, 또는 R1과 함께 -K-L-M-의 환[여기서, K는 CR4R5, CR4R5CR6R7, 산소원자, 황원자 또는 C1-C6의 알킬기로 치환된 질소원자이고, L은 CR8R9, 산소원자, 황원자 또는 C1-C6의 알킬기로 치환된 질소원자이고, M은 CR10R11, 산소원자, 황원자 또는 C1-C6의 알킬기로 치환된 질소원자이고(여기서, 치환기 R4내지 R11은 각각 독립적으로 수소원자 또는 C1-C6의 알킬기이다), 단 K, L 및 M이 동시에 산소원자, 황원자 또는 C1-C6의 알킬기로 치환된 질소원자인 것은 아니다]을 형성함을 특징으로 하는 화학식 I의 3-치환된 페닐-4-할로피리다진 유도체.The method of claim 1, wherein, R 1 is a haloalkyl group of a hydrogen atom, a C 1 -C 6 alkyl group or a C 1 -C 6, R 2 is with a hydrogen atom, an alkyl group, or R 1 a C 1 -C 6 - Ring of KLM-, wherein K is CR 4 R 5 , CR 4 R 5 CR 6 R 7 , an oxygen atom, a sulfur atom or a nitrogen atom substituted with an alkyl group of C 1 -C 6 , and L is CR 8 R 9 , oxygen Is a nitrogen atom substituted with an atom, a sulfur atom or an alkyl group of C 1 -C 6 , and M is a CR atom substituted with CR 10 R 11 , an oxygen atom, a sulfur atom or an alkyl group of C 1 -C 6 (wherein the substituents R 4 to R 11 are each independently a hydrogen atom or an alkyl group of C 1 -C 6 ), provided that K, L and M are not oxygen atoms, sulfur atoms or nitrogen atoms substituted with C 1 -C 6 alkyl groups at the same time. 3-Substituted Phenyl-4-halopyridazine Derivatives of Formula (I). 제1항에 있어서, R2가 R1과 함께 -K-L-M-의 환[여기서, K는 CR4R5, CR4R5CR6R7또는 산소원자이고, L은 CR8R9또는 산소원자이고, M은 CR10R11또는 산소원자이고(여기서, 치환기 R4내지 R11은 각각 독립적으로 수소원자 또는 C1-C6의 알킬기이다), 단 K, L 및 M이 동시에 산소원자인 것은 아니다]을 형성함을 특징으로 하는 화학식 I의 3-치환된 페닐-4-할로피리다진 유도체.The compound of claim 1, wherein R 2 is a ring of —KLM— with R 1 , wherein K is CR 4 R 5 , CR 4 R 5 CR 6 R 7 or an oxygen atom, and L is CR 8 R 9 or an oxygen atom. And M is CR 10 R 11 or an oxygen atom (wherein the substituents R 4 to R 11 are each independently a hydrogen atom or an alkyl group of C 1 -C 6 ), provided that K, L and M are oxygen atoms at the same time 3-substituted phenyl-4-halopyridazine derivative of formula (I). 제1항에 있어서, R2가 R1과 함께 -K-L-M-의 탄소 환[여기서, K는 CR4R5또는 CR4R5CR6R7이고, L은 CR8R9이고, M은 CR10R11이다(여기서, 치환기 R4내지 R11은 각각 독립적으로 수소원자 또는 C1-C6의 알킬기이다)]을 형성함을 특징으로 하는 화학식 I의 3-치환된 페닐-4-할로피리다진 유도체.2. The carbon ring of claim 1, wherein R 2 together with R 1 is a carbon ring of —KLM—, wherein K is CR 4 R 5 or CR 4 R 5 CR 6 R 7 , L is CR 8 R 9 , and M is CR 10 R 11 , wherein the substituents R 4 to R 11 are each independently a hydrogen atom or an alkyl group of C 1 -C 6 . Chopped derivatives. 제1항에 있어서, R3이 수소원자, 니트로기 또는 -QR12{여기서, Q는 산소원자 또는 -NR13-(여기서, R13은 수소원자, C2-C6의 아실기, C1-C6의 알킬설포닐기 또는 C2-C6의 알콕시카보닐기이다)이고, R12는 수소원자, C1-C10의 알킬기, C2-C10의 알케닐기, C2-C10의 알키닐기, C3-C8의 사이클로알킬기, C3-C8의 사이클로알케닐기, C1-C10의 할로알킬기, C2-C10의 할로알케닐기, C2-C10의 할로사이클로알킬기, C2-C7의 시아노알킬기, C2-C10의 알콕시알킬기, C3-C6의 옥소알킬기, C1-C6의 알킬설포닐기, 페닐기로 치환된 C1-C3의 알킬기, 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자를 함유한다), 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자를 함유한다)로 치환된 C1-C3의 알킬기, 화학식(II)의 기 또는 화학식(III)의 기[여기서, R14는 수소원자 또는 C1-C4의 알킬기이고, W는 산소원자 또는 -NR16-(여기서, R16은 수소원자 또는 C1-C4의 알킬기이다)이고, R15는 수소원자 또는 C1-C6의 알킬기이다]이다}임을 특징으로 하는 화학식 I의 3-치환된 페닐-4-할로피리다진 유도체.The compound of claim 1, wherein R 3 is a hydrogen atom, a nitro group or —QR 12 {wherein Q is an oxygen atom or —NR 13 —, where R 13 is a hydrogen atom, an acyl group of C 2 -C 6 , C 1 alkylsulfonyl group, or a -C alkoxycarbonyl group of C 2 -C 6 of 6), and, R 12 is a hydrogen atom, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 of the Alkynyl group, C 3 -C 8 cycloalkyl group, C 3 -C 8 cycloalkenyl group, C 1 -C 10 haloalkyl group, C 2 -C 10 haloalkenyl group, C 2 -C 10 halocycloalkyl group , C 2 -C 7 cyanoalkyl group, C 2 -C 10 alkoxyalkyl group, C 3 -C 6 oxoalkyl group, C 1 -C 6 alkylsulfonyl group, C 1 -C 3 alkyl group substituted with phenyl group , C 1 -substituted with 3 to 6 membered heterocyclic groups (wherein the ring contains 1 or 2 oxygen atoms), with 3 to 6 membered heterocyclic groups (the ring contains 1 or 2 oxygen atoms) Alkyl group of C 3 Group or formula of (II) Group of (III) wherein R 14 is a hydrogen atom or an alkyl group of C 1 -C 4 , W is an oxygen atom or -NR 16- (wherein R 16 is a hydrogen atom or an alkyl group of C 1 -C 4 ) Wherein R 15 is a hydrogen atom or an alkyl group of C 1 -C 6 ]. 3 -substituted phenyl-4-halopyridazine derivatives of formula (I). 제1항에 있어서, R3가 수소원자, 니트로기 또는 -QR12{여기서, Q는 산소원자 또는 -NR13-(여기서, R13은 수소원자, C1-C6의 알킬설포닐기 또는 C2-C6의 알콕시카보닐기이다)이고, R12는 수소원자, C1-C10의 알킬기, C2-C10의 알케닐기, C2-C10의 알키닐기, C3-C8의 사이클로알킬기, C1-C10의 할로알킬기, C2-C10의 할로알케닐기, C2-C7의 시아노알킬기, C2-C10의 알콕시알킬기, C3-C6의 옥소알킬기, C1-C6의 알킬설포닐기, 페닐기로 치환된 C1-C3의 알킬기, 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자를 함유한다), 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자를 함유한다)로 치환된 C1-C3의 알킬기, 화학식(II)의 기 또는 화학식(III)의 기[여기서, R14는 수소원자 또는 C1-C4의 알킬기이고, W는 산소원자 또는 -NR16-(단, R16은 수소원자 또는 C1-C4의 알킬기이다)이고, R15는 수소원자 또는 C1-C6의 알킬기이다]이다}임을 특징으로 하는 화학식 I의 3-치환된 페닐-4-할로피리다진 유도체.The compound of claim 1, wherein R 3 is a hydrogen atom, a nitro group or —QR 12 {wherein Q is an oxygen atom or —NR 13 —, where R 13 is a hydrogen atom, an alkylsulfonyl group of C 1 -C 6 or C 2 -C 6 alkoxycarbonyl group), R 12 is a hydrogen atom, C 1 -C 10 alkyl group, C 2 -C 10 alkenyl group, C 2 -C 10 alkynyl group, C 3 -C 8 Cycloalkyl group, C 1 -C 10 haloalkyl group, C 2 -C 10 haloalkenyl group, C 2 -C 7 cyanoalkyl group, C 2 -C 10 alkoxyalkyl group, C 3 -C 6 oxoalkyl group, C 1 -C 6 alkylsulfonyl group, C 1 -C 3 alkyl group substituted with a phenyl group, 3- to 6-membered heterocyclic group (the ring contains 1 or 2 oxygen atoms), 3- to 6-membered An alkyl group of C 1 -C 3 substituted with a heterocyclic group, wherein the ring contains one or two oxygen atoms, Group or formula of (II) Group of (III), wherein R 14 is a hydrogen atom or an alkyl group of C 1 -C 4 , W is an oxygen atom or -NR 16- (where R 16 is a hydrogen atom or an alkyl group of C 1 -C 4 ) Wherein R 15 is a hydrogen atom or an alkyl group of C 1 -C 6 ]. 3 -substituted phenyl-4-halopyridazine derivatives of formula (I). 제1항에 있어서, R3이 -QR12[여기서, Q는 산소원자이고, R12는 C1-C10의 알킬기, C2-C10의 알케닐기, C2-C10의 알키닐기, C3-C8의 사이클로알킬기, C1-C10의 할로알킬기, C2-C10의 할로알케닐기, C2-C7의 시아노알킬기, C2-C10의 알콕시알킬기, C3-C6의 옥소알킬기, 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자를 함유한다), 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자를 함유한다)로 치환된 C1-C3의 알킬기 또는 화학식(II)의 기이다]임을 특징으로 하는 화학식 I의 3-치환된 페닐-4-할로피리다진 유도체.The method of claim 1, wherein, R 3 is -QR 12 [wherein, Q is an oxygen atom, R 12 is an alkynyl group of the alkenyl group, C 2 -C 10 in C 1 -C 10 alkyl, C 2 -C 10 a, C 3 -C 8 cycloalkyl group, C 1 -C 10 haloalkyl group, C 2 -C 10 haloalkenyl group, C 2 -C 7 cyanoalkyl group, C 2 -C 10 alkoxyalkyl group, C 3- A C 6 oxoalkyl group, a 3-6 membered heterocyclic group (the ring contains one or two oxygen atoms), a 3-6 membered heterocyclic group (the ring contains one or two oxygen atoms) Substituted C 1 -C 3 alkyl group or formula 3-substituted phenyl-4-halopyridazine derivative of formula (I). 제1항에 있어서, R2가 R1과 함께 -K-L-M-의 탄소 환[여기서, K는 CR4R5또는 CR4R5CR6R7이고, L은 CR8R9이고, M은 CR10R11이다(여기서, 치환기 R4내지 R11은 각각 독립적으로 수소원자 또는 C1-C6의 알킬기이다)]을 형성하고,2. The carbon ring of claim 1, wherein R 2 together with R 1 is a carbon ring of —KLM—, wherein K is CR 4 R 5 or CR 4 R 5 CR 6 R 7 , L is CR 8 R 9 , and M is CR 10 R 11 , wherein the substituents R 4 to R 11 are each independently a hydrogen atom or an alkyl group of C 1 -C 6 . R3이 수소원자, 니트로기 또는 -QR12{여기서, Q는 산소원자 또는 -NR13-(여기서, R13은 수소원자, C1-C6의 알킬설포닐기 또는 C2-C6의 알콕시카보닐기이다)이고, R12는 수소원자, C1-C10의 알킬기, C2-C10의 알케닐기, C2-C10의 알키닐기, C3-C8의 사이클로알킬기, C1-C10의 할로알킬기, C2-C10의 할로알케닐기, C2-C7의 시아노알킬기, C2-C10의 알콕시알킬기, C3-C6의 옥소알킬기, C1-C6의 알킬설포닐기, 페닐기로 치환된 C1-C3의 알킬기, 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자를 함유한다), 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자를 함유한다)로 치환된 C1-C3의 알킬기, 화학식(II)의 기 또는 화학식(III)의 기[여기서, R14는 수소원자 또는 C1-C4의 알킬기이고, W는 산소원자 또는 -NR16-(여기서, R16은 수소원자 또는 C1-C4의 알킬기이다)이고, R15는 수소원자 또는 C1-C6의 알킬기이다]이다}임을 특징으로 하는 화학식 I의 3-치환된 페닐-4-할로피리다진 유도체.R 3 is a hydrogen atom, a nitro group or -QR 12 {wherein Q is an oxygen atom or -NR 13- (wherein R 13 is a hydrogen atom, an alkylsulfonyl group of C 1 -C 6 or an alkoxy of C 2 -C 6 a carbonyl group), and, R 12 is a hydrogen atom, an alkynyl group, a cycloalkyl group of C 3 -C 8 of the C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 of, C 1 - Haloalkyl group of C 10 , haloalkenyl group of C 2 -C 10 , cyanoalkyl group of C 2 -C 7 , alkoxyalkyl group of C 2 -C 10 , oxoalkyl group of C 3 -C 6 , C 1 -C 6 Alkylsulfonyl group, C 1 -C 3 alkyl group substituted with phenyl group, 3- to 6-membered heterocyclic group (the ring contains 1 or 2 oxygen atoms), 3- to 6-membered heterocyclic group (wherein the ring is 1 Or a C 1 -C 3 alkyl group substituted with one of two oxygen atoms, Group or formula of (II) Group of (III) wherein R 14 is a hydrogen atom or an alkyl group of C 1 -C 4 , W is an oxygen atom or -NR 16- (wherein R 16 is a hydrogen atom or an alkyl group of C 1 -C 4 ) Wherein R 15 is a hydrogen atom or an alkyl group of C 1 -C 6 ]. 3 -substituted phenyl-4-halopyridazine derivatives of formula (I). 제1항에 있어서, R2가 R1과 함께 -K-L-M-의 환[여기서, K는 CR4R5또는 CR4R5CR6R7이고, L은 CR8R9이고, M은 CR10R11이다(여기서, 치환기 R4내지 R11은 각각 독립적으로 수소원자 또는 C1-C6의 알킬기이다)]을 형성하고, R3이 -QR12[여기서, Q는 산소원자이고, R12는 C1-C10의 알킬기, C2-C10의 알케닐기, C2-C10의 알키닐기, C3-C8의 사이클로알킬기, C1-C10의 할로알킬기, C2-C10의 할로알케닐기, C2-C7의 시아노알킬기, C2-C10의 알콕시알킬기, C3-C6의 옥소알킬기, 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자를 함유한다), 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자를 함유한다)로 치환된 C1-C3의 알킬기 또는 화학식(II)의 기이다]임을 특징으로 하는 화학식 I의 3-치환된 페닐-4-할로피리다진 유도체.The compound of claim 1, wherein R 2 is a ring of —KLM— with R 1 , wherein K is CR 4 R 5 or CR 4 R 5 CR 6 R 7 , L is CR 8 R 9 , and M is CR 10. R 11 (wherein the substituents R 4 to R 11 are each independently a hydrogen atom or an alkyl group of C 1 -C 6 ), and R 3 is —QR 12 , wherein Q is an oxygen atom, and R 12 is an alkyl group of C 1 -C 10, C 2 -C 10 alkenyl group, an alkynyl group, a haloalkyl group of C 3 -C 8 cycloalkyl group, C 1 -C 10 of the C 2 -C 10, C 2 -C 10 Haloalkenyl group, C 2 -C 7 cyanoalkyl group, C 2 -C 10 alkoxyalkyl group, C 3 -C 6 oxoalkyl group, 3- to 6-membered heterocyclic group (the ring being 1 or 2 oxygen atoms Or a C 1 -C 3 alkyl group substituted with a 3- to 6-membered heterocyclic group (wherein the ring contains 1 or 2 oxygen atoms) 3-substituted phenyl-4-halopyridazine derivative of formula (I). 제1항 내지 제9항 중의 어느 한 항에 있어서, Y가 할로겐 원자임을 특징으로 하는 화학식 I의 3-치환된 페닐-4-할로피리다진 유도체.10. The 3-substituted phenyl-4-halopyridazine derivative of formula I according to any one of claims 1 to 9, wherein Y is a halogen atom. 화학식 V의 3-치환된 페닐-4-하이드록시피리다진 유도체 또는 화학식 V'의 3-치환된 페닐피리다진-4-온 유도체.3-substituted phenyl-4-hydroxypyridazine derivatives of formula V or 3-substituted phenylpyridazin-4-one derivatives of formula V '. 화학식 VFormula V 화학식 V'Formula V ' 위의 화학식 V와 V'에서,In the above formulas V and V ', Y, Z, R1, R2및 R3은 제1항에서 정의한 바와 같다.Y, Z, R 1 , R 2 and R 3 are as defined in claim 1. 화학식 VI의 3-치환된 페닐-4-하이드록시피리다진 유도체 또는 화학식 VI'의 3-치환된 페닐피리다진-4-온 유도체.3-substituted phenyl-4-hydroxypyridazine derivatives of formula VI or 3-substituted phenylpyridazin-4-one derivatives of formula VI '. 화학식 VIFormula VI 화학식 VI'Formula VI ' 위의 화학식 VI와 VI'에서,In the above formulas VI and VI ', k는 1 내지 2이고,k is 1 to 2, R3은 수소원자, 니트로기 또는 -QR12[여기서, Q는 산소원자 또는 -NR13-(여기서, R13은 수소원자, C1-C6의 알킬설포닐기 또는 C2-C6의 알콕시카보닐기이다)이고, R12는 수소원자, C1-C10의 알킬기, C2-C10의 알케닐기, C2-C10의 알키닐기, C3-C8의 사이클로알킬기, C1-C10의 할로알킬기, C2-C10의 할로알케닐기, C2-C7의 시아노알킬기, C2-C10의 알콕시알킬기, C3-C6의 옥소알킬기, C1-C6의 알킬설포닐기, 페닐기로 치환된 C1-C3의 알킬기, 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자를 함유한다) 또는 3원 내지 6원의 복소환기(당해 환은 1 또는 2개의 산소원자를 함유한다)로 치환된 C1-C3의 알킬기이다]이다.R 3 is a hydrogen atom, a nitro group or -QR 12 where Q is an oxygen atom or -NR 13- (wherein R 13 is a hydrogen atom, an alkylsulfonyl group of C 1 -C 6 or alkoxy of C 2 -C 6 a carbonyl group), and, R 12 is a hydrogen atom, an alkynyl group, a cycloalkyl group of C 3 -C 8 of the C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 of, C 1 - Haloalkyl group of C 10 , haloalkenyl group of C 2 -C 10 , cyanoalkyl group of C 2 -C 7 , alkoxyalkyl group of C 2 -C 10 , oxoalkyl group of C 3 -C 6 , C 1 -C 6 An alkylsulfonyl group, a C 1 -C 3 alkyl group substituted with a phenyl group, a 3- to 6-membered heterocyclic group (wherein the ring contains 1 or 2 oxygen atoms) or a 3-6 membered heterocyclic group (wherein the ring is 1 Or a C 1 -C 3 alkyl group substituted with two oxygen atoms. 제11항 또는 제12항에 있어서, Y가 할로겐 원자임을 특징으로 하는 3-치환된 페닐-4-하이드록시피리다진 유도체 또는 3-치환된 페닐피리다진-4-온 유도체.13. The 3-substituted phenyl-4-hydroxypyridazine derivative or the 3-substituted phenylpyridazin-4-one derivative according to claim 11 or 12, wherein Y is a halogen atom. 제1항 내지 제10항 중의 어느 한 항에 따르는 3-치환된 페닐-4-할로피리다진 유도체를 유효 성분으로 하는 농약.A pesticide comprising the 3-substituted phenyl-4-halopyridazine derivative according to any one of claims 1 to 10 as an active ingredient. 제14항에 있어서, 제초제임을 특징으로 하는 농약.15. The pesticide of claim 14, which is a herbicide. 제14항에 있어서, 수도용(水稻用) 제초제임을 특징으로 하는 농약.The pesticide of Claim 14 which is a herbicide for water use.
KR1019997012591A 1997-07-01 1998-06-30 3-(Substituted phenyl)-4-halopyridazine derivatives, pesticides containing the same as the active ingredient, and intermediates thereof KR20010014410A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17558997 1997-07-01
JP97-175589 1997-07-01

Publications (1)

Publication Number Publication Date
KR20010014410A true KR20010014410A (en) 2001-02-26

Family

ID=15998732

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019997012591A KR20010014410A (en) 1997-07-01 1998-06-30 3-(Substituted phenyl)-4-halopyridazine derivatives, pesticides containing the same as the active ingredient, and intermediates thereof

Country Status (3)

Country Link
KR (1) KR20010014410A (en)
AU (1) AU7935798A (en)
WO (1) WO1999001436A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL139463A0 (en) * 1998-05-20 2001-11-25 Basf Ag Substituted 6-aryl-3-thioxo-5-(thi) oxo 2,3,4,5-tetrahydro-1,2,4-triazines
CN107074779B (en) * 2014-10-03 2020-05-01 住友化学株式会社 Pyridazine compounds
CN111820224B (en) * 2019-04-22 2022-04-05 江苏清原农冠杂草防治有限公司 Herbicidal composition containing trifluoromethyl pyridazinol compound and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56113767A (en) * 1980-02-14 1981-09-07 Mitsui Toatsu Chem Inc Phenylpyridazine derivative, its salt, and agricultural and gardening fungicide
AT397598B (en) * 1990-04-05 1994-05-25 Agrolinz Agrarchemikalien HERBICIDAL AGENT
DE4013734A1 (en) * 1990-04-28 1991-10-31 Agrolinz Agrarchemikalien Muen Herbicidal compsns. contg. 3-phenyl-pyridazine derivs. - active against mono- and dicotyledonous weeds in e.g. cereal, onion, tomato or peanut crops
AT397085B (en) * 1992-02-17 1994-01-25 Agrolinz Agrarchemikalien HERBICIDES N-CYANOPYRIDAZINONE

Also Published As

Publication number Publication date
WO1999001436A1 (en) 1999-01-14
AU7935798A (en) 1999-01-25

Similar Documents

Publication Publication Date Title
CA2382435C (en) Novel herbicidally active phenyl-substituted heterocycles
EP0203428A1 (en) Herbicidal 4-benzoyl-1-alkyl(alkenyl)-pyrazoles
SK439090A3 (en) Isoxazoles herbicides, process for their preparation, intermediates for their preparation, herbicidal composition them containing, and their use
CA2500207A1 (en) Novel herbicide, method of using the same, novel substituted thienopyrimidine derivative and intermediate thereof, and process for producing the same
JP2005531549A (en) Substituted pyrazolo-pyrimidin-4-ones
PL137719B1 (en) Herbicide
JPH03120265A (en) 5h-furan-2-one derivative
CS207657B2 (en) Herbicide means and method of making the active substances
JPH09188676A (en) New uracil derivative and herbicide containing the same as active ingredient
KR20010014410A (en) 3-(Substituted phenyl)-4-halopyridazine derivatives, pesticides containing the same as the active ingredient, and intermediates thereof
EP0398258A1 (en) Indan-1,3-dione derivative and herbicidal composition containing the same as active ingredient
WO2000029387A1 (en) 2-anilino-4(3h)-pyrimidinone derivatives, intermediates in the production thereof, process for producing the same and pesticides containing the same as the active ingredient
CH657360A5 (en) N-PHENYLPYRAZOLE DERIVATIVES FOR USE IN HERBICIDE COMPOSITIONS AND PROCESS FOR THEIR PREPARATION.
EP0548593B1 (en) Tetrahydrofuran derivative and herbicide containing the same as effective ingredient
JPH1192456A (en) New 3-substituted phenyl-4-halopyridazine derivative and agrochemical containing the same as active ingredient and its intermediate
JP2666380B2 (en) Condensed heterocyclic derivative, production method and herbicide
JPH11180964A (en) 1,2,4-triazine-3,5-dione and herbicide containing the same as active ingredient
JPH1053508A (en) 1,2,4-triazine compound and herbicide comprising the same as active ingredient
US6365753B1 (en) Phthalimides and herbicide containing the same as active component
AU2012331286A1 (en) Substituted 4-cyano-3-phenyl-4-(pyridin-3-yl)butanoates, processes for preparation thereof and use thereof as herbicides and plant growth regulators
JP2001106675A (en) 4-substituted phenyl-5-halopyrimidine derivative and herbicide using the same as effective ingredient
WO2012010575A1 (en) (4-halogenalkyl-3-thiobenzoyl)cyclohexanediones and use thereof as herbicides
JPH08504414A (en) Benzoylcyclohexenones, a process for their preparation and their use as herbicides and plant growth regulators
JP4565286B2 (en) 6-haloalkyl-3- (substituted amino) -1,2,4-triazin-5-one derivatives, agricultural chemicals containing this as an active ingredient, and production intermediates thereof
JP2003212859A (en) Substituted phenylheterocycles and herbicide containing the same as active ingredient

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid